cephalosporin c has been researched along with cefotaxime in 1177 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 482 (40.95) | 18.7374 |
1990's | 453 (38.49) | 18.2507 |
2000's | 176 (14.95) | 29.6817 |
2010's | 47 (3.99) | 24.3611 |
2020's | 19 (1.61) | 2.80 |
Authors | Studies |
---|---|
Girlich, D; Leclercq, R; Naas, T; Nordmann, P | 1 |
Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
Belve, V; Shah, PM | 1 |
Johnson, DM; Jones, RN | 2 |
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 2 |
Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M | 1 |
Campillo, F; Rubio, JM | 1 |
Hannecart-Pokorni, E; Nulens, E; Nyssen, HJ; Vanhoof, R | 1 |
Hohl, P; von Graevenitz, A; Zollinger-Iten, J | 1 |
Palillo, ES; Salleh, MA | 1 |
Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
Ben Yaghlane-Bouslama, H; Boujnah, A; Kallel, H; Labia, R; Petit, A; Sirot, J; Sofer, L | 1 |
Bombeck, CT; Dougherty, SH; Flint, LM; Grant, MD; Jonasson, O; Jones, RC; Soroff, HS; Stellato, TA; Wilson, SE | 1 |
Crenier, L; Gratia, JP | 1 |
Arguedas, AG; Stutman, HR | 1 |
D'Amico, G; Maccarrone, G; Nicoletti, G; Pellegrino, MB; Privitera, A; Privitera, O; Russo, G; Stefani, S | 1 |
Bertasso, A; Georgopapadakou, NH; Pace, J | 1 |
Bauernfeind, A; Eberlein, E; Jungwirth, R; Schweighart, S | 1 |
Iseki, K; Miyazaki, K; Sugawara, M | 1 |
Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Uchino, J | 1 |
Doyle, WJ; Pinero, BP; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
García García, MI; García Sánchez, JE; García-Rodríguez, JA; Muñoz Bellido, JL | 1 |
Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
Chaine, G; Mezzanotte, F; Oliary, J; Petitjean, O; Tod, B; Tod, M | 1 |
Grimm, H | 1 |
Neu, HC | 3 |
Jacobs, RF | 1 |
Hanberger, H; Maller, R; Nilsson, LE; Nilsson, M | 1 |
Broketa, G; Mazuran, R; Schrinner, E; Tomasić, J | 1 |
Brumfitt, W; Hamilton-Miller, JM | 1 |
Crane, VS; Holbein, ME | 1 |
Flanagan, C; Nash, DR; Steele, LC; Wallace, RJ | 1 |
Albrecht, HA; Beskid, G; Christenson, JG; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Rossman, PL; Wei, CC | 1 |
Nichols, RL; Smith, JW | 1 |
Aronsson, B; Eriksson, S | 1 |
Kim, H; Kim, WJ; Ko, KY; Oh, J | 1 |
Inoue, M; Maejima, T; Mitsuhashi, S | 1 |
Kees, F; Naber, KG | 1 |
Bauernfeind, A; Jungwirth, R; Schweighart, S; Theopold, M | 1 |
Ansorg, R; Primavesi, CA; von Recklinghausen, G | 1 |
el Benna, J; Labro, MT | 1 |
Acevedo, A; Schoop, W | 1 |
Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J | 1 |
Kaplan, SL | 1 |
Amyes, SG; Marriott, MS; Payne, DJ | 1 |
Meyran, M; Thabaut, A | 1 |
Gudipati, S; Midkiff, BR; Westblom, TU | 1 |
Cojocel, C | 1 |
Hiraoka, M; Inoue, M; Matsui, H; Mitsuhashi, S | 1 |
Fukasawa, M; Mutoh, M; Nagata, H; Nouda, H; Okuda, T; Ueda, S; Yamada, H | 1 |
Bies, M; Kessler, RE; Leitner, F; Tsai, YH | 1 |
Isert, D; Klesel, N; Limbert, M; Markus, A; Schrinner, E; Seibert, G | 1 |
DeOrio, FJ; Dougherty, TJ; Fung-Tomc, J; Kessler, RE; Simich-Jacobson, V | 1 |
Albayrak, D; Taşdemir, HA | 1 |
Roche, G | 1 |
Couraud, L; Grellet, J; Roche, G; Saux, MC | 1 |
Bingen, E; Lambert-Zechovsky, N | 1 |
Adam, D; Naber, K; Schäfer, H | 1 |
Chaffin, DO; Henritzy, LL; Lent, K; Mendelman, PM; Smith, AL; Stull, TL; Wiley, EA | 1 |
Hiraoka, M; Mitsuhashi, S; Satake, S | 1 |
Hirano, M; Hiraoka, M; Inoue, M; Masuyoshi, S; Mitsuhashi, S; Tomatsu, K | 1 |
Fuchs, PC; Jones, RN | 1 |
Ben-Yaghlane, H; Bricout, F; Deny, P; Garbarg-Chenon, A; Godard, V; Labia, R; Nicolas, JC; Vu Thien, H | 1 |
Beale, AS; Gisby, J | 1 |
Bertasso, A; Chan, KK; Chapman, JS; Cleeland, R; Cummings, LM; Dix, BA; Georgopapadakou, NH; Keith, DD | 1 |
Berger, SA; Dan, M; Gorea, A; Krispin, M; Levenberg, A; Serour, F | 1 |
Klug, PW; Leitner, G; Mayer, HG | 1 |
Inoue, E; Mitsuhashi, S | 1 |
Akbary, MA; Chen, JS; Hou, MF; Ker, CG; Lee, KT; Sheen, PC | 1 |
Balsamo, A; Broccali, G; Lapucci, A; Macchia, B; Macchia, F; Orlandini, E; Rossello, A | 1 |
Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
Matsumoto, K; Morito, T; Oishi, K; Yamamoto, M; Yoshida, T | 1 |
Hanano, M; Iga, T; Nohjoh, T; Sawada, Y; Sugiyama, Y; Suzuki, H | 1 |
Beskid, G; Chan, K; Cleeland, R; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, DH; Unowsky, J | 1 |
Andreoni, G; Arione, R; Bendiscioli, L; Bramato, C; Cimino, T; Daghero, O; Salassa, B; Soranzo, ML; Spezia, C | 1 |
Ansquer, M; Brun-Buisson, C; Duval, J; Legrand, P; Montravers, F; Philippon, A | 1 |
Bartmann, K; Tarbuc, R | 1 |
Houben, AW; Stobberingh, EE | 1 |
Konishi, H | 1 |
Chanal, CM; Cluzel, RA; Labia, R; Morand, A; Petit, A; Sirot, DL; Sirot, JL | 1 |
Noel, GJ; Teele, DW | 1 |
Hino, J; Kawane, H; Kawanishi, M; Matsushima, T; Nakagawa, Y; Niki, Y; Soejima, R; Sumi, M; Umeki, S; Watanabe, M | 2 |
Neiderriter, K; Norden, CW | 1 |
Hazumi, N; Matsuda, K; Nakagawa, S; Sanada, M; Tanaka, N | 1 |
Li, JT; Yan, SY | 1 |
Katsu, K; Kitoh, K; Moriyama, M; Watanabe, N | 1 |
Fontana, R; Pelosi, E | 1 |
Clavijo, E; García Luque, IG; Nogales, MC; Perea, EJ | 1 |
Fung-Tomc, J; Huczko, E; Kessler, RE; Pearce, M | 1 |
Barry, AL; Jones, RN | 2 |
Ford, LC; Hammill, HA; Nilsson, JD | 1 |
Matsubara, T; Mizuno, A; Nakashima, M; Takiguchi, Y; Uchida, K; Uematsu, T | 1 |
Perronne, C; Vildé, JL | 1 |
Bellée, H; Fiedler, FB; Link, M | 1 |
Hori, R; Inui, K; Kato, M; Maegawa, H; Okano, T; Takano, M | 1 |
Heizmann, W; Luft, G; Werner, H | 1 |
Blanchin, MD; Fabre, H; Mandrou, B; Rondot-Dudragne, ML | 1 |
Aldridge, KE; Barry, AL; Fuchs, PC; Jones, RN | 1 |
Chin, NX; Neu, HC | 3 |
Cullmann, W; Dick, W; Opferkuch, W; Stieglitz, M | 1 |
Donald, FE; Ispahani, P | 1 |
Hiraoka, M; Inoue, M; Masuyoshi, S; Mitsuhashi, S; Tomatsu, K | 1 |
Asai, H; Itoh, Y; Kawamura, S; Kobayashi, K; Matsunaga, T; Ogino, H; Onishi, S; Sakamoto, Y; Shiraishi, T; Ueda, R | 1 |
Arione, R; Di Nola, F; Marietti, G | 1 |
Tural, D; Willke, A | 1 |
Graninger, W; Havel, M; Horcher, E; Korninger, H; Kurz, R; Müller, M | 1 |
Kin, Y; Tamai, I; Tsuji, A | 1 |
Bivins, BA; Crots, L; Horst, HM; Obeid, FN; Sorensen, VJ | 1 |
Bellée, H; Link, M; Löser, B | 1 |
Arai, T | 1 |
Hosutt, JA; Lentnek, AL; McDevitt, JT; Nichols, RL; Wikler, MA | 1 |
Braveny, I; Machka, K | 2 |
Aldridge, KE; Sanders, CV | 1 |
Finley, DR; Koehler, R; Messenger, RJ; Ott, JT; Wheeler, WJ | 1 |
Arpi, M; Frimodt-Møller, N; Hønberg, PZ | 1 |
Barba, D; Esposito, S; Galante, D | 2 |
Del Bene, VE; Lewis, JW; Rowland, MD | 1 |
Barry, AL; Fuchs, PC; Jones, RN | 1 |
Aldridge, KE; Barry, AL; Gerlach, EH; Jones, RN | 1 |
Goto, S; Kikuchi, H; Kuwahara, S; Mine, Y; Tawara, S; Watanabe, Y | 1 |
Nitti, V | 1 |
Inouye, S; Ito, T; Kazuno, Y; Murata, S; Shomura, T; Yoshida, T | 1 |
Bryskier, A; Le Noc, D; Le Noc, P | 3 |
Fujimoto, T; Nakajima, R; Osada, Y; Otani, T; Une, T | 1 |
Ando, S; Hirano, M; Kawaguchi, H; Masuyoshi, S; Miyaki, T; Tomatsu, K | 1 |
Bentsi, IK; Chisholm, GD; Elton, RA; Gould, JC; Hargreave, TB; Ritchie, AW; Smith, G | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Borobio, V; Garcia-Iglesias, MC; Pascual, A; Perea, EJ | 1 |
Kaplan, SL; McCracken, GH; Nelson, JD; Overturf, GD; Rodriguez, WJ; Steele, RW | 1 |
Weinstein, RA | 1 |
Acar, JF; Bleriot, JP; Goldstein, FW; Menard, R | 1 |
Faulkner, RD; Hiltke, MF; McAteer, JA; Silber, BM | 1 |
Bentzon, MW; Frimodt-Møller, N; Thomsen, VF | 1 |
Barry, AL; Jones, RN; Thornsberry, C | 2 |
Figini, G; Germiniani, R; Mastropasqua, E; Mauri, J; Rosina, M | 1 |
Berche, P; Gaillard, JL | 1 |
Becerra, S; Godoy, J; Herrera, N; Jofre, M; Silva, J; Urdanivia, R | 1 |
Hackbarth, CJ; Rusnak, MG; Sande, MA; Scott, KG; Täuber, MG | 1 |
Guggenbichler, JP; Parth, J | 1 |
Fujimura, H; Nozaki, M; Okada, K; Tsurumi, K; Yanagihara, M | 2 |
Mendel, N; Mester, U; Völker, B | 1 |
Bosso, JA; Townsend, RJ | 1 |
Barba, D; Esposito, S; Galante, D; Limauro, D; Pennucci, C | 1 |
Daly, JA; Gooch, WM | 1 |
Amess, JA; Green, AR; Grint, PC; Knowles, S; Metcalfe, P; Murphy, MF; Waters, AH | 1 |
Marsh, TD | 1 |
Muckenhuber, P; Salem, G | 1 |
Bies, M; Buck, RE; Chisholm, DR; Kessler, RE; Leitner, F; Misiek, M; Price, KE; Pursiano, TA; Tsai, YH | 1 |
Antal, M; Knothe, H; Krcméry, V | 1 |
Fu, KP; Gregory, FJ; Hung, PP; McCloud, S | 1 |
Jones, CW; Scher, KS | 1 |
Barry, AL; Fuchs, PC; Jones, RN; Thornsberry, C | 1 |
Norrby, SR | 1 |
Bauernfeind, A | 1 |
Bayer, AS; Kim, KS | 1 |
Barza, M; Noble, JT | 1 |
Goto, S; Hasebe, S; Kanno, H; Ozaki, K; Sato, K; Takagi, T; Tomizawa, M; Tsuji, A; Yakata, M; Yatagai, S | 1 |
Lyng, RV; Maeland, JA; Svarva, PL | 1 |
Borowski, J; Jakoniuk, P; Talarczyk, J | 1 |
Davy, KW; Livermore, DM; Williams, JD | 1 |
Dawes, R; de la Hunt, M; Goh, H; Karran, SJ; McDonald, P; Royce, C; Smallwood, J; Tasker, G; Townend, I; Walmsley, B | 1 |
Andrews, J; Bywater, MJ; Emmerson, AM; Hall, MJ; Holt, HA; Lamport, PA; Reeves, DS; Wise, R | 1 |
Frimodt-Møller, N; Hvass, E; Højbjerg, T; Mortensen, I; Møller, S; Thomsen, VF | 1 |
Citron, DM; Goldstein, EJ | 1 |
Hernández, NI; Nevárez, M; Ramírez-Ronda, CH; Rodríguez, JR | 1 |
Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
Fass, RJ; Helsel, VL | 1 |
Gerlach, EH; Jones, RN | 1 |
Bourne, DW; Cao, GR; English, PB; Filippich, LJ; Guerrini, VH | 1 |
Ayers, LW; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM | 1 |
Jung, K; Löffler, G; Schreiber, G | 1 |
Dette, GA; Knothe, H; Shah, PM | 1 |
Allerberger, F; Guggenbichler, JP; Kofler, J | 1 |
Stille, W | 2 |
Hara, K; Mori, K; Saito, A; Shigeno, Y; Yamaguchi, K | 1 |
McCracken, GH | 1 |
Bialer, M; Tonelli, AP; Yacobi, A | 1 |
Limbert, M; Novick, WJ; Schrinner, E; Seeger, K; Seibert, G | 1 |
Bakken, JS; Hulsund, M | 1 |
Carret, G; Flandrois, JP | 1 |
Bryskier, A; Fourtillan, JB; Ingrand, I; Lefebvre, MA | 1 |
Drusano, GL; Koch, TR; Kroll, MH; Warren, JW | 1 |
Gadebusch, HH; Koupal, LR; Shungu, DL; Weinberg, E; Weissberger, B | 1 |
Celozzi, E; Gadebusch, HH; Pelak, BA; Stapley, EO | 1 |
Meyer, JM | 1 |
Ikeda, C; Komiya, M; Matsui, H; Tachibana, A | 1 |
File, TM; Salstrom, SJ; Tan, JS | 1 |
Bryan, JP; Rocha, H; Sande, MA; Scheld, WM | 1 |
Blanchard, R; Lertzman, J; Louie, TJ; McLeod, J; Yaffe, C | 1 |
Michel, MF; Ong, L; Stolz, E; van Joost, T | 1 |
Guggenbichler, JP; Kofler, J | 1 |
Fujimura, N; Kurokawa, K; Uema, K; Yuasa, K | 1 |
Bryskier, A; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
Behrendt, H; Korting, HC; Neubert, U; Roth, KH | 1 |
Brunham, R; Kunimoto, D; Ronald, A | 1 |
Klesel, N; Limbert, M; Schrinner, E; Seibert, G; Winkler, I | 1 |
Concia, E; Marino, P; Marone, P; Verani, D | 1 |
Iegri, F; Lorenzi, A; Mascellino, MT; Prignano, G | 1 |
Jones, RN; Packer, RR | 1 |
Inoue, M; Katsu, K; Kitoh, K; Mitsuhashi, S | 1 |
Shah, PM | 2 |
Burk, P; Mondorf, AW; Scherberich, JE; Schoeppe, W; Stefanescu, T | 1 |
Bax, RP; Connellan, SJ; Newsom, SW | 1 |
Mitrou, PS; Mondorf, AW; Scherberich, JE; Schoeppe, W; Stefanescu, T | 1 |
Wise, R; Wright, N | 1 |
Barrow, J; Boakes, AJ; Eykyn, SJ; Phillips, I | 1 |
Goodwin, CS; Middle, GJ; Moulsdale, MT; Peterson, GW | 1 |
Peters, G; Pulverer, G | 2 |
Aswapokee, P; Fu, KP; Ho, I; Matthijssen, C; Neu, HC | 1 |
Kojo, H; Nishida, M; Shigi, Y | 1 |
Doi, H; Kobayashi, S; Kurimura, O; Morioka, Y; Nozaki, K; Sasaki, H; Tamaki, K | 1 |
Mirelman, D; Nuchamowitz, Y | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Gerding, DN; Hall, WH; Opfer, BJ | 1 |
Durack, DT; Lang, SD | 1 |
Garcia-Rodriguez, JA | 2 |
Belmega, D; Jendroschek, H; Kemmerich, B; Koeppe, P; Lode, H | 1 |
Kafetzis, DA; Legakis, NJ; Papadatos, CJ; Papavassiliou, JT | 1 |
Schassan, HH; Seidel, H; Welter, J; Wittmann, DH | 1 |
Callies, R; Siekmann, U | 1 |
Bertola, D; Pellerito, R; Poletti, T; Soragna, A | 1 |
Baker, CN; Jones, RN; Thornsberry, C | 1 |
Alexander, GA; Crawford, SA; Jorgensen, JH | 3 |
Erich, M; Freitag, V; Kopf, PO; Kult, K; Pröpper, H; Welter, J; Wittmann, DH | 1 |
Dubois, J; Guay, R; Letarte, R; Pechère, JC | 1 |
Gründer, K; Malerczyk, V; Petzoldt, D; Seeger, K; Seidel, G | 1 |
Bundtzen, RW; Craig, WA; Madsen, PO; Nielsen, OS; Toothaker, RD; Welling, PG | 1 |
Adam, D; Schalhäuser, K | 1 |
Bauernfeind, A; Petermüller, C | 1 |
Arai, S; Masuyoshi, S; Mitsuhashi, S; Miyamoto, M | 1 |
Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Sommers, HM; Thornsberry, C | 1 |
Fillastre, JP; Godin, M; Humbert, G; Leroy, A | 1 |
Belohradsky, BH; Marget, W; Roos, R; von Hattingberg, HM | 1 |
Karimi, A; Knothe, H; Seeger, K; Stolke, D | 1 |
Biclet, P; Durand, H; Moreau, L | 1 |
Besnard, Y; Monrocq, N; Morel, C | 1 |
Daval, JR; Deforges, LP; Feghali, W; Le Van Thoi, J; Soussy, CJ | 1 |
Richmond, MH | 1 |
Danon, J | 1 |
Rosin, H; Uphaus, W; Vent, J | 1 |
Georgakopoulos, PA; Kafetzis, DA; Lazarides, CV; Papadatos, CJ; Siafas, CA | 1 |
Busse, H; Seeger, K; Wreesmann, P | 1 |
Daikos, GK; Kosmidis, J; Mantopoulos, K; Papathanassiou, B; Pouriezi, T; Stathakis, C | 1 |
de Weck, AL; Schneider, CH | 1 |
Miki, F; Shiota, K | 1 |
Briggs, MS; Bryn, RD; Jenkinson, SG | 1 |
Hänninen, P; Toivanen, A; Toivanen, P; Vainio, O | 1 |
Davies, BI; Drenth, BM; Elfers, H; Maesen, FP | 1 |
Guionie, M; Kazmierczak, A; Labia, R; Masson, JM | 1 |
Dzwillo, G; Gruhlke, G; Kemmerich, B; Koeppe, P; Lode, H; Wagner, I | 1 |
Matthews, J; Newsom, SW; Pearce, VR | 1 |
Knebel, L; Ludwig, G | 1 |
Kawada, Y; Nishiura, T; Shimizu, Y | 1 |
Glöckner, WM; Höffler, U; Kindler, J; Peters, G; Sieberth, HG | 1 |
Casellas, JM; Farinati, A; Iribarren, MA; Matteucci, A; Ortiz, RG | 1 |
Kuroda, K; Ohkawa, M | 1 |
Aufrant, C; Bingen, E; Blum, C; Lambert-Zechovsky, N; Mathieu, H; Proux, MC | 1 |
Kafetzis, DA; Kanarios, J; Papadatos, CJ | 1 |
Bonesana, NF; Grinstein, S; López, EL; Rubeglio, E; Schugurensky, A; Sommersguter, G | 1 |
Limbert, M; Lutz, A; Penasse, L; Schrinner, E | 1 |
Daikos, GK; Dranidis, B; Giamarellou, H; Kosmidis, J; Mantopoulos, K; Stathakis, C | 1 |
Armengaud, M; Aubertin, J; Bertrand, A; Lepeu, G; Massip, P; Ragnaud, JM | 1 |
Helm, EB; Shah, PM; Stille, W | 1 |
Dutoy, JP; Wauters, G | 1 |
Bax, R; Geddes, AM; McKendrick, MW; Wise, R | 1 |
Boscq, G; Chazara, C; Prieur, D; Quentin, R; Soutoul, JH | 1 |
Hard, S; Moberg, I; Wennberg, K | 1 |
Backhaus, A; Meyer-Rohn, J | 1 |
Blomer, RJ; Bruch, K; Husson, JM; Savopoulos, C; Young, JP | 1 |
Knothe, H | 2 |
Inoue, M; Masuyoshi, S; Mitsuhashi, S | 1 |
Colaert, J; Piot, P; Ursi, JP; Van Dyck, E | 1 |
Butzler, JP; Denolf, R; Hubrechts, JM; Khodjasteh, F; Vanhoof, R | 1 |
Bernard, C; Gaya, H; Klastersky, J; Ryff, JC; Zinner, SH | 1 |
Bormann, D; Bucourt, R; Heymes, R; Perronnet, M | 1 |
Chamberlain, J; Coombes, JD; Dell, D; Fromson, JM; Ings, RJ; Macdonald, CM; McEwen, J | 1 |
Doerr, BI; Glomot, R; Kief, H; Kramer, M; Sakaguchi, T | 1 |
Esmieu, F; Guibert, J; Ho, I; Le Go, A; Rosenkilde, HC | 1 |
Bahari, D; Bax, RP; Bywater, MJ; Holt, HA; Reeves, DS; White, LO | 1 |
Fabricius, K; Riegel, H | 1 |
Shah, PM; Stille, W; Troche, G | 1 |
Eley, A; Greenwood, D; O'Grady, F; Pearson, N | 2 |
Murray, PR | 1 |
Durack, DT; Edwards, DJ; Lang, SD | 1 |
Baker, S; Livingston, R; Wise, R | 1 |
McCracken, GH; Nelson, JD; Shelton, S | 1 |
Pang, R; Rajan, VS; Sng, EH; Tan, NJ; Thirumoorthy, T; Yeo, KL | 1 |
Rogers, DT; Russell, AD | 1 |
Aznar, J; Iglesias, MC; Martin, E; Nogales, MC; Perea, EJ | 1 |
King, A; Phillips, I; Shannon, K; Warren, C | 1 |
Hewitt, WL; Hindler, JA; Kurtz, TO; Martin, WJ; Winston, DJ; Young, LS | 1 |
Bianchi, P; Frongillo, RF | 1 |
Albertini, A; Galizzi, A; Mazza, G | 1 |
Blomer, R; Bruch, K | 1 |
Foz, A; Fuster, C; Roy, C; Segura, C; Tirado, M | 1 |
Adam, D; Naber, K | 1 |
Bethke, RO; Malerczyk, V; Seidel, G; von Gablenz, E | 1 |
Perronnet, J | 1 |
Chabbert, YA; Lutz, A | 1 |
Chaigneau, H; Eveno, J; Mariel, C; Tancrede, C | 1 |
Guy, I; Klut, P; Le Faou, A; Tardieu, JC | 1 |
Aufrant, C; Bingen, E; Lambert-Zechovsky, N; Mathieu, H; Proux, MC | 1 |
Duval, J; Soussy, CJ; Thibault, M | 1 |
Acar, JF; Guibert, J; Kitzis, MD | 1 |
Galy, J; Mantel, O | 1 |
Fillastre, JP; Godin, M; Humbert, G; Ings, RM; Leroy, A | 1 |
Borderon, JC; Huguet, B; Prieur, D | 1 |
Berthoumieu, C; Monnier, J; Peltier, M; Pous, J | 1 |
Bergogne-Berezin, E; Pierre, J; Ravina, J; Vernant, D | 1 |
Boussougant, Y; Carbon, C; Contrepois, A; Doquir, C | 1 |
Armengaud, M; Aubertin, J; Bertrand, A; Lepeu, G | 1 |
Bastin, R; Bure, A; Frottier, J; Vilde, JL | 1 |
Canton, P; Dureux, JB; Gérard, A; Roche, G; Weber, M | 1 |
Boussougant, Y; Carbon, C; Destaing, F; Portier, H | 1 |
Gajdos, P; Goulon, M; Pilliot, J | 1 |
Auboyer, C; Bouletreau, P; Bui-Xuan, B; Flandrois, JP; Motin, J; Reverdy, ME | 1 |
Butzler, JP; Clumeck, N; George, G; Jaspar, N; Rapin, M; Van Laethem, Y; Vanhoof, R | 1 |
Acar, JF; Guibert, J; Justin, C; Kitzis, MD | 1 |
Garnier, JM; Giraud, F | 1 |
Borderon, JC; Boulard, P; Despert, F; Grenier, B; Laugier, J; Santini, JJ | 1 |
Aufrant, C; Aujard, Y; Beaufils, F; Bingen, E; Blum, C; Lambert-Zechovsky, N; Mathieu, H | 1 |
Gérard, A; Paris, J; Paris, JC | 1 |
Kermarec, J; Sauvaget, J | 1 |
Chavanet, P; Cortet, P; Guy, H; Kazmierczak, A; Portier, H | 1 |
Aguirre, M; Alés, JM; Torres, A | 1 |
Bryk, DA; Panwalker, AP; Trager, GM; White, GW; Zimelis, VM | 1 |
Barnham, M; Husband, P | 1 |
Loock, CA; McCracken, GH; Schaad, UB; Thomas, ML | 1 |
Ferrero, R; Pavesio, D; Pecco, P; Viretto, A | 1 |
Dominiak, P; Grobecker, H; Kees, F; Seeger, K; Seidel, G; Strehl, E | 1 |
Bergan, T; Solberg, R | 1 |
Harvengt, C; Meunier, H; Wauters, G | 1 |
Legg, EF; Mckendrick, MW | 1 |
Gilchrist, MJ; Spelhaug, DR; Washington, JA | 1 |
Chodos, J; Francke, EL; Neu, HC; Saltzman, M | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH | 1 |
Pang, R; Rajan, VS; Sng, EH; Yeo, KL | 1 |
Bax, RP; Young, JP | 1 |
Henkel, W; Krüger, C; Marre, R | 1 |
Frongillo, RF; Galuppo, L; Moretti, A | 2 |
Verbist, L; Verhaegen, J | 3 |
Ehret, J; Eickhoff, TC | 1 |
Bower, RR; Girolami, RL; Shipkowitz, NL; Stamm, JM | 1 |
Wills, PJ; Wise, R; Wright, N | 1 |
Dominici, C; Frongillo, RF; Galuppo, L | 1 |
Lareng, MB; Lefèvre, JC; Prère, MF | 1 |
Durosoir, JL; Saliou, P; Thabaut, A | 1 |
Hamelmann, H; Jostarndt, L; Sonntag, HG; Thiede, A | 1 |
Andrews, JA; Geddes, AM; McKendrick, MW; Wise, R | 1 |
Hanslo, D; King, A; Phillips, I; Shannon, K; Warren, C | 1 |
Bermudez, RH; Nevarez, M; Ramirez-Ronda, CH; Saavedra, S | 1 |
Durack, DT; Perfect, JR | 2 |
Hyams, KC; Mader, JT; Parks, DH; Pollard, RB; Reinarz, JA; Thomson, PD | 1 |
Blomer, R; Seidel, G; Subke, H; von Gablenz, E | 1 |
Balasegaram, M; Devanand, MR; Singh, B | 1 |
Verbist, L | 1 |
Braga, PC; Copponi, V; Fraschini, F; Maccari, M; Piovani, D; Scaglione, F; Scarpazza, G | 1 |
Biebach, A; Seibert, G | 1 |
Lichtenberger, C; Perlino, CA | 1 |
Inoue, M; Masuyoshi, S; Mitsuhashi, S; Takaoka, M | 1 |
Fu, KP; Neu, HC | 2 |
Armengaud, M; Barza, M; Cherubin, CE; Corrado, ML; Landesman, SH; Shah, PM | 1 |
McCloskey, RV; Trent, JA; Tutlane, VA | 1 |
Kida, M; Kuno, M; Mitsuhashi, S; Okonogi, K | 1 |
Hirai, K; Inoue, M; Katsumata, R; Matsubara, N; Mitsuhashi, S; Sato, K | 1 |
Slack, MP | 1 |
Hall, MJ; Westmacott, D; Wong-Kai-In, P | 1 |
Fox, JM; Quall, CO; Woolfrey, BF | 1 |
Cherubin, CE; Corrado, ML; Landesman, SH; Sierra, MF | 1 |
Arnold, K; Chau, PY; Ng, WS | 1 |
Miyawaki, T; Morimoto, A; Ochiai, M | 1 |
Livermore, DM; Williams, JD; Williams, RJ | 1 |
Neu, HC; Srinivasan, S | 1 |
Forsgren, A | 1 |
Baumgärtner, M; Dickgiesser, N; Müller, S; Wundt, W | 1 |
Fugono, T; Shirakawa, Y; Yamazaki, I | 2 |
Gootz, TD; Martin, RR; Moellering, RC; Perkins, RL; Sanders, CC; Sanders, WE; Strike, DG | 1 |
Navashin, SM; Rozenfel'd, GS | 1 |
Blaser, J; Bonetti, A; Lüthy, R; Siegenthaler, W; Simmen, H; Wise, R | 1 |
Gruninger, RP; Khan, MY; Siddiqui, Y; Simpson, ML | 1 |
Chow, AW; Drulak, MW | 1 |
Barry, AL; Jones, RN; Thornsberry, C; Wilson, HW | 1 |
LeFrock, JL; Miller, MA; Vercler, MJ | 1 |
Häfelein, J; Marklein, G | 1 |
Brogard, JM; Comte, F | 1 |
Kosakai, N; Oguri, T | 1 |
Weinstein, AJ | 1 |
Braveny, I; Elsser, R; Machka, K | 1 |
Grimm, L; McCracken, GH; Nelson, JD | 1 |
Bayer, AS; Kim, KS; Morrison, JO | 1 |
Labthavikul, P; Neu, HC | 1 |
Febvre, N; Juge, F; Lecaillon, JB; Rouan, MC; Souppart, C | 1 |
Maskell, JP; Nasu, M; Williams, JD; Williams, RJ | 1 |
Klastersky, J; Lagast, H; Zinner, SH | 1 |
Neu, HC; Prince, AS | 1 |
Cherubin, CE; Corrado, ML; Gombert, ME; Shulman, M; Sierra, MF | 1 |
Fasching, CE; Peterson, LR | 1 |
Selwyn, S | 1 |
Granneman, GR; Sennello, LT | 1 |
Farrar, WE; Rotstein, C | 1 |
Aoki, I; Itakura, K; Mitani, M; Usui, Y | 1 |
Ahonkhai, VI; Cherubin, CE; Shulman, MA; Sierra, MF | 1 |
Deguchi, K; Fujimaki, Y; Kawamura, S; Ohsawa, H; Sugita, R | 1 |
Kawakita, J; Kawamura, N; Ohkoshi, M; Okada, K; Satake, Y | 1 |
Aronoff, GR; Blase, DK; Connors, BA; Evan, AP; Gattone, VH; Luft, FC | 1 |
Craig, WA; Greenfield, RA; Kurzynski, TA | 1 |
Nakano, H | 1 |
Acar, JF; Goldstein, F; Gutmann, L; Kitzis, MD; Nasnas, R | 1 |
Chanal, M; Cluzel, R; Glanddier, Y; Sirot, D; Sirot, J | 1 |
Feshchenko, IuI; Molotkov, VN; Pristaĭko, IaI; Shcherbakova, EG; Vyrenkov, IuE | 1 |
Ahonkhai, VI; Bancroft, U; Cherubin, CE; Shulman, MA | 1 |
Traub, WH | 1 |
Gever, LN | 1 |
Bergogne-Berezin, E; Joly-Guillou, ML; Verin-Prevost, C | 1 |
Baumgärtner, M; Grehn, M; Wundt, W | 1 |
Drew, WL; Mintz, L | 1 |
Ernest, KD; Magnussen, CR; Sammartino, MT | 1 |
Deguchi, K; Fukayama, S; Nishimura, Y | 1 |
Arisawa, M; Maruyama, HB; Mitsuhashi, S; Ohsawa, E; Ohshima, J; Sekine, Y | 1 |
Ehrenkranz, NJ; Hoffman, TA | 1 |
Horiuchi, N; Kanai, M; Kawakami, Y; Okimura, Y | 1 |
Iversen, P; Madsen, PO | 1 |
Pranada, F; Pusztai-Markos, Z | 1 |
Hoogkamp-Korstanje, JA; Meijer, CA | 1 |
Bergeron, MG; Simard, P | 1 |
Dunlop, WE; Fabian, TC; Stone, HH; Strom, PR | 1 |
Dunn, GL | 1 |
Bermudez, RH; Luina, A; Rodriguez, J; Ronda, CH; Vazquez, GJ | 1 |
Carr, BB; Chandrasekar, PH; Kannangara, W; LeFrock, JL; Lentnek, AL; Molavi, A; Oaks, SS; Rolston, KV; Schell, RF; Smith, BR | 1 |
Amaram, N; Daniels, JA; Den, M; Grieco, MM; Kornfeld, H; Lange, M | 1 |
Brock, SM; Lahiri, B; Lyons, RW | 1 |
Penn, RL | 1 |
Cohen, E; Mogabgab, WJ | 1 |
Gentry, LO; Gould, PL; Lea, AS; Sudan, AW | 1 |
Klein, D; Mills, J; Schecter, W; Slutkin, G | 1 |
Aughey, DR; Maki, DG | 1 |
Gordon, SF; Russell, J | 1 |
Duma, RJ | 1 |
Chow, AW; Finegold, SM | 1 |
Eliopoulos, GM; Moellering, RC; Willey, S | 1 |
Nightingale, CH; Quintiliani, R | 1 |
Crawford, ED; Plimpton, HW | 1 |
Bakker-Woudenberg, IA; Michel, MF; van den Berg, JC | 1 |
Connor, E; Melick, C; Yogev, R | 1 |
Denolf, BL; Lambert, AM; Pyckavet, M; Van Landuyt, HW | 1 |
Freiesleben, H; Herhahn, D; Marre, R; Sack, K; Schulz, E | 1 |
Livermore, DM | 1 |
De Toffoli, A; Fantin, B | 1 |
Dette, GA; Henckel, S; Knothe, H | 1 |
Ishiyama, T; Miyayama, T; Nomoto, H; Shiokawa, Y; Sugaya, N; Sugimoto, M; Wakabayashi, Y | 1 |
Bremner, DA; Rothwell, DL; Taylor, KM | 1 |
Belmega, G; Borner, K; Jendroschek, T; Kemmerich, B; Koeppe, P; Lode, H | 1 |
Gruninger, RP; Khan, MY; Nelson, SM; Obaid, SR | 1 |
Botta, GA; Menozzi, MG; Privitera, G | 1 |
Fugono, T; Kasahara, A; Mizuta, E; Momose, A | 1 |
Fujimoto, S; Furuta, I; Harikane, O; Hiromatsu, K; Iimori, M; Kamiki, T; Kodama, J; Kotera, K; Maejima, K; Masutani, T; Matsunaga, K; Miwatani, T; Nishimura, T; Nukina, M; Shimizu, Y; Tabuki, K; Takahashi, M; Takashima, E; Takashima, T; Takeda, Y; Tanaka, M; Yabuuchi, E; Yamanaka, K; Yoshizaki, E | 1 |
Finegold, SM; Owens, WE | 1 |
Chadwick, EG; Connor, EM; Shulman, ST; Yogev, R | 1 |
Marks, MI | 1 |
Pagani, L; Perduca, M; Romero, E | 1 |
Harvengt, C | 1 |
Smith, BR | 1 |
Francisco, MA; LeFrock, JL; Schell, RF; Smith, BR | 1 |
Abadie, F; Juge, F; Leclerc, A; Rouan, MC | 1 |
Cluzel, R; Garnier, R; Joly, B; Sirot, D; Sirot, J | 1 |
Ankirskaia, AS; Emel'ianova, AI; Maĭorova, VN; Saakian, SS; Voropaeva, SD | 1 |
Alpegiani, M; Arcamone, F; Battistini, C; Bedeschi, A; Della Bruna, C; Foglio, M; Franceschi, G; Perrone, E; Sanfilippo, A; Zarini, F | 1 |
Gutmann, L; Williamson, R | 1 |
Duez, JM; Kazmierczak, A; Kohli, E; Pechinot, A; Tremeaux, JC | 1 |
Aber, RC; Appelbaum, PC; Pankuch, GA; Tamim, J | 1 |
Garzone, P; Lyon, J; Yu, VL | 1 |
Mester, U; Völker, B | 1 |
Agostini, M; Barlocco, G; Bonomi, U; Borgo, G; Bozzino, L; Cabrini, G; Cappelletti, LM; Castellani, L; Conforti, M; Mastella, G | 1 |
Childs, SJ; Mirelman, S; Wells, WG | 1 |
Bothof, T; de Pauw, BE; Kauw, F; Muytjens, H; Williams, KJ | 1 |
Nakao, M; Yamada, J; Yamamura, K; Yotsuyanagi, T | 1 |
Acar, JF; Bure, A; Christol, D; Courtieu, AL; Dabernat, H; Deforges, L; Duval, J; Kitzis, D; Le Van Thoi, J; Soussy, CJ | 1 |
Gorbach, SL; Jacobus, NV; Keenholtz, SL; Tally, FP | 1 |
Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
Ansorg, R; Quentin, CD | 1 |
Bodey, GP; Fainstein, V; Garcia, I; Rosenbaum, B; Wong, Y | 1 |
Blumbach, J; Dürckheimer, W; Fleischmann, K; Klesel, N; Lattrell, R; Limbert, M; Schrinner, E; Seeger, K; Seibert, G; Winkler, I | 1 |
Jaarsma, EY; Marcelis, JH; van Asbeck, BS; van Kats, JH; Verhoef, J | 1 |
Baumgartner, JD; Glauser, MP | 1 |
Hara, K; Kanda, T; Saito, A; Sawatari, K; Toro, J | 1 |
Guggenbichler, JP | 1 |
Francisco, M; LeFrock, JL; Schell, RF; Smith, BR | 1 |
LeBel, M; Lewis, GP; Paone, RP | 1 |
Matsuo, K; Uete, T | 1 |
Meyer, RD; Pasiecznik, K | 1 |
Schaad, UB | 1 |
Cohen, SH; Demling, R; Franti, CE; Gunther, R; Hoeprich, PD; Merry, JM; Miner, DJ | 1 |
Asahi, Y; Isono, M; Kesado, T; Ueno, K; Watanabe, K | 1 |
McCracken, GH; Olsen, KD; Sakata, Y; Thomas, ML | 1 |
Monteil, H; Peladan, F; Zinsius, M | 1 |
Hansen, BG | 1 |
Azuma, K; Nishino, T; Saito, M; Tanino, T | 1 |
Fujita, S; Matsubara, F; Okado, N; Yoshida, T | 1 |
Echols, RM; McCormick, EM; Rosano, TG | 1 |
Lindridge, MA; Livermore, DM; Said, AA; Williams, JD; Williams, RJ | 1 |
Gannon, RH; Levy, RM | 1 |
Bayer, AS; Eisenstadt, R; Morrison, JO | 1 |
Chase, HA; Fuller, C; Reynolds, PE | 1 |
Li, QZ; Zhang, CL | 1 |
Durova, AA; Ovechko-Fillipova, LN; Simakova, MG; Smirnova, VS | 1 |
Beloeil, H; Buisson, JC; Chavanet, P; Duigou, F; Duong, M; Kazmierczak, A; Neuwirth, C; Pechinot, A; Portier, H | 1 |
Lo, P; Low, DE; Matsumura, S; Mazzulli, T; Patel, MP; Porter, CR; Skulnick, M; Small, GW | 1 |
Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M | 1 |
Chahime, H; Guibert, M; Labrune, P; Odièvre, M; Petit, J | 1 |
Agbo, P; Carnot, JF; Cayroche, P; Chalvon-Demersay, A; Hacquard, B; Mariani, P | 1 |
Belliveau, PP; Nightingale, CH; Quintiliani, R | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA | 2 |
Luzzaro, F; Pagani, L; Porta, F; Romero, E | 1 |
Cony Makhoul, P; Darmaillac, V; Fourche, J; Maugein, J; Perrier, F | 1 |
Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
Lewis, RT; Lloyd-Smith, W; Mamazza, J; Tataryn, D; Weigand, FM | 1 |
Coffey, TJ; Daniels, M; Dowson, CG; McDougal, LK; Spratt, BG; Tenover, FC | 1 |
Brandis, M; Burghard, R; Gordjani, N; Leititis, JU; Mathäi, H; Mergehenn, G; Müller, D | 1 |
Badoual, J; Bergeret, M; Bingen, E; Brahimi, N; Doit, C; Gendrel, D; Raymond, J | 1 |
Baquero, F; Cantón, R; García de Lomas, J; Gimeno, C; Liñares, J; Martínez-Beltrán, J; Tubau, F | 1 |
Chen, CH; Lee, YC; Lin, JS; Perng, RP; Yang, MH | 1 |
Babálová, M; Blahová, J; Hupková, M; Králiková, K; Krcméry, V | 1 |
Choi, EC; Choi, KH; Choi, MJ; Kim, BO; Kim, DJ; Park, NJ; Shim, JS; Yu, YH | 1 |
Tilse, M; Tudehope, DI | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
Báez, C; Castaño, E; García, R; McCracken, GH; Pérez, M; Sáez-Llorens, X; Tejeira, F | 1 |
Crucq, AS; Hickel, B; Tilquin, BL | 1 |
Anderson, RL; McKnight, JT; Rodman, DP | 1 |
Rubinovitch, B; Rubinstein, E | 1 |
Blandino, G; Cocuzza, G; Dainelli, B; Debbia, EA; Maida, A; Nicoletti, G; Schito, GC | 1 |
Kafetzis, DA | 1 |
Hamano, S; Nakanishi, M; Tamai, I; Terasaki, T; Tsuji, A | 1 |
Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R | 1 |
Garcia Iglesias, MC; Perea, EJ | 1 |
Bauernfeind, A; Cornaglia, G; Fontana, R; Ligozzi, M; Satta, G | 1 |
Courvalin, P; Fonzé, E; Frère, JM; Goussard, S; Lamotte-Brasseur, J; Raquet, X | 1 |
Jones, RN; Sanchez, ML | 1 |
Veverka, M | 1 |
Kaplan, SL; Mason, EO; Schutze, GE; Tan, TQ | 1 |
Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M; Takahashi, M; Toda, T | 1 |
Rodriguez, WJ; Wiedermann, BL | 1 |
Aleksandrova, AE; Tschegoleva, RA; Vinogradova, TI | 1 |
Barckow, D; Schwigon, CD | 1 |
Hemsell, DL; Newton, ER; Pastorek, JG; Soper, DE; Yeomans, ER | 1 |
Dantzig, AH; Duckworth, DC; Tabas, LB | 1 |
Bass, JW; Chan, DS; Demers, DM | 1 |
Inamoto, Y; Kawabata, K; Sakane, K; Takaya, T; Yamanaka, H | 1 |
Badik, A; Budai, I; Marosvári, I; Nagy, Z | 1 |
Coulthard, M; Ehrett, S; Friedland, IR; Jafari, H; McCracken, GH; Olsen, K; Paris, M; Rinderknecht, S; Saxen, H | 1 |
Benes, L; Cíz, M; Kubícková, D; Lojek, A; Pillich, J | 1 |
O'Hara, K; Parker, CE; Perkins, JR; Shida, Y; Tomer, KB | 1 |
Bertasso, A; Georgopapadakou, NH | 1 |
Berman, S; Roark, R | 1 |
Huletsky, A; Knox, JR; Levesque, RC | 1 |
Doyle, WJ; Greene, I; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
Appelbaum, PC; Jacobs, MR; Pankuch, GA; Spangler, SK | 1 |
Hirano, Y; Maruyama, S; Sakata, H | 1 |
Kumano, K; Kuroyama, M; Motohashi, S; Murase, S; Tomonaga, F | 1 |
Adu, A; Armour, CL | 1 |
Gómez, J; Hernández, JL; Martinez, M; Martinez-Lage, J; Poza, M; Valdés, M | 1 |
Hausen, T; Schmitt, J; Weidlich, G | 1 |
Bégué, P; Boulesteix, J; Dabernat, H; de La Rocque, F; Dubreuil, C; Geslin, P; Mégraud, F; Trinh, A | 1 |
Adam, D; Hostalek, U; Tröster, K | 1 |
Low, DE | 1 |
Acar, JF; Goldstein, FW; Gutmann, L; Mainardi, JL | 1 |
Charvalos, E; Hamzehpour, MM; Köhler, T; Pechere, JC; Tselentis, Y | 1 |
Bryskier, A; Coussediere, D; Lenfant, B; Logeais, C; Namour, F; Rivault, O; Surjus, A | 1 |
Goldwater, PN | 1 |
Schuler, D | 1 |
Champion, MP; Marsh, MJ; Murdoch, IA; Sajjanhar, T | 1 |
Freeman, DJ; Parnes, LS; Sun, AH | 1 |
Kahn, JB; Madsen, PO; Malek, GH | 1 |
Amor, A; Barguellil, F; Burucoa, C; Fauchère, JL; Fendri, C | 1 |
Barry, AL; Brown, SD; Novick, WJ | 2 |
Harnisch, L; Mendes, P; Rokitta, C; Weber, W; Zimmer, M | 1 |
Bux, D; Hasan, M; Rathore, MH | 1 |
Chesney, PJ; Davis, Y; English, BK; Wang, WC | 1 |
Blondeau, JM; Yaschuk, Y | 1 |
Grebe, T; Guenzi, E; Hakenbeck, R; König, A; Krauss, J; Reichmann, P | 1 |
Guenzi, E; Hakenbeck, R | 1 |
Banke, S; Bruno, AM; Carlsson, M; Cronberg, S; Elmrud, H; Elowsson, S; Josefsson, K; Lindholm, AC; Montelius, H; Neringer, R | 1 |
Dupont, MJ; Estavoyer, JM; Guibourdenche, M; Kirchgesner, V; Michel-Briand, Y; Plesiat, P; Riou, JY | 1 |
Liston, TE | 1 |
Galds, M; Gutkind, G; Lopardo, H; Mariño, M; Picandet, AM; Radice, M; Rossi, A; Woloj, M | 1 |
Biro, FM; Friedland, LR; Kulick, RM; Patterson, A | 1 |
Danan, G; Rauss, A; Rothschild, E | 1 |
Lesna, M; Parham, DM | 1 |
Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
Cassetta, MI; Conti, S; Dei, R; Fallani, S; Mazzei, T; Novelli, A | 1 |
Blandino, G; Nicoletti, G; Speciale, A | 1 |
Imajo, S; Ishiguro, M; Ishii, Y; Matsuzawa, H; Ohno, A; Taguchi, H | 1 |
Bell, SM; Gatus, BJ; Pham, JN | 1 |
Boyter, A; Davey, P; Fegan, PG; Nathwani, D | 1 |
Danks, J; Renton, TF; Rosenfeld, JV | 1 |
Lee, YS; Park, H | 1 |
Karas, JA; Muckart, D; Pillay, DG; Sturm, AW | 1 |
Kang, MW; Kim, YR; Min, CK; Shin, WS; Yoo, JH | 1 |
de Groot, R; Hählen, K; Kornelisse, RF; Mulder, PH; Neijens, HJ; Savelkoul, HF; Sukhai, RN; Suur, MH; van der Heijden, AJ; van der Straaten, PJ | 1 |
Shopova, E; Zhekova, N | 1 |
Aleksandrova, AE; Vinogradova, TI | 1 |
Ariza, J; Xiol, X | 1 |
Boocock, GR; Bowley, JA | 1 |
Cocuzza, G; Zanussi, C | 1 |
Issopoulos, PB; Salta, SE | 1 |
Cárcamo Valor, P; Coronel Granado, P; Diez-Enciso, M; Gastón de Iriarte, E; Gimeno del Sol, M; Morán Soto, MJ; Pérez Balcabao, I; Prieto Prieto, J | 1 |
Kowalski, M; Szechiński, J | 1 |
Anderson, G; Boldiston, C; O'Brien, P; Woods, S | 1 |
Cuenca Estrella, M; Esteban Moreno, J; Nuñez García, A; Ramos Rincón, JM | 1 |
Babálová, M; Krălíková, K; Krcméry, V; Kubonová, K | 1 |
Grcevska, L; Polenaković, M | 1 |
Langman, G | 1 |
López, MM; Martín, C; Merino, J; Navarro, V; Roig, PP; Sánchez, B; Zorraquino, A | 1 |
Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL | 1 |
Domínguez Herrera, JM; Hernández Guisado, JM; Infante Cossio, P; Jiménez Mejías, ME | 1 |
Arora, R; Jain, BL; Kaker, AK; Khalil, A; Khalilullah, M; Trehan, V; Tyagi, S | 1 |
Cappelletty, DM; Rybak, MJ | 1 |
Dan, M; Hafeli, H; Heifetz, L; Poch, F; Somekh, E; Tanai, A | 1 |
Briggs, RJ; Fabinyi, G; Kamarulzaman, A; Richards, MJ | 1 |
Coronel, P; Fernández-Roblas, R; Gimeno, M; López, JC; Ramos, JM; Soriano, F | 1 |
Baker, CN; Swenson, JM; Tenover, FC | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 4 |
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T | 1 |
Deguchi, K; Fukayama, S; Fukumoto, T; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S | 1 |
Cabellos, C; Gudiol, F; Liñares, J; Martínez-Lacasa, J; Pallares, R; Tubau, F; Viladrich, PF | 1 |
Barreiro Casal, G; Cilleruelo Ortega, MJ; García López, M; Martín Fontelos, P; Mellado Peña, MJ; Pérez Jurado, ML; Villota Arrieta, J | 1 |
Garrison, SF; Schutze, GE | 1 |
Johnson, CD | 1 |
Hoffman, JA; Kim, KS | 1 |
Kasteridou, N; Mamzoridi, K; Niopas, I; Peonides, A | 1 |
Choi, YJ; Hong, T; Kish, A; Millett, W; Ndamukong, J; Win, KK | 1 |
Arroyo, V; Bañares, R; Castells, L; Clemente, G; Follo, A; Forné, M; Guarner, C; Jimenez De Anta, MT; Llovet, JM; Marco, F; Navasa, M; Planas, R; Rimola, A; Rodés, J; Vargas, V | 1 |
Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
Cunningham, B; Nickerson, B; Scypinski, S | 1 |
Alonso, JM; Fournier, JL; Jacolot, AC; Petitjean, OJ; Ramisse, F; Scavizzi, MR; Szatanik, M | 1 |
Appelbaum, PC; Jacobs, MR; Visalli, MA | 1 |
Bakkaloglu, A; Besbas, N; Ozen, S; Saatci, I; Saatci, U; Soylemezoglu, O; Topaloglu, R | 1 |
Hyodo, A; Ishida, N; Miyake, Y; Muratsugu, M; Terayama, K | 1 |
Blesa Sánchez, E; Núñez Núñez, R; Vázquez Rueda, F | 1 |
Dajani, AS; Jacobs, RF; Kaplan, SL; Leggiadro, RJ; Puri, SK; Rim, CS; Schutze, GE | 1 |
Arweiler, D; Fischer, M | 1 |
Abunijem, Z; al Shohaib, S; Satti, MS | 1 |
Flórez, C; Martín, E; Silva, G | 1 |
Gould, IM; Hobson, RP; MacKenzie, FM | 1 |
Earnest, R | 1 |
Herzberg, O; Smith, TJ; Zawadzke, LE | 1 |
Nieto, E; Parra, A; Ponte, C; Soriano, F | 2 |
Bonczar, T; Haas, DW | 1 |
Appelbaum, PC; Bajaksouzian, S; Jacobs, MR; Visalli, MA | 1 |
Barry, AL; Fuchs, PC | 1 |
Chesney, PJ; English, BK | 1 |
Burton, PH; Thornsberry, C; Vanderhoof, BH | 1 |
Abuekteish, F; Daoud, A; Masaadeh, H | 1 |
Barreca, GS; Berlinghieri, MC; Focà, A; Foti, F; Matera, G | 1 |
Budanov, SV; Khess, R | 1 |
Amir, J; Eidlitz-Markus, T; Harel, L; Varsano, I | 1 |
Hedge, DD | 1 |
Deguchi, K; Fukumoto, T; Ishihara, R; Ishii, Y; Matsumoto, Y; Nakane, Y; Nakazawa, A; Nishinari, C; Suzuki, Y | 1 |
Aller, R; Boixeda, D; De Argila, CM; de Luis, DA; Ruiz Del Arbol, L | 1 |
Araki, A; Sendo, F | 1 |
Eyal, A; Greif, F; Lelcuk, S; Shalit, I | 1 |
Cree, IA; Henderson, IS; Jones, M; McCafferty, AC; McGregor, E | 1 |
Fink, U; Reiser, M; Sauter, G; Seemann, M; Wintersperger, BJ | 1 |
Montagne, JP; Osika, E; Pointe, HD; Prudent, M; Sebbouh, D; Tournier, G | 1 |
Besisik, F; Boztas, G; Cakaloglu, Y; Calangu, S; Demir, K; Eraksoy, H; Kaymakoglu, S; Okten, A | 1 |
Gooch, WM; Philips, A; Rhoades, R; Rosenberg, R; Schaten, R; Starobin, S | 1 |
Braga, PC; Dal Sasso, M; Maci, S | 1 |
Levit, AL; Spitsyn, PI | 1 |
Pasiukov, VV; Ryzhko, IV; Samokhodkina, ED; Shcherbaniuk, AI; Tsuraeva, RI | 1 |
Bryskier, A; Duez, JM; Kazmierczak, A; Neuwirth, C; Péchinot, A | 1 |
Brogden, RN; Spencer, CM | 1 |
Allende, H; Almirante, B; Capdevila, JA; Crespo, E; Gavaldà, J; Laguarda, M; Otero, J; Pahissa, A; Pigrau, C; Ruiz, I | 1 |
Aldridge, KE; Johnson, WD | 1 |
Caillon, J; Jacolot, A; Louchahi, K; Mimoz, O; Padoin, C; Petitjean, O; Samii, K; Tod, M | 1 |
André-Alves, MR; Dagrosa, EE; Palombini, BC | 1 |
Härtl, A; Mrestani, Y; Neubert, R; Schiewe, J | 1 |
Chen, DK; Chen, YF; Gu, JM; Hou, J; Hu, WZ; Jia, YX; Li, JT; Li, LJ; Liu, DM; Lu, Y; Miao, JZ; Sun, L; Wang, HL; Wang, Z; Wu, J; Zhang, XZ; Zhang, YL | 1 |
Nakagawa, T; Yamaoka, K; Yasui, H | 1 |
Sato, Y | 1 |
Agneter, E; Burgdorff, T; Eichler, HG; Georgopoulos, A; Haag, O; Jansen, B; Müller, M; Pehamberger, H; Stanek, G; Weninger, W | 1 |
Nicolau, DP; Nightingale, CH; Patel, KB; Quintiliani, R | 1 |
Azoulay-Dupuis, E; Bédos, JP; Carbon, C; Darras-Joly, C; Moine, P; Rieux, V; Sauve, C | 1 |
Aguilar, L; Balcabao, IP; Dal-Ré, R; García, Y; Martín, M; Prieto, J | 1 |
Derevianko, II; Khodyreva, LA; Kondrat'eva, EM; Kotliarova, GA; Siniukhin, VN | 1 |
Altwein, JE; Baur, H; Frimberger, M | 1 |
Aller, R; Arocena, C; Boixeda, D; de Luis, DA; Martín de Argila, C; Moreira, V | 1 |
Hakenbeck, R; Krauss, J | 1 |
Forrest, A; Hyatt, J; Nix, DE; Schentag, JJ; Strenkoski-Nix, LC; Thomas, J; Wilton, JH | 1 |
Jones, RN; Pfaller, MA | 1 |
Ohsawa, R; Okazaki, N; Sata, S; Suzuki, R; Wada, A; Watanabe, H; Watanabe, Y; Yamai, S | 1 |
Hładki, W; Keller-Skomska, M; Krzesiwo-Stempak, K | 1 |
Albrecht, WE; Bamberger, DM; Fiorella, R; Papasian, CJ; Riddell, SW | 1 |
Hakenbeck, R; König, A; Marton, A; Reichmann, P | 1 |
Grebe, T; Hakenbeck, R; Krauss, J; van der Linden, M | 1 |
Alonso, R; Cisterna, R; Colom, K; Fernández-Aranguiz, A | 1 |
Impallomeni, M; Starr, JM | 1 |
Cebrero García, M; García Frías, E; Oria de Rueda Salguero, O; Pérez Moro, A; Romanyk Cabrera, J | 1 |
Aguilar, L; Balcabao, IP; Frías, J; Giménez, MJ; Martín, M; Prieto, J; Rosendo, J | 1 |
Buhr, HJ; Foitzik, T; Hotz, HG; Kinzig, M; Sörgel, F | 1 |
Commins, DJ; Koay, B; Milford, CA; Renowden, S | 1 |
Alestig, K; Eilard, T; Ek, E; Hebelka, M; Johansson, E; Olinder-Nielsen, AM; Sandberg, T | 1 |
Fernández Ordóñez, R; Moreno Palomares, JJ; Reverte Cejudo, D | 1 |
Amato, GM; Giuffrè, M; Manfrè, L; Morello, A | 1 |
Aguilar-Zacarías, C; Silva-Sánchez, J | 1 |
Dagrosa, EE; Facco, EB; Mendoza, F; Palombini, BC; Piovano, CF | 1 |
Bow, L; Nicolau, DP; Nightingale, CH; Quintiliani, R; Tessier, PR; Xuan, D | 1 |
Gorby, GL; Phanucharas, JP | 1 |
Bartunek, A; Graninger, W; Hiesmayr, M; Parschalk, B; Pernerstorfer, T; Wenisch, C; Zedtwitz-Liebenstein, K | 1 |
Betts, RF; Bonnez, W; Cooper, CK; Hardy, DJ; Pacheco, TR | 1 |
Blahová, J; Hupková-Lesická, M; Králiková, K; Krcméry, V; Kubonová, K | 1 |
Klugman, KP; Koornhof, HJ | 1 |
Eppes, S; Salen, PN | 1 |
Hanberger, H; Nilsson, LE | 1 |
Hitt, CM; Nicolau, DP; Nightingale, CH; Quintiliani, R | 1 |
Bouza, E; Lode, H; Mouton, Y; Wilson, WR | 1 |
Jones, RN; Malledant, J; Privitera, G; Wittmann, DH | 1 |
Cooke, J; Doreau, C; Eandi, M | 1 |
Goldstein, FW | 1 |
Bean, K; Hook, EW; Jones, RB; Maroli, AN; Martin, D; McCormack, WM | 1 |
Block, SL; Chartrand, SA; Harrison, CJ; Hedrick, JA; Pollack, J; Rodriguez, W; Schwartz, R; Thedinger, B | 1 |
Schein, M | 1 |
Bajaksouzian, S; Jacobs, MR | 1 |
Ghaffarzadeh, K; Rastegar Lari, A; Shamshiri, AR; Validi, N | 1 |
Chaibi, EB; Labia, R; Scanvic, AM; Scavizzi, MR; Soilleux, MJ | 1 |
Friedland, IR; Klugman, KP | 1 |
Barre, J; Bingen, EH; Bonacorsi, S; Bourrillon, A; Cohen, R; Doit, C | 1 |
Ahn, B; Chay, K; Jung, Y; Lee, M; Song, D; Yang, S | 1 |
Gasc, AM; Geslin, P; Giammarinaro, P; Selakovitch-Chenu, L; Sicard, M | 1 |
Medeiros, AA | 1 |
Chuang, YC; Huang, KY; Ko, WC; Lin, KY; Liu, JW; Wu, JJ | 1 |
Arcidiacono, MM; Baratelli, M; De Martini, G; Fraschini, F; Ghezzi, R; Peretto, L; Scaglione, F | 1 |
Alcaide, F; Hakenbeck, R; König, A; Liñares, J; McDougal, L; Reichmann, P; Swidsinski, S; Tenover, FC | 1 |
Bertram, P; Schumpelick, V; Töns, C; Winkeltau, GJ | 1 |
Van Deynse, E; Van Noyen, G; Van Noyen, R; Vermijlen, P | 1 |
Blahová, J; Králiková, K; Krcméry, V; Kubonová, K | 1 |
Grimm, H; Jones, RN; Marshall, SA | 1 |
de Pablos, M; Lezaun, MJ; López-Bayón, J; Michaus, ML; Pérez-Díaz, L | 1 |
Billoo, AG; Memon, HI; Memon, IA | 1 |
Konstantinova, TD; Lenkova, NI; Minaev, VI; Nonikov, VE; Ritchik, LA | 1 |
Barquet, N; Casado-Flores, J; Domingo, P; Osona, B | 1 |
Dryden, M; Page, A; Sampson, M; Samuel, W; Shepherd, H | 1 |
Ashkenazi, S; Rachmel, A; Samra, Z; Steinberg, T | 1 |
Feshchenko, IuI; Opanasenko, NS; Pristaĭko, IaI | 1 |
Braga, PC; Ricci, D | 1 |
Libby, JM | 1 |
Doern, GV; Jones, RN; Pfaller, MA; Salazar, JC | 1 |
Bhutta, ZA; Hussain, R; Mansoorali, N | 1 |
Butt, CJ; Palmer, KT; Rampling, A; Tully, M; West, AA | 1 |
Bhutta, ZA | 1 |
Brown, SP; Buckingham, SC; Joaquin, VH | 1 |
Aguilar, JC; Daza, R; Martínez, MM; Mendaza, P | 1 |
Borde, M; Escande, F; Pateyron, F | 1 |
Derendorf, H; Eichler, HG; Georgopoulos, A; Kovar, A; Müller, M; Rohde, B | 1 |
Bennis, M; Elleuch, A; Krid, M; Mosbah, A | 1 |
Ben Hassen, A; Ben Redjeb, S; Kamoun, A; Mahjoubi, F | 1 |
Gazouli, M; Gladin, DP; Kozlova, NS; Sidorenko, SV; Tzelepi, E; Tzouvelekis, LS | 1 |
Comis, SD; Hayward, TL; Osborne, MP; Stephen, J; Tarlow, MJ; Winter, AJ | 1 |
Joyanes, P; Martínez-Martínez, L; Pascual, A; Perea, EJ; Suárez, AI | 1 |
Aldridge, KE; Patel, MM; Saenz, RE; Sanders, CV | 1 |
Bégué, P; Boulesteix, J; Dabernat, H; de La Roque, F; Dubreuil, C; Geslin, P; Megraud, F; Scheimberg, A; Trinh, A | 1 |
Dufillot, D; Gahouma, D; Kani, F; Koko, J; Reymond-Yeni, A | 1 |
Fresnadillo, MJ; García Sánchez, E; García Sánchez, JE; García-Rodríguez, JA | 1 |
Bauernfeind, A; Gniadkowski, M; Jungwirth, R; Mikiewicz, B; Pałucha, A; Schneider, I | 1 |
Jabbar, A; Siddique, T | 1 |
Fachinelli, H; Kijanczuk, S; Mingrone, H; Salvarezza, CR | 1 |
Cuadrado Bello, P; Herrera Martín, M; Hortelano López, M | 1 |
Gazouli, M; Sidorenko, SV; Tzelepi, E; Tzouvelekis, LS | 1 |
Asherov, J; Atzmon, Y; Dan, M; Edelman, A; Hafely, H; Poch, F | 1 |
Makarovskaia, LN; Markovskaia, EI; Ryzhkova, VV; Sorokina, TB; Zurabian, VA | 1 |
Anderson, AN; Ebrahim, O; Wessels, F | 1 |
Asvanich, K; Fugpholngam, V; Srimuang, S; Tanphaichitra, D | 1 |
Lyons, CJ; Marshman, WE | 1 |
Fremaux, A; Geslin, P; Sissia, G; Spicq, C | 1 |
Choi, EH; Lee, HJ | 1 |
Gautam, A; Gupta, A; Pandey, M; Shukla, VK; Singh, H | 1 |
Alekseev, AA; Elagina, LV; Grishina, IA; Iakovlev, VP; Khlebnikov, EP; Krutikov, MG; Kubyshkin, VA; Kurochkina, AI; Pavlova, MV | 1 |
Arnow, PM; Bova, JL; Newell, KA; Thistlethwaite, JR; Thompson, KD; Zachary, KC | 1 |
Rivers, T; Waites, KB | 1 |
Bhathena, HM; Kavarana, NM | 1 |
Barberán, J; Campos, A; García, MC; Khorrami, S | 1 |
Bartoníková, N; Blahová, J; Hupková-Lesická, M; Králiková, K; Krcméry, V; Kubonová, K; Schäfer, V; Torsová, V | 1 |
Abo Rahmy, E | 1 |
Begue, P; Carles, P; Garabedian, EN; Pangon, B; Polonovski, JM; Roger, G; Thien, HV | 1 |
Bradford, PA; Gardovska, D; Grope, I; Sahm, D; Storch, G; Yang, Y | 1 |
Blahová, J; Hupková, M; Králiková, K; Krcméry, V; Kubonová, K; Lísková, A | 1 |
Kessler, A; Nagar, H; Weiss, J | 1 |
Casey, AT; Davies, AP; Hart, AJ; Stannard, AJ; Thompson, P | 1 |
Ispahani, P; Punt, J; Vloebeghs, M; Watson, AR; Weston, VC | 1 |
Bernhardt, H; Knoke, M; Schulz, K; Zimmermann, K | 1 |
Gazouli, M; Legakis, NJ; Markogiannakis, A; Tzelepi, E; Tzouvelekis, LS | 1 |
Bergeron, MG; Bergeron, Y; Deslauriers, AM; Olivier, M; Ouellet, N; Simard, M | 1 |
Fenoll, A; Ruiz, J; Sempere, M; Simarro, E | 1 |
Quiles Durá, JL | 1 |
Iqbal, I; Malik, MS; Rabbani, W | 1 |
Buschiazzo, H; Lacchini, R; Mordujovich, P; Quiroga, G; Rule, R | 1 |
Adam, D | 1 |
Matsumoto, Y | 1 |
Lorenz, J | 1 |
de Lalla, F | 1 |
Hamilton-Miller, J | 1 |
Ludwig, E | 1 |
Roussel-Delvallez, M | 1 |
Parrish, AG | 1 |
Biryol, I; Yilmaz, N | 1 |
Billot-Klein, D; Coutrot, A; Gutmann, L; Legrand, R; Mainardi, JL; Schoot, B | 1 |
Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
Peters, G; Schumacher-Perdreau, F | 1 |
Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S | 1 |
Iqbal, I; Malik, MS; Rabbani, MW | 1 |
Burman, LG; Finnström, O; Haeggman, S; Isaksson, B | 1 |
Bosch-Reig, F; Campíns-Falcó, P; Martinez, LG; Sevillano-Cabeza, A | 1 |
Corosu, R; Di Roberto, R; Marziali, M; Roma, B | 1 |
Arita, K; Eguchi, K; Kurisu, K; Mizoguchi, N; Tajima, T; Tominaga, A; Yoshioka, H | 1 |
Greenman, J; Hassan, IJ; Millar, MR; Stark, RM | 1 |
Almela, M; García San Miguel, J; Marco, F; Martínez, JA; Mensa, J; Moreno-Martínez, A; Soriano, E; Vila, J | 1 |
Nikoskelainen, J; Oksi, J; Viljanen, MK | 1 |
Gazouli, M; Legakis, NJ; Tzouvelekis, LS | 1 |
Leung, D | 1 |
Berry, I; Gilard, V; Malet-Matino, M; Manelfe, C; Ranjeva, JP; Sabatier, J; Tremoulet, M | 1 |
Caron, F | 1 |
Chadha, IA; Jalewa, AK; Pillai, TA | 1 |
Dmitriev, AE; Murylev, VIu; Shishlo, VK; Vtorenko, VI; Vyrenkov, IuE; Zorokhovich, OL | 1 |
González, R; Hoogmartens, J; Nuevas, L; Rodríguez, JC | 1 |
Agbaba, D; Eric-Jovanovic, S; Vladimirov, S; Zivanov-Stakic, D | 1 |
Abdellatef, HE; Ayad, MM; Elsaid, HM; Shalaby, AA | 2 |
Bellosta, C; Boccazzi, A; Careddu, P; Tonelli, P | 1 |
Blackshear, P; Branch, S; Chernoff, N; Hall, L | 1 |
Fernández-Fernández, FJ; García-Rodríguez, JF; González-González, C; Sesma, P | 1 |
Basly, I; Basly, JP; Bernard, M | 1 |
Guo, S; Liang, X | 1 |
Cao, XT; Kneen, R; Nguyen, TA; Parry, CM; Truong, DL; White, NJ | 1 |
Hubbard, RW; Slocum, R | 1 |
Benfield, P; Foster, RH; Plosker, GL | 1 |
Abe, T; Ikeuchi, S; Isoshima, A; Tanaka, T; Yoshino, K | 1 |
Mouffok, N; Perez-Eid, C | 1 |
Arcidiacono, MM; Demartini, G; Dugnani, S; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
Ell, C; Gossner, L; Hahn, EG; Keymling, J | 1 |
Bonvin, P; Dons-Jensen, H; Ejlertsen, T | 1 |
Cox, CE; Echols, RM; Klimberg, IW; Kowalsky, SF; Malek, GH; Patterson, AL; Whalen, E | 1 |
Bourrillon, A | 1 |
Blahová, J; Králiková, K; Krcméry, V; Schäfer, V | 1 |
Komiyama, S; Komune, S; Nakagawa, T | 1 |
Hay, AJ; Lo, TY | 1 |
Imamura, S; Teramoto, H; Uchino, M; Yamashita, S | 1 |
Manzor, O; Pawlak, J; Saravolatz, L | 1 |
Chin, NX; Della-Latta, P; Haddad, J; Saiman, L | 1 |
Baskin, M; Charron, M; Hickey, RW; Hoberman, A; Janosky, JE; Kearney, DH; Majd, M; Reynolds, EA; Ruley, J; Wald, ER | 1 |
Gené Giralt, A; González Pascual, E; Huguet Carol, R; May Llanas, E; Pons Odena, M; Ros Viladoms, J | 1 |
Dulaney Lopez, AM; Estes, KS; Lopez-Samblas, AM; Rodriguez, JC | 1 |
Aldeguer, X; Arroyo, V; Castells, L; Ginès, P; Guevara, M; Navasa, M; Planas, R; Rodés, J; Ruiz-del-Arbol, L; Soriano, G; Sort, P; Vargas, V | 1 |
Bass, NM | 1 |
Hao, F; Li, J; Zhao, C | 1 |
Chen, M; Wang, H; Xu, Y | 1 |
Hermanowska-Szpakowicz, T; Kasprzycka, E; Zajkowska, JM | 1 |
Alberty, J; Hermann, W; Stoll, W | 1 |
Bradley, JS; Feris, JM; Khan, WN; McCracken, GH; Odio, CM; Puig, JR; Rodriguez, WJ | 1 |
Ji, M; Li, G; Zhang, Y | 1 |
Chen, X; Sun, Z; Xu, W | 1 |
Chiu, CH; Lin, TY; Ou, JT | 1 |
Gasc, AM; Giammarinaro, P; Sicard, M | 1 |
Hájek, V; Kolár, M; Látal, T | 1 |
Bergeron, MG; Bergeron, Y; Deslauriers, AM; Gauthier, MC; Ouellet, N | 1 |
Dowell, SF; Leversedge, K; Smith, T; Snitzer, J | 1 |
Clemente González, C; García Bragado, F; Ruiz Aguirre, J; Vilert Garrofa, E | 1 |
Enrique, E; Gaig, P; García-Ortega, P; San Miguel, MM | 1 |
Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM | 1 |
Fasheh, WY; López Vílchez, MA | 1 |
Fauser, AA; Finke, J; Höffken, G; Pasold, R; Pflüger, KH; Szelenyi, H; Wagner, J | 1 |
Dalmau, D; Fenyves, D; Layrargues, GP; Turgeon, F; Turgeon, P; Willems, B | 1 |
Baraldés, MA; Castellanos, M; Domingo, P; Mauri, A; Monmany, J; Pericas, R; Vázquez, G | 1 |
Burke, JF; Gaughan, WJ; Hassan, MH; McCue, PA; Sharma, K | 1 |
Kusuhara, H; Sugiyama, Y; Suzuki, H | 1 |
Aliaga Martínez, L; Arrebola Nacle, JP; Cobo Martínez, F; de la Rosa Fraile, M; Díaz Monllor, F; Mediavilla García, JD | 1 |
Doré, P; Fauchère, JL; Ferrand, E; Grollier, G; Hira, M; Robert, R | 1 |
Lehman, SS | 1 |
Callister, SM; Jobe, DA; Rawal, N; Schell, RF | 1 |
Cinco, M; Marchetti, F; Murgia, R | 1 |
Barberis, C; de Mier, C; Famiglietti, A; Gutkind, G; Maltagliatti, M; Mollerach, M; Power, P; Radice, M; Vay, C | 1 |
Edwards, MS; Noyola, DE | 1 |
Petlak, A; Słomiński, JM; Wolska-Goszka, L | 1 |
Beall, B; Facklam, RR; Gherardi, G; Whitney, CG | 1 |
Burroughs, A; Patch, D | 1 |
Breiman, RF; Cetron, M; Farley, MM; Fiore, AE; Harrison, LH; Jorgensen, JH; Kolczak, MS; Moroney, JF; Patterson, JE; Schuchat, A | 1 |
Inoue, M; Kawakami, S; Matumura, M; Miyazawa, Y; Okamoto, R; Ono, Y; Yamamoto, M | 1 |
Mykhaĭlovych, IuI | 1 |
Braga, PC; Sala, MT; Sasso, MD | 1 |
Costa, G; Lepre, L; Liotta, G; Maggiolini, F; Mazzoni, G; Tocchi, A | 1 |
Balci, M; Bozcuk, H; Ersoy, FF; Ozcan, S; Sezer, T; Süleymanlar, G; Ustün, H; Yakupoglu, G; Yegin, O | 1 |
Casado Flores, J; Lalinde Fernández, M; Martínez de Azagra, A; Riaza Gómez, M | 1 |
Erdem, G; Schleiss, MR | 1 |
Barrett, NL; Farley, MM; Feikin, DR; Harrison, LH; Jorgensen, JH; Kolczak, M; Lefkowitz, L; Lexau, C; McGeer, A; Patterson, JE; Schuchat, A; Stefonek, KR; Vugia, DJ | 1 |
Elert, O; Krein, AE; Spindler, R | 1 |
Gagnon, L; Huletsky, A; Langaee, TY | 1 |
Bernier, C; Bouvard, E; Meyniel, D; Parrot, A; Saidi, F | 1 |
Bost-Bru, C; Croize, J; Francois, P; Kay's Kayemba, S; Raobijoana, H | 1 |
Brkljacic, B; Jadrijevic, S; Kocman, B; Martinac, M; Patrlj, L; Sebecic, B; Sosa, T | 1 |
Aguilar, C; Ayala, G; Estrada, MA; Garza-Ramos, U; Lara-Lemus, R; Ledezma, L; Silva, J | 1 |
Christodoulou, C; Dellagrammaticas, HD; Kapetanakis, J; Kourakis, G; Megaloyanni, E; Papadimitriou, M | 1 |
de Man, P; van den Anker, JN; Verbrugh, HA; Verhoeven, BA; Vos, MC | 1 |
Aspiroz, C; Castillo, J; Duran, E; Egido, P; Garcia, C; Gomez-Lus, R; Goñi, P; Navarro, C; Rubio, MC; Vergara, Y | 1 |
Chen, CF; Chen, KC; Chen, YF; Shum, AY; Tsai, TH | 1 |
Barrio, JL; Dedéu, JM; Gómez, C; Guarner, C; Kolle, L; Miñana, J; Novella, MT; Ortiz, J; Ricart, E; Sàbat, M; Sola-Vera, J; Soriano, G | 1 |
Aguilar, L; Casal, J; Fenoll, A; Giménez, MJ; Jado, I | 1 |
De Arriba, JJ; Escribano, E; Fernández, JM; Ferreras, P; Sánchez, MV; Serrano, M | 1 |
Lung, JM; Mallory, SB | 1 |
Arlet, G; Donay, L; Herrmann, J; Lagrange, PH; Nadjar, D; Philippon, A; Rouveau, M; Verdet, C | 1 |
Li, L; Lim, CK | 1 |
Bonnet, R; Chanal, C; De Champs, C; Labia, R; Sampaio, JL; Sirot, D; Sirot, J | 1 |
Barbé, J; Miró, E; Navarro, F; Prats, G; Sabaté, M; Tarragó, R; Vergés, C | 1 |
Kato, H; Matsuo, Y; Nagai, K; Sakata, Y; Tsumura, N | 1 |
Bethe, U; Cornely, OA; Diehl, V; Fätkenheuer, G; Salzberger, B; Schrappe, M; Seifert, H | 1 |
Newton, W; Reed, K | 1 |
Chuang, YC; Ko, WC; Lee, HC; Liu, CC; Wu, JJ | 1 |
Mackay, AD; Sam, WI | 1 |
Baril, L; Bricaire, F; Cracco, C; Delafosse, C; Derenne, JP; Lefort, Y; Morelot, C; Similowski, T | 1 |
Bégué, CR; Bégué, RE; English, MR; Perez Mato, S | 1 |
Guttigoli, A; Zaman, MM | 1 |
Baas, I; Hart, W; Koopmans, RP; Schreuder, MC | 1 |
Allouch, PY; Chardon, H; Lallali, AK; Pangon, B; Pina, P; Rio, Y | 1 |
Cassetta, MI; Conti, S; Esposito, S; Fallani, S; Mazzei, T; Novelli, A; Noviello, S; Periti, P | 1 |
Baquero, F; Blázquez, J; Levin, BR; Lipsitch, M; Negri, MC | 1 |
Angel, C; Chand, N; Murillo, C; Rowen, J; Sankar, A | 1 |
Borgia, F; Cannavò, SP; Guarneri, F; Vaccaro, M | 1 |
Chang, SC; Fang, CT; Hsueh, PR; Luh, KT; Wang, JT | 1 |
Louie, M; Simor, AE; Watt, C | 1 |
Fini, A; González, M; Hernández, R; López, MA; Rodríguez, JC | 1 |
Kushnareva, MV | 1 |
Aloni, D; Bessler, H; Gurary, N; Sirota, L; Vishne, TH | 1 |
Klugman, KP; Smith, AM | 1 |
DeFranco, PE; Goebel, J; Lee, B; Shook, LA | 1 |
Diemont, WL; van Grootheest, AC; van Puijenbroek, EP | 1 |
McWhinney, PH; Ragunathan, PL; Rowbottham, TJ | 1 |
Zanen, HC | 1 |
Edwards, WD; Grogg, KL; Patel, R; Schwenk, NM; Wright, AJ | 1 |
Begué, P; Cohen, R; Floret, D; Olivier, C | 1 |
Geraedts, AA; Tytgat, GN; van der Ende, A; van der Hulst, RW; van der Voort, PH; Zandstra, DF | 1 |
de Lalla, F; Lazzarini, L; Nicolin, R | 1 |
Graham, A; Skinner, JA; Smith, HR; Threlfall, EJ; Ward, LR | 1 |
Butkevich, OM; Vinogradova, TL | 1 |
Alvarez de Cózar, F; Barberá Durbán, R; Sendra Tello, J | 1 |
Blandino, G; Milazzo, I; Musumeci, R; Nicoletti, G; Nicolosi, VM; Speciale, A | 1 |
Baquero, F; Cantón, R; Coque, TM; Oliver, A; Pérez-Díaz, JC | 1 |
Galindo, J; Meseguer, MA; Oliver, A; Peromingo, R; Pujol, I; Sabán, J; Tarragó, D | 1 |
Brun, J; Leclercq, R; Malbruny, B; Prévost, JN; Vergnaud, M | 1 |
Barry, AL; Brown, SD | 1 |
Barbadillo Izquierdo, F; Carpintero Martín, I; González De La Rosa, JB; Merino Arribas, J; Rodrigo Palacios, J | 1 |
Musiał, W; Pawłowski, L; Zajac, M | 1 |
Hundt, AF; Hundt, HK; Scanes, T; Swart, KJ | 1 |
Fruchart, A; Husson, MO; Izard, D; Quelquejay, J | 1 |
Brett, MS | 1 |
Samsygina, GA | 1 |
Haber, M; Hommel, G; Kramann, C; Pfeiffer, N; Pitz, S; Schwenn, O | 1 |
Chuang, YC; Ko, WC; Lee, HC; Su, CY; Ten, SH; Wu, JJ | 1 |
Phantumchinda, K; Suankratay, C; Tachawiboonsak, W; Wilde, H | 1 |
Coales, UF; Solomons, N | 1 |
Kottilil, S; Menon, M; Papudesu, B; Yunis, N | 1 |
Basta, SA; Oldfield, EC | 1 |
Arr, M; Flautner, L; Pulay, I; Williams, C; Zsirka, KA | 1 |
Arrieta, A; Bradley, JS | 1 |
O'Ryan, M; Sáez-Llorens, X | 1 |
Krishna, S; Puri, V | 1 |
Abbott, K; Bear, J; Goldwater, PN; Grieve, A; Masendycz, PJ; Palombo, EA; Rowland, K; Thesinger, M; Wilkinson, I | 1 |
Barson, WJ; Bradley, JS; Givner, LB; Kaplan, SL; Kim, KS; Mason, EO; Schutze, GE; Tan, TQ; Wald, ER; Yogev, R | 1 |
Cohen, C; Matthews, RP; Shah, SS | 1 |
Porcalla, AR; Rodriguez, WJ | 1 |
Deng, W; Gao, B; Hu, J | 1 |
Corkill, JE; Hart, CA; Kariuki, S; Musoke, R; Revathi, G | 1 |
Dranitsaris, G; McGeer, A; Pitre, M; Spizzirri, D | 1 |
Alvarez-Lerma, F; Cerda, E; Olaechea, P; Palomar, M; Sierra, R | 1 |
Cornaglia, G; Fontana, R; Ligozzi, M | 1 |
Eller, J; Lode, H; Mauch, H; Raffenberg, M | 1 |
Bonnet, R; Chanal, C; De Champs, C; Dutour, C; Labia, R; Sampaio, JL; Sirot, D; Sirot, J | 1 |
Li, Y; Wang, K; Zhao, Y | 1 |
Cars, O; Gustafsson, I; Löwdin, E; Odenholt, I | 1 |
Bouza, E; Cordero, E; Pachon, J; Ruiz, I | 1 |
Barbarina, N; de Hoffmann, E; Tilquin, B | 1 |
Al-Tamimi, SA; Alwarthan, AA; Metwally, FH | 1 |
Boriszova, D; Glatz, K; Rozgonyi, F; Szabó, D; Szabó, G | 1 |
Chawla, HP; Panchagnula, R; Sharma, P | 1 |
Amir, J; Harel, L; Straussberg, R | 1 |
Ho, SW; Hsueh, PR; Jean, SS; Luh, KT; Teng, LJ | 1 |
Wareham, DW | 1 |
Bitsori, M; Galanakis, E; Maraki, S; Raissaki, M; Sbyrakis, S; Velivassakis, E | 1 |
Choh, H; Nakao, A; Okada, K; Takenaka, N; Takeuchi, Y; Yamashita, Y | 1 |
Chen, P; Hou, X; Ma, Z | 1 |
Baquero, F; Baquero, MR; Blázquez, J; del Campo, R; Morosini, MI; Negri, MC | 1 |
De Champs, C; Gerome, P; Naas, T; Nordmann, P; Poirel, L; Stephanazzi, J | 1 |
Arisi, A; Beghi, C; Cabassi, A; Campodonico, R; Fiaccadori, E; Gherli, T; Maggiore, U | 1 |
Jones, ME; Karlowsky, JA; Mayfield, DC; Sahm, DF; Thornsberry, C | 1 |
Chanawong, A; Hawkey, PM; Heritage, J; M'Zali, FH; Xiong, JH | 1 |
Brunner, J; Kirkpatrick, CJ; Lehr, HA; Rangoonwala, R | 1 |
Cagatay, AA; Calangu, S; Dilmener, M; Eraksoy, H; Kaygusuz, A; Ozsut, H; Punar, M | 1 |
Hamada, T; Kodama, H; Osaki, T; Ueta, E | 1 |
Bedenić, B | 1 |
Babu, E; Endou, H; Narikawa, S; Takeda, M | 1 |
Baliga, S; Prabha Adhikari, MR | 1 |
Issack, MI; Ragavoodoo, C | 1 |
Guban, V; Jurkovic, R; Klokocníková, L; Satko, I | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Cao, V; Courvalin, P; Lambert, T | 1 |
Adair, CG; Byers, LM; Crowe, M; Feron, B; Gorman, SP; Jones, DS; McCarthy, GJ; Milligan, KR; Webb, HC | 1 |
Domínguez Escribano, JR; Falcó Jover, G; Roig Rico, P | 1 |
Chang, FY; Ho, M; Ishii, Y; Ma, L; Siu, LK; Yamaguchi, K | 1 |
Anderson, GJ; Biddle, JW; Bush, K; Jacoby, GA; Oliver, A; Queenan, AM; Rasheed, JK; Tenover, FC | 1 |
Byrnes, GB; Dartnell, JG; Ioannides-Demos, LL; Kirsa, SW; Korman, TM; Lord, JA; Munafo, L; Robertson, MB | 1 |
Crist, C; Masters, E | 1 |
Hameed, R; Riordan, FA | 1 |
Aguado, JM; Almirante, B; Dronda, F; Fernandez-Guerrero, ML; Fernandez-Viladrich, P; Gatell, JM; Llinares, P; Martínez, E; Miró, JM; Montejo, M; Moreno-Torrico, A; Villanueva, JL | 1 |
Beall, B; Besser, JM; Boxrud, DJ; Gertz, RE; Harrison, LH; Jorgensen, JH; McEllistrem, MC; Whitney, CG | 1 |
Blanca, M; Florido, JF; Mayorga, C; Quiralte, J; Sáenz de San Pedro, B; Torres, MJ | 1 |
Boukadida, J; Monastiri, K; Salem, N; Seket, B; Snoussi, N; Taher, NB | 1 |
Arndt, PA; Garratty, G | 1 |
Aller, SC; Chusid, MJ | 1 |
Chang, MC; Chuang, YC; Huang, KY; Ko, WC; Lee, CL; Tang, HJ | 1 |
Bafeltowska, JJ; Buszman, E; Hawranek, J; Mandat, K | 1 |
Guo, SJ; Li, X; Tang, Y; Wen, B; Yan, XJ | 1 |
Ding, Q; Huang, AJ; Long, H; Sun, YL; Wang, TS | 1 |
Jones, ME; Karlowsky, JA | 1 |
Lin, E; Mufson, MA; Stanek, RJ | 1 |
Anzai, N; Babu, E; Endou, H; Enomoto, A; Huang, XL; Khamdang, S; Narikawa, S; Noshiro, R; Onozato, ML; Piyachaturawat, P; Takeda, M; Tojo, A | 1 |
Falcó Ferrer, V; Pahissa Berga, A | 1 |
Freeman, J; O'Neill, FJ; Wilcox, MH | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F | 1 |
Baquero, F; Baquero, MR; Galán, JC; Morosini, MI; Reig, M | 1 |
Aumeran, C; Bonnet, R; Chanal, C; Labia, R; Sirot, D; Sirot, J | 1 |
Hellerstein, S | 1 |
Knox, JR; Kumar, S; Nukaga, K; Nukaga, M; Pratt, RF | 1 |
Brandileone, MC; Castanheira, M; Jones, RN; Sader, HS; Silbert, S | 1 |
Kitazato, M; Minami, S; Mitsuyama, J; Mizunaga, S; Morikawa, Y; Watanabe, Y | 1 |
Høiby, N; Walther-Rasmussen, J | 1 |
Bertrand, X; Lopez-Lozano, JM; Muller, A; Talon, D | 1 |
Brown, A; Corrado, O; Donaldson, K; Fawley, W; Freeman, J; MacKinlay, S; Wilcox, MH | 1 |
Bruining, HA; Buijk, SE; Groenland, TH; Gyssens, IC; Metselaar, HJ; Mouton, JW; Verbrugh, HA | 1 |
Dower, SK; Moore, LJ; Pridmore, AC; Read, RC | 1 |
Lee, WS; Lin, ML; Liu, CY; Wang, FD | 1 |
Cao, LD; Naruhiko, I; Nobue, T; Yoichi, K | 1 |
Amin, AS; Ragab, GH | 1 |
Castro, S; Famiglietti, A; Gutkind, G; Juárez, J; Perazzi, B; Radice, M; Rodríguez, C; Santini, P; Vay, C | 1 |
Aleksić, M; Burić, N; Kapetanović, V; Popović, G; Savić, V | 1 |
Althoff, EA; Carter, BT; Cornish, VW; Goldberg, SD; Lin, H; Raushel, J | 1 |
García-García, MI; García-Rodriguez, JA; García-Sánchez, E; García-Sánchez, JE; Munõz-Bellido, JL; Trujillano, I | 1 |
Di Conza, JA; Gutkind, GO; Méndez, E; Mollerach, A; Mugna, V; Radice, M; Truppia, LA | 1 |
Akova, M; Hasçelik, G; Metan, G; Zarakolu, P | 1 |
Chuang, YM; Ho, YC; Hsueh, PR; Teng, LJ; Tseng, SP | 1 |
Gannouni, A; Golli, M; Haddad, A; Hafsa, C; Jerbi-Omezzine, S; Kriaa, S; Sakkouhi, M; Salem, R; Zbidi, M | 1 |
Ikonomidis, A; Kristo, I; Maniatis, AN; Markogiannakis, A; Pournaras, S; Tsakris, A | 1 |
Bilewska, A; Dukaczewska, A; Goławski, C; Kicman, A; Luczak, M; Młynarczyk, A; Młynarczyk, G; Pupek, J; Serafin, I | 1 |
Jouy, E; Kobisch, M; Lazizzera, C; Madec, JY; Meunier, D | 1 |
Chatsuwan, T; Chokephaibulkit, K; Dejsirilert, S; Nunthapisud, P; Phongsamart, W; Rungnobhakhun, P; Srifeungfung, S; Treerauthaweeraphong, V | 1 |
Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
Andrasi, M; Buglyo, P; Gaspar, A; Zekany, L | 1 |
Abraham, OC; Brahmadathan, KN; Jagannati, M; John, G; Kaul, S; Pitchamuthu, K; Sudarsanam, TD | 1 |
Aguilar, L; Fenoll, A; Giménez, MJ; Granizo, JJ; Martín-Herrero, JE; Robledo, O; Tarragó, D | 1 |
D'Andrea, MM; Mugnaioli, C; Rossolini, GM | 1 |
Aguilar, L; Alou, L; Cafini, F; Giménez, MJ; González, N; Granizo, JJ; Martín-Herrero, JE; Prieto, J; Sevillano, D; Torrico, M | 1 |
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
Arakawa, Y; Kato, H; Kimura, K; Kurokawa, H; Nagano, N; Shibata, N; Shibayama, K; Suzuki, S; Wachino, J; Yamane, K | 1 |
Aguilar, L; Biek, D; Fenoll, A; Giménez, MJ; Granizo, JJ; Robledo, O; Tarragó, D | 1 |
Chen, QX; Li, WG; Qiu, L; Zhong, X; Zhou, JJ; Zhuang, JX | 1 |
Tapsall, JW | 1 |
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
Arlet, G; Bakour, R; Dallenne, C; Geneste, D; Iabadene, H; Messai, Y | 1 |
Bauernfeind, A; Keuleyan, E; Markova, B; Markovska, R; Queenan, AM; Schneider, I | 1 |
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D | 1 |
Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E | 1 |
Behbood, L; Härtl, A; Mrestani, Y; Neubert, RH | 1 |
Deb, M; Gaind, R; Mohanty, S; Ranjan, R | 1 |
Caroff, N; Corvec, S; Crémet, L; Dauvergne, S; Giraudeau, C; Lepelletier, D; Reynaud, A | 1 |
Appelbaum, PC; Kosowska-Shick, K; McGhee, PL | 1 |
Dai, J; Huang, H; Li, M; Liao, LC; Liu, XM; Ma, XN; Sheng, X; Su, G; Yan, YY; Yang, L | 1 |
Birck, C; Bonnet, R; Delmas, J; Dubois, D; Leyssene, D; Robin, F; Vazeille, E | 1 |
Chen, D; Song, Z; Wang, Z | 1 |
Jayahar Bharathi, M; Murugan, N; Ramakrishnan, R; Ramesh, S | 1 |
Lu, PL; Ma, L; Siu, LK | 1 |
Baptiste, KE; Damborg, P; Guardabassi, L; Marskar, P | 1 |
Graf, JF; Scholz, BJ; Zavodszky, MI | 1 |
Bercot, B; Drancourt, M; Nordmann, P; Poirel, L | 1 |
Jang, W; Park, KG; Park, YJ; Yu, J | 1 |
Bai, KJ; Chang, FY; Chen, RJ; Chen, YH; Chen, YS; Hsu, CW; Hsueh, PR; Jean, SS; Ko, WC; Lam, C; Lee, WS; Liao, CH; Liu, CY; Liu, JW; Lu, MC; Wu, JJ; Yu, KW | 1 |
Chauvin, C; Francart, S; Jouy, E; Kempf, I; Le Cornec, M; Le Devendec, L; Marois-Créhan, C | 1 |
Aubert, V; Baserni, MN; Jugo, MB; Villar, HE | 1 |
Burke, L; de Pinna, E; Fitzgerald-Hughes, D; Hopkins, KL; Humphreys, H; Meunier, D; Woodford, N | 1 |
Livermore, DM; Mushtaq, S; Warner, M | 1 |
Singh, HL; Singh, RM | 1 |
Beydemir, Ş; Söyüt, H; Türkeş, C | 1 |
Berhin, C; Bogaerts, P; De Smet, B; Glupczynski, Y; Huang, TD; Jacobs, JA; Peetermans, WE; Phe, T; Vlieghe, ER | 1 |
Acosta-Gutierrez, S; Bodrenko, I; Ceccarelli, M; Scorciapino, MA | 1 |
Chen, QX; Cui, Y; Hu, YH; Yan, CL; Yu, F; Yu, WW; Zhuang, JX | 1 |
Ardıç, N; Duyan, S; Kılıç, A; Yılmaz, S | 1 |
Decousser, JW; Desroches, M; Jayol, A; Nordmann, P; Poirel, L | 1 |
Bachiller-Luque, P; Briongos-Figuero, LS; Carreres-Rodríguez, A; Mena-Martín, FJ; Pastor-Mancisidor, L | 1 |
Adler, AL; Elward, A; Haaland, W; Kronman, MP; Miles-Jay, A; Newland, JG; Qin, X; Weissman, SJ; Zaoutis, T; Zerr, DM; Zhou, C | 1 |
Cole, NC; Greenwood-Quaintance, KE; Harper, LW; Ihde, SM; Kohner, PC; Mushtaq, A; Patel, R; Strand, GJ; Virk, A | 1 |
Hulin, A; Khoudour, N; Legrand, T; Tournier, N; Vodovar, D | 1 |
Bekeredjian-Ding, I; El-Jade, MR; Hoerauf, A; Meilaender, A; Molitor, E; Parcina, M; Schmithausen, RM; Stein, C | 1 |
An, YJ; Cha, SS | 1 |
Cao, Y; Chen, XJ; Chen, YP; Du, LZ; Hua, CZ; Hua, ZY; Jing, CM; Li, XL; Lin, ZL; Lu, HP; Luo, QE; Wang, CQ; Xu, HM; Yu, H; Yu, HM; Zhang, H; Zhang, T; Zhuang, JQ | 1 |
Ahn, DR; Chang, J; Kim, Y; Oh, EJ; Park, KG; Park, MJ; Park, YJ; Yu, J | 1 |
Chang, FY; Chang, SC; Chen, YS; Chuang, YC; Fung, CP; Huang, IW; Lai, JF; Lauderdale, TL; Lin, WP; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
Fröding, I; Giske, CG; Vondracek, M | 1 |
Abo, H; Asai, T; Hamamoto, S; Hiki, M; Kawanishi, M; Koike, R; Kojima, A; Ozawa, M; Shimizu, Y; Suzuki, S | 1 |
Feicht, S; Finney, S; Habing, G; Hutchinson, H; Masterson, M; Muñoz-Vargas, L | 1 |
Bortolaia, V; Dalsgaard, A; Dang, STT; Le, HQ; Tran, NT | 1 |
Jayaraman, R; Kumar, JL; Neeravi, A; Ralph, R; Shanmugasundaram, D; Thomas, K; Varghese, R; Veeraraghavan, B | 1 |
Fukuda, A; Okubo, T; Sukpanyatham, N; Tagaki, C; Tamura, Y; Usui, M | 1 |
Cheng, JS; Jiang, JL; Kong, XX; Liu, H; Qiao, B; Yuan, YJ | 1 |
Loprasert, S; Mongkolsuk, S; Ploypradith, P; Sungkeeree, P; Toewiwat, N; Whangsuk, W | 1 |
Hu, L; Palzkill, T; Prasad, BVV; Sankaran, B; Sun, Z | 1 |
Sharma, AK; Vats, P | 1 |
Alavoine, L; Andremont, A; Benhayoun, M; Bourabha, K; Bridier-Nahmias, A; Burdet, C; Clermont, O; d'Humières, C; Denamur, E; Duval, X; Grall, N; Linard, M; Magnan, M; Massias, L; Mentré, F; Tenaillon, O; Tubiana, S | 1 |
Birkegård, AC; Clasen, J; Folkesson, A; Græsbøll, K | 1 |
An, YJ; Bae, DW; Cha, SS; Jung, YE; Na, JH | 1 |
Boxer, SG; Kozuch, J; Schneider, SH | 1 |
Memon, FQ; Si, H; Sun, Y; Wang, S; You, C; Zhang, G | 1 |
Maquieira, Á; Morais, S; Peña-Mendizabal, E | 1 |
Asai, Y; Hirata, Y; Kagi, T; Matsuzawa, A; Noguchi, T; Suzuki, M; Yamada, M | 1 |
Courter, J; Mortensen, JE; Murphy, ME; Powell, E | 1 |
Di Conza, JA; Liebrenz, KI; Marchisio, ML; Méndez, ELA | 1 |
Gelhaye, S; Gonzalez, C; Moguet, C; Naas, T; Sallustrau, A; Simon, S; Volland, H | 1 |
Aouam, K; Ben Fadhel, N; Ben Fredj, N; Ben Romdhane, H; Chaabane, A; Chadli, Z; Mansour, K | 1 |
Franco, S; Hammerschlag, MR; Mesa, D; Rampersad, D | 1 |
Coronel, P; Del Río, I; Domenech, M; Gimeno, M; González-Camacho, F; Lago, D; Llamosí, M; López Ruiz, B; Pérez-García, C; Sempere, J; Yuste, J | 1 |
Ali, A; Alqahtani, YS; Alqarni, AO; Alyami, BA; Ehsan, M; Hassan, M; Javed, Q; Mahnashi, MH | 1 |
Baier, C; Bange, FC; Böhne, C; Bohnhorst, B; Ebadi, E; Hansen, G; Knegendorf, L; Peter, C; Pirr, S; Schlüter, D; Schwab, F; Vital, M | 1 |
Barba-Bon, A; Ghai, I; Lafitte, D; Masi, M; Nau, WM; Pagès, JM; Schembri, T; Vergalli, J; Winterhalter, M | 1 |
Ardanuy, C; Ariza, J; Cabellos, C; Gudiol, F; Guillem, L; Pelegrin, I; Tubau, F; Viladrich, PF | 1 |
Hu, L; Judge, A; Palzkill, T; Sankaran, B; Van Riper, J; Venkataram Prasad, BV | 1 |
Harada, K; Kawahara, M; Kido, N; Miyashita, N; Morikaku, K; Omiya, T; Shimizu, T; Tanaka, S | 1 |
Al Laham, NA; Ayesh, BM; El Aila, NA | 1 |
Duval, X; Le Turnier, P; Tattevin, P; Varon, E | 1 |
Ajmal, M; Alqahtani, F; Aziz, M; Imran, I; Majeed, A; Rasool, MF; Rehman, AU; Saeed, H; Zamir, A | 1 |
64 review(s) available for cephalosporin c and cefotaxime
Article | Year |
---|---|
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Current status of bacterial resistance to third-generation cephalosporins.
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial | 1992 |
Cephalosporins--cefotaxime 10 years later, a major drug with continued use.
Topics: Bacterial Infections; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Time Factors | 1991 |
Efficacy and safety of cefotaxime in the management of pediatric infections.
Topics: Age Factors; Ampicillin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Infant, Newborn | 1991 |
Use of third-generation cephalosporins. Anaerobes.
Topics: Bacteria, Anaerobic; Bacterial Infections; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests | 1991 |
Serious pediatric infections.
Topics: Bacterial Infections; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infant, Newborn | 1990 |
[Pulmonary diffusion of cefixime in man].
Topics: Cefixime; Cefotaxime; Cephalosporins; Female; Humans; Lung; Lung Neoplasms; Male; Premedication | 1989 |
[Ceftizoxime and its place in the context of modern cephalosporins].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftizoxime; Cell Membrane Permeability; Cell Wall; Cephalosporins; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Drug Tolerance; Kinetics; Tissue Distribution | 1986 |
The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Moxalactam | 1985 |
Prevention of infection in high risk biliary operations.
Topics: Anti-Bacterial Agents; Biliary Tract Diseases; Biliary Tract Surgical Procedures; Cefotaxime; Ceftriaxone; Cephalosporins; Humans; Injections, Intravenous; Postoperative Complications; Premedication; Prospective Studies; Respiratory Tract Infections; Risk; Surgical Wound Infection | 1985 |
Beta-lactams in sexually transmitted diseases: rationale for selection and dosing regimens.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chancroid; Chlamydia Infections; Female; Gonorrhea; Humans; Infant, Newborn; Male; Ophthalmia Neonatorum; Pelvic Inflammatory Disease; Penicillins; Sexually Transmitted Diseases; Syphilis; Time Factors; Urethritis | 1984 |
[Concentrations of cefotaxime in human tissues and fluids. A review of published data (author's transl)].
Topics: Adult; Body Fluids; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Male; Pregnancy | 1981 |
Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Blood-Brain Barrier; Cefamandole; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cephalothin; Cephamycins; Child, Preschool; Enterobacteriaceae; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Moxalactam; Pseudomonas aeruginosa | 1981 |
Antipseudomonal beta-lactams.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Lactams; Moxalactam; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1981 |
[Achievements in the field of obtaining and studying new semisynthetic cephalosporin antibiotics. Research in the field of directed cephalosporin synthesis].
Topics: Acylation; Cefotaxime; Cephalosporins; Cephamycins; Chemical Phenomena; Chemistry; Heterocyclic Compounds; Methods; Research; Structure-Activity Relationship | 1981 |
Pharmacokinetics of the new cephalosporins.
Topics: Cefaclor; Cefadroxil; Cefamandole; Cefazolin; Cefmetazole; Cefonicid; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalexin; Cephalosporins; Cephamycins; Cephradine; Humans; Intestinal Absorption; Kinetics; Moxalactam; Tissue Distribution | 1982 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
Structure-activity relationships related to ceftizoxime (FK 749).
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Drug Stability; Escherichia coli; Klebsiella pneumoniae; Lactams; Mice; Proteus; Pseudomonas aeruginosa; Rats; Structure-Activity Relationship | 1981 |
Third-generation and investigational cephalosporins: II. Microbiologic review and clinical summaries.
Topics: Bacteria; Bacterial Infections; Bacteroides fragilis; Cefamandole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Humans; Moxalactam; Pseudomonas aeruginosa | 1983 |
The cephalosporin compounds in severe neonatal infection.
Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae Infections; Humans; Infant, Newborn; Meningitis; Moxalactam; Sepsis | 1984 |
[Clinical aspects, diagnosis and treatment of intrauterine infections].
Topics: Acyclovir; Ampicillin; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Cefotaxime; Cells, Cultured; Cephalosporins; Cytomegalovirus Infections; Diagnosis, Differential; Enzyme-Linked Immunosorbent Assay; Erythromycin; Female; Fetal Diseases; Herpes Genitalis; Humans; Infant, Newborn; Infant, Newborn, Diseases; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Prenatal Diagnosis; Ultrasonography, Prenatal; Virus Diseases | 1995 |
A critical review of the new oral cephalosporins. Considerations and place in therapy.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Humans | 1994 |
Treatment of severe infections caused by penicillin-resistant pneumococci. Role of third generation cephalosporins.
Topics: Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumococcal Infections; Population Surveillance; Prevalence; Streptococcus pneumoniae | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
[Research and development of new oral cephems, cefixime and cefdinir].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship | 1993 |
Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime.
Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Economics, Pharmaceutical; Humans; Pharmacokinetics | 1995 |
The role of penicillin-binding proteins in penicillin resistance of Streptococcus pneumoniae.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Genes, Bacterial; Hexosyltransferases; Humans; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Streptococcus pneumoniae | 1995 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Penicillins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Cerebral abscess complicating dental treatment. Case report and review of the literature.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Anti-Bacterial Agents; Brain Abscess; Cefotaxime; Cephalosporins; Chloramphenicol; Drug Therapy, Combination; Focal Infection, Dental; Humans; Male; Parietal Lobe; Periodontal Ligament; Postoperative Complications; Stereotaxic Techniques | 1996 |
Skull osteomyelitis due to Salmonella species: two case reports and review.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Osteomyelitis; Salmonella Infections; Salmonella typhimurium; Skull; Tomography, X-Ray Computed | 1996 |
[Meningitis due to cefotaxime-resistant Streptococcus pneumoniae].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Rifampin; Streptococcus pneumoniae; Vancomycin | 1996 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
[Retropharyngeal abscess. A report of 3 cases].
Topics: Amikacin; Anesthesia, General; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Retropharyngeal Abscess; Streptococcal Infections; Suction | 1996 |
Neonatal meningitis due to Moraxella catarrhalis and review of the literature.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Fatal Outcome; Gentamicins; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Penicillins | 1996 |
[Cefotaxime (klaforan) in modern therapy of bacterial infections].
Topics: Anti-Bacterial Agents; Blood-Brain Barrier; Cefotaxime; Cephalosporins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1996 |
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Drug Administration Schedule; Humans; Microbial Sensitivity Tests | 1997 |
Risk of diarrhoea, Clostridium difficile and cefotaxime in the elderly.
Topics: Aged; Cefotaxime; Cephalosporins; Clostridioides difficile; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Forecasting; Humans; Risk Factors | 1997 |
Failure of cefotaxime treatment in an adult with Streptococcus pneumoniae meningitis.
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Streptococcus pneumoniae | 1997 |
The use of cefotaxime for the treatment of common infections: in vitro, pharmacokinetic and clinical considerations.
Topics: Adolescent; Adult; Cefotaxime; Cephalosporins; Child; Clinical Trials as Topic; Community-Acquired Infections; Cross Infection; Humans; Microbial Sensitivity Tests; Middle Aged | 1997 |
Cefotaxime in the treatment of prophylaxis of surgical infections.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Humans; Surgical Wound Infection | 1997 |
Pharmacoeconomic aspects of antibacterial treatment with cefotaxime.
Topics: Cefotaxime; Cephalosporins; Humans | 1997 |
[Role of antibiotic prophylaxis using cefotaxime in interventional urinary endoscopy].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Endoscopy; Female; Female Urogenital Diseases; Humans; Male; Male Urogenital Diseases; Middle Aged; Postoperative Complications; Retrospective Studies; Time Factors; Urinary Tract Infections | 1995 |
[Cefotaxime: current status and future prospectives after 15 years of experience].
Topics: Cefotaxime; Cephalosporins; Forecasting; Humans | 1996 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Hospital Costs; Humans; Infant; Length of Stay; Odds Ratio; Pneumonia, Bacterial; Retrospective Studies; South Africa; Treatment Outcome | 1998 |
Spontaneous disappearance of a middle cranial fossa arachnoid cyst after suppurative meningitis.
Topics: Arachnoid Cysts; Cefotaxime; Cephalosporins; Haemophilus Infections; Humans; Infant; Magnetic Resonance Imaging; Male; Meningitis, Bacterial; Penicillins; Remission, Spontaneous; Skull; Tomography, X-Ray Computed | 1998 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
Cefotaxime. A pharmacoeconomic review of its use in the treatment of infections.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Costs and Cost Analysis; Economics, Pharmaceutical; Humans | 1998 |
[A survival case of fulminant pneumococcal meningitis as overwhelming postsplenectomy infection (OPSI) syndrome].
Topics: Adult; Ampicillin; Anti-Inflammatory Agents; Cefotaxime; Cephalosporins; Dexamethasone; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meningitis, Pneumococcal; Penicillins; Postoperative Complications; Purpura, Thrombocytopenic, Idiopathic; Splenectomy; Treatment Outcome | 1998 |
[Citrobacter freundii endocarditis].
Topics: Aged; Aortic Valve; Cefotaxime; Cephalosporins; Citrobacter freundii; Endocarditis, Bacterial; Enterobacteriaceae Infections; Heart Valve Diseases; Humans; Male; Mitral Valve | 1999 |
Group A streptococcal meningitis in the antibiotic era.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Female; Follow-Up Studies; Humans; Male; Meningitis, Bacterial; Streptococcal Infections; Streptococcus pyogenes; Treatment Outcome | 1999 |
Kinetic and biochemical analysis of carrier-mediated efflux of drugs through the blood-brain and blood-cerebrospinal fluid barriers: importance in the drug delivery to the brain.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cefotaxime; Cephalosporins; Choroid Plexus; Drug Delivery Systems; In Vitro Techniques; Mice; Pharmacokinetics; Quinidine; Rats | 1999 |
Bacteremic cellulitis caused by Non-01, Non-0139 Vibrio cholerae: report of a case in a patient with hemochromatosis.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cellulitis; Cephalosporins; Doxycycline; Hemochromatosis; Humans; Male; Treatment Outcome; Vibrio cholerae | 2000 |
Drug-resistant Streptococcus pneumoniae spinal epidural abscess in a toddler.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acid; Drug Resistance, Microbial; Epidural Abscess; Humans; Male; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2000 |
Empiric use of cefepime in the treatment of lower respiratory tract infections in children.
Topics: Adolescent; Cefepime; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Humans; Infant; Recurrence; Respiratory Tract Infections; Safety; Treatment Outcome | 2001 |
Cefepime in the empiric treatment of meningitis in children.
Topics: Adolescent; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Humans; Infant; Latin America; Meningitis, Bacterial; Randomized Controlled Trials as Topic; Safety; Treatment Failure; Treatment Outcome | 2001 |
Infant botulism: case reports and review.
Topics: Botulism; Cefotaxime; Cephalosporins; Diagnosis, Differential; Humans; Infant, Newborn; Male | 2001 |
Group C streptococcal meningitis: case report and review of the literature.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Meningitis, Bacterial; Streptococcal Infections; Streptococcus equi; Vancomycin | 2001 |
Role of long-acting cephalosporins in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2000 |
Antibiotic treatment for urinary tract infections in pediatric patients.
Topics: Acute Disease; Administration, Oral; Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cystitis; Gentamicins; Hospitalization; Humans; Infant; Infant, Newborn; Injections, Intravenous; Outpatients; Pyelonephritis; Time Factors; Urinary Tract Infections | 2003 |
Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enzyme Inhibitors; Gene Transfer, Horizontal; Monobactams; Penicillanic Acid; Penicillins; Phylogeny; Sulbactam; Tazobactam | 2004 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
The spread of CTX-M-type extended-spectrum beta-lactamases.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Models, Molecular; Prevalence | 2008 |
Clinical pharmacokinetics of cefixime: a systematic review.
Topics: Anti-Bacterial Agents; Biological Availability; Cefixime; Cefotaxime; Cephalosporins; Humans | 2023 |
135 trial(s) available for cephalosporin c and cefotaxime
Article | Year |
---|---|
Comparative study of single-dose cefotaxime and multiple doses of cefoxitin and cefazolin as prophylaxis in gynecologic surgery.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefazolin; Cefotaxime; Cefoxitin; Cephalosporins; Drug Administration Schedule; Female; Genitalia, Female; Humans; Middle Aged; Postoperative Complications; Premedication | 1992 |
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
Single dose cephalosporin prophylaxis in high-risk patients undergoing surgical treatment of the biliary tract.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Bacteria; Bile; Biliary Tract Surgical Procedures; Cefamandole; Cefotaxime; Cephalosporins; Cholecystectomy; Double-Blind Method; Female; Gallbladder; Humans; Male; Middle Aged; Postoperative Complications; Premedication; Prospective Studies; Risk Factors | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
[Cefixime, the first oral third-generation cephalosporin].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Gram-Negative Bacteria; Humans; Prodrugs; Random Allocation | 1989 |
[Hemostasis disturbance caused by cephalosporins with an N-methylthiotetrazole side chain. A randomized pilot study].
Topics: Aged; Aged, 80 and over; Azoles; Blood Coagulation Disorders; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Male; Moxalactam; Pilot Projects; Protein C; Prothrombin Time; Random Allocation; Tetrazoles; Urinary Tract Infections; Vitamin K Deficiency | 1989 |
[Prevention of postoperative complications following vaginal hysterectomy].
Topics: Bacteria; Bacterial Infections; Cefamandole; Cefotaxime; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Drainage; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Middle Aged; Premedication; Prospective Studies; Risk Factors; Surgical Wound Infection | 1989 |
A comparative study of cefotaxime sodium versus a combination of cefapirin and gentamicin in the prophylactic treatment of patients undergoing cholecystectomy.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Cephapirin; Cholecystectomy; Creatinine; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Premedication; Randomized Controlled Trials as Topic; Surgical Wound Infection | 1989 |
[Comparative study of cefuzonam (CZON) with cefmenoxime in chronic respiratory tract infections by the double-blind method].
Topics: Adult; Aged; Cefmenoxime; Cefotaxime; Ceftizoxime; Cephalosporins; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1986 |
[A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis].
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Clinical Trials as Topic; Double-Blind Method; Humans; Tonsillitis | 1987 |
Effects of cephalosporins and carumonam on blood coagulation.
Topics: Blood Coagulation; Blood Coagulation Tests; Cefotaxime; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Humans; Moxalactam; Random Allocation; Structure-Activity Relationship | 1987 |
Preventative antibiotics for penetrating abdominal trauma--single agent or combination therapy?
Topics: Abdominal Injuries; Bacterial Infections; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Costs and Cost Analysis; Drug Therapy, Combination; Gentamicins; Humans; Prospective Studies; Random Allocation; Wounds, Penetrating | 1988 |
Coagulopathy associated with extended-spectrum cephalosporins in patients with serious infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Ceftizoxime; Cephalosporins; Double-Blind Method; Female; Humans; Hypoprothrombinemias; Male; Middle Aged; Moxalactam; Peritonitis; Pneumonia; Prothrombin Time; Random Allocation | 1987 |
Antibiotic prophylaxis for prostatic surgery. Single-dose cephradine compared with single-dose cefotaxime.
Topics: Aged; Cefotaxime; Cephalosporins; Cephradine; Clinical Trials as Topic; Humans; Male; Premedication; Prospective Studies; Prostate; Prostatic Diseases; Random Allocation | 1987 |
[Prospective randomized study: cefuroxime and netilmicin versus ceftriaxone as prophylaxis in vascular surgery].
Topics: Aged; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Female; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection; Vascular Surgical Procedures | 1985 |
Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
Topics: Animals; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Haemophilus influenzae; Humans; Kinetics; Meningitis; Microbial Sensitivity Tests | 1984 |
Randomized, double-blind comparison of cefotaxime, cefoxitin, cefazolin or placebo as prophylaxis during gastric, small bowel or complicated biliary surgery.
Topics: Adult; Aged; Biliary Tract Surgical Procedures; Cefazolin; Cefotaxime; Cefoxitin; Cephalosporins; Clinical Trials as Topic; Digestive System Surgical Procedures; Double-Blind Method; Female; Humans; Intestine, Small; Male; Middle Aged; Premedication; Random Allocation; Stomach; Vagotomy | 1984 |
Treatment of non-complicated urogenital, rectal and oropharyngeal gonorrhoea with intramuscular cefotaxime 1.0 g or cefuroxime 1.5 g.
Topics: beta-Lactamases; Cefotaxime; Cefuroxime; Cephalosporins; Female; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Pharyngeal Diseases; Random Allocation; Rectal Diseases; Urethral Diseases; Uterine Cervical Diseases | 1984 |
Comparative pharmacokinetics of cefoperazone and cefotaxime.
Topics: Adult; Cefoperazone; Cefotaxime; Cephalosporins; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged | 1980 |
[Clinical trial of a new broad-spectrum cephalosporin: HR 756 (cefotaxime)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Urinary Tract Infections | 1980 |
Cefotaxime in lower respiratory tract infections compared to cefazolin.
Topics: Bacteria; Cefazolin; Cefotaxime; Cephalosporins; Humans; Pneumonia; Respiratory Tract Infections | 1980 |
Cefotaxime in the treatment of pneumococcal pneumonia.
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Female; Humans; Male; Middle Aged; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1980 |
Treatment of acute exacerbations of chronic bronchitis with cefotaxime: a controlled clinical trial.
Topics: Bronchitis; Cefotaxime; Cephalosporins; Chronic Disease; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1980 |
Cefotaxime in urinary tract infections--comparative clinical studies with gentamicin and with cefoxitin.
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Gentamicins; Humans; Urinary Tract Infections | 1980 |
Comparative studies of cefotaxime and sulbenicillin in complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin G; Sulbenicillin; Urinary Tract Infections | 1980 |
A double blind clinical trial of cefotaxime and cefazolin in complicated urinary tract infections.
Topics: Cefazolin; Cefotaxime; Cephalosporins; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Random Allocation; Urinary Tract Infections | 1980 |
[Renal tolerance of combined treatment with cefotaxime and gentamicin (author's transl)].
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Creatinine; Female; Gentamicins; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged; Urea | 1981 |
Cefotaxime: United Kingdom clinical trial results in the treatment of severe infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; United Kingdom | 1981 |
Cefotaxime sodium (Claforan).
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Humans | 1981 |
[Systemic antibiotic prophylaxis in elective colon surgery. Results of a controlled study].
Topics: Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Colon; Female; Humans; Male; Middle Aged; Preoperative Care; Prospective Studies; Random Allocation; Surgical Wound Infection | 1981 |
Cefotaxime--a clinical study.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Sepsis; Urinary Tract Infections | 1981 |
[Prevention of infection in abdominal surgery using cefotaxim].
Topics: Abdomen; Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Humans; Middle Aged; Surgical Wound Infection | 1981 |
Comparative multiple-dose pharmacokinetics of cefotaxime, moxalactam, and ceftazidime.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Humans; Kinetics; Male; Moxalactam; Stereoisomerism; Time Factors | 1981 |
[Clinico-laboratory basis for the endolymphatic use of beta-lactam antibiotics in pulmonology].
Topics: Adult; Ampicillin; B-Lymphocytes; Cefotaxime; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Female; Humans; Immunity, Cellular; Injections, Intralymphatic; Lung Abscess; Male; Middle Aged; Pneumonia; T-Lymphocytes | 1982 |
Short-term cephalosporin prophylaxis in transurethral surgery.
Topics: Aged; Bacteriuria; Cefazolin; Cefotaxime; Cephalosporins; Humans; Male; Premedication; Prostate; Urethra; Urinary Bladder | 1982 |
Third-generation cephalosporins for polymicrobial surgical sepsis.
Topics: Abscess; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Child; Clindamycin; Clinical Trials as Topic; Female; Gentamicins; Humans; Kidney Diseases; Male; Middle Aged; Moxalactam; Peritoneal Diseases; Peritonitis; Postoperative Complications; Random Allocation; Surgical Wound Infection | 1983 |
A randomized clinical trial of ceftizoxime and cefamandole in the treatment of serious lower respiratory tract infections.
Topics: Adult; Aged; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Clinical Trials as Topic; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Respiratory Tract Infections | 1982 |
Comparative study of ceftizoxime and cefamandole in the treatment of bronchopulmonary infections.
Topics: Adult; Aged; Bronchitis; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia | 1982 |
Single-blind controlled study of ceftizoxime and cefamandole in the treatment of community-acquired pneumonia.
Topics: Adolescent; Adult; Aged; Body Temperature; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Child, Preschool; Female; Humans; Leukocyte Count; Male; Middle Aged; Pneumonia; Radiography | 1982 |
Ceftizoxime and cefamandole in adult patients with acute respiratory failure.
Topics: Acute Disease; Adult; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Clinical Trials as Topic; Female; Humans; Male; Respiratory Insufficiency | 1982 |
A double-blind evaluation of ceftizoxime versus cefamandole therapy for urinary tract infections.
Topics: Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Urinary Tract Infections | 1982 |
Ceftizoxime therapy of infections in hospitalized patients and comparison with cefamandole for urinary tract infections.
Topics: Adult; Aged; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Female; Hospitalization; Humans; Male; Middle Aged; Pneumonia; Pyelonephritis; Random Allocation; Sepsis; Urinary Tract Infections | 1982 |
A comparative trial of ceftizoxime versus cefamandole in the treatment of acute urinary tract infections.
Topics: Acute Disease; Adult; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Female; Humans; Time Factors; Urinary Tract Infections | 1982 |
Ceftizoxime compared with cefamandole for treatment of soft tissue infections.
Topics: Adult; Aged; Bacterial Infections; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Female; Humans; Male; Middle Aged; Random Allocation | 1982 |
Comparative study of cefazolin, cefoxitin, and ceftizoxime for surgical prophylaxis in colo-rectal surgery.
Topics: Cefazolin; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Colon; Humans; Middle Aged; Premedication; Rectum | 1982 |
A randomized controlled study comparing ceftizoxime, cefamandole, and cefoxitin in obstetric and gynaecological surgery: a preliminary report.
Topics: Adolescent; Adult; Cefamandole; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cesarean Section; Creatine Kinase; Female; Humans; Hysterectomy; Pregnancy; Premedication; Random Allocation | 1982 |
Ceftizoxime in the treatment of urinary tract infections.
Topics: Adolescent; Adult; Aged; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Clinical Trials as Topic; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas Infections; Random Allocation; Urinary Tract Infections | 1982 |
Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.
Topics: Adult; Aged; Cefotaxime; Ceftriaxone; Cephalosporins; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Kinetics; Male; Microbial Sensitivity Tests; Middle Aged; Random Allocation; Urinary Tract Infections | 1983 |
Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam.
Topics: Adult; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Moxalactam | 1983 |
Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
Topics: Adolescent; Alcohol Deterrents; Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Cephalosporins; Child; Clinical Trials as Topic; Cystic Fibrosis; Double-Blind Method; Eosinophilia; Humans; Moxalactam; Penicillins; Piperacillin; Pseudomonas Infections; Random Allocation; Respiratory Tract Infections | 1983 |
Perioperative use of ceftazidime as a prophylactic agent in transurethral surgery.
Topics: Adult; Aged; Cefotaxime; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection; Urethra; Urogenital System | 1983 |
Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Cefotaxime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Random Allocation | 1983 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
Should antibiotic prophylaxis be used routinely in clean surgical procedures: a tentative yes.
Topics: Adult; Aged; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Cholecystectomy; Double-Blind Method; Female; Humans; Male; Middle Aged; Preoperative Care; Risk Factors; Surgical Procedures, Operative; Surgical Wound Infection; Treatment Outcome | 1995 |
Urinary excretion of adenosine deaminase binding protein in neonates treated with tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta 2-Microglobulin; Biomarkers; Cefotaxime; Cephalosporins; Creatinine; Dipeptidyl Peptidase 4; Humans; Infant, Newborn; Prospective Studies; Tobramycin | 1995 |
Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.
Topics: Adolescent; Cefepime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Humans; Infant; Meningitis, Bacterial; Prospective Studies | 1995 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Cefepime versus cefotaxime in the treatment of lower respiratory tract infections.
Topics: Adult; Aged; Aged, 80 and over; Bronchopneumonia; Cefepime; Cefotaxime; Cephalosporins; Female; Humans; Injections, Intravenous; Male; Middle Aged; Respiratory Tract Infections; Treatment Outcome | 1993 |
Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Female; Genital Diseases, Female; Humans; Middle Aged; Pregnancy; Puerperal Infection | 1993 |
Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef.
Topics: Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Single-Blind Method; Smell; Suspensions; Taste | 1994 |
Factors influencing outcome in children treated with antibiotics for acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome | 1993 |
Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Nasopharynx; Otitis Media | 1995 |
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Topics: Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Tonsillitis | 1995 |
Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
Topics: Adolescent; Adult; Cefotaxime; Cephalosporins; Half-Life; Humans; Injections, Intravenous; Male; Spectrophotometry, Ultraviolet | 1995 |
Effect of cefotaxime or ceftriaxone treatment on nasopharyngeal Haemophilus influenzae type b colonization in children.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Male; Nasopharynx; Prospective Studies | 1995 |
Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Drug Tolerance; Humans; Infant; Meropenem; Metronidazole; Thienamycins | 1995 |
Single dose UTI prophylaxis in transurethral surgery. Oral ofloxacin vs parenteral cefotaxime.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Urethra; Urinary Tract Infections | 1995 |
NONMEM analysis in determining the tri-exponential disposition of cefotaxime: a method of evaluating serum and urinary phase I data.
Topics: Body Weight; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Half-Life; Humans; Infusions, Intravenous; Models, Theoretical; Predictive Value of Tests | 1995 |
Ampicillin plus mecillinam vs. cefotaxime/cefadroxil treatment of patients with severe pneumonia or pyelonephritis: a double-blind multicentre study evaluated by intention-to-treat analysis.
Topics: Amdinocillin; Ampicillin; Cefadroxil; Cefotaxime; Cephalosporins; Double-Blind Method; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Humans; Male; Middle Aged; Penicillins; Pneumonia, Bacterial; Pyelonephritis | 1995 |
Betalactam therapy and intestinal flora.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Anaerobic; Bronchitis; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cephalosporins; Chronic Disease; Clostridium; Enterobacteriaceae; Enterococcus; Feces; HeLa Cells; Humans; Intestines; Microbial Sensitivity Tests; Middle Aged | 1995 |
Open, controlled, randomized study on the efficacy and safety of cefodizime single daily dose versus two daily doses and versus ceftriaxone single daily dose in patients with acute purulent bronchitis and acute purulent exacerbation of chronic bronchitis.
Topics: Acute Disease; Bronchitis; Cefotaxime; Ceftriaxone; Cephalosporins; Chronic Disease; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Male | 1995 |
[Cefminox versus cefotaxime in the treatment of complicated urinary tract infection].
Topics: Adult; Aged; Aged, 80 and over; Cefotaxime; Cephalosporins; Cephamycins; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1995 |
A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Cost-Benefit Analysis; Gastrointestinal Diseases; Humans; Penicillins; Prospective Studies; Surgical Wound Infection; Ticarcillin | 1996 |
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial Infections; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Outpatients; Patient Compliance | 1996 |
High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins.
Topics: Adult; Aged; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Administration Schedule; Female; Humans; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Middle Aged; Spain | 1996 |
Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Topics: Adolescent; Adult; Area Under Curve; Cefixime; Cefotaxime; Cephalosporins; Child; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Urinary Tract Infections | 1996 |
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Peritonitis | 1996 |
Comparison of ceftriaxone versus cefotaxime for childhood upper urinary tract infections.
Topics: Adolescent; Bacteriuria; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Double-Blind Method; Enterobacteriaceae; Female; Humans; Male; Pyelonephritis; Radiography; Urinary Tract Infections | 1996 |
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillins; Pneumonia, Pneumococcal; Radiography | 1996 |
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Treatment Outcome | 1997 |
Cefodizime given in single or divided doses for the treatment of lower respiratory tract infection.
Topics: Adult; Aged; Aged, 80 and over; Cefotaxime; Cephalosporins; Cough; Double-Blind Method; Female; Humans; Male; Middle Aged; Radiography; Respiratory Tract Infections; Sputum | 1997 |
Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; Skin Diseases, Bacterial; Sulbactam; Urinary Tract Infections | 1997 |
Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans.
Topics: Adipose Tissue; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cefpirome; Cellulitis; Cephalosporins; Erythromycin; Female; Fleroxacin; Humans; Macrolides; Male; Microdialysis; Muscle, Skeletal; Skin | 1996 |
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae.
Topics: Adult; Cefotaxime; Ceftizoxime; Cephalosporins; Cross-Over Studies; Female; Humans; Male; Middle Aged; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae | 1996 |
[Effectiveness of cefpirome in the treatment of complicated infections of the upper and lower urinary tracts].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Cephalothin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Urinary Tract Infections | 1996 |
Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Cefotaxime; Cephalosporins; Cross-Over Studies; Drug Combinations; Drug Interactions; Female; Hemofiltration; Humans; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin | 1997 |
Pharmacodynamic effects of amoxicillin versus cefotaxime against penicillin-susceptible and penicillin-resistant pneumococcal strains: a phase I study.
Topics: Adult; Amoxicillin; Cefotaxime; Cephalosporins; Cross-Over Studies; Humans; Male; Penicillin Resistance; Penicillins; Serum Bactericidal Test; Streptococcus pneumoniae | 1997 |
Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis; Tobramycin | 1997 |
Cefodizime once daily in the treatment of lower respiratory tract infections.
Topics: Adult; Aged; Bronchitis; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections | 1997 |
Prospective randomized comparison of cefodizime versus cefuroxime for perioperative prophylaxis in patients undergoing coronary artery bypass grafting.
Topics: Aged; Cefotaxime; Cefuroxime; Cephalosporins; Coronary Artery Bypass; Escherichia coli; Female; Humans; Intraoperative Care; Male; Middle Aged; Monitoring, Physiologic; Neutrophils; Phagocytosis; Prospective Studies; Reactive Oxygen Species; Staphylococcus aureus | 1997 |
Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Fluoroquinolones; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin Resistance; Piperazines; Quinolones | 1997 |
Cerebrospinal fluid bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in children with meningitis treated with high-dosage cefotaxime.
Topics: Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Dose-Response Relationship, Drug; Humans; Meningitis; Pneumococcal Infections; Serum Bactericidal Test; Streptococcus pneumoniae | 1997 |
Pharmacokinetic study of cefodizime and ceftriaxone in sera and bones of patients undergoing hip arthroplasty.
Topics: Aged; Antibiotic Prophylaxis; Arthroplasty, Replacement, Hip; Bone and Bones; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Humans; Infusions, Intravenous; Male; Middle Aged | 1997 |
Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Cost-Benefit Analysis; Drug Resistance, Multiple; Female; Humans; Male; Prospective Studies; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1997 |
[Amoxycillin/potassium clavulanate in inpatients with bronchopulmonary infections].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Cefotaxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Length of Stay; Male; Middle Aged; Pneumonia, Bacterial; Treatment Outcome | 1997 |
Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome.
Topics: Adolescent; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Interleukin-6; Male; Morbidity; Salmonella typhi; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Typhoid Fever | 1997 |
Relationship between serum and free interstitial concentrations of cefodizime and cefpirome in muscle and subcutaneous adipose tissue of healthy volunteers measured by microdialysis.
Topics: Adipose Tissue; Adult; Area Under Curve; Cefotaxime; Cefpirome; Cephalosporins; Cross-Over Studies; Drug Monitoring; Extracellular Space; Humans; Male; Microdialysis; Muscles; Tissue Distribution | 1997 |
Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Nasopharynx; Otitis Media; Streptococcus pneumoniae; Treatment Outcome | 1998 |
Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Roxithromycin; Streptococcus pneumoniae | 1998 |
Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cephalosporins; Cross-Over Studies; Female; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Male; Serum Bactericidal Test; Streptococcus | 1998 |
[Clinical and laboratory study of cefodizime (Modivid) in prophylaxis and treatment of surgical patients].
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antibody Formation; Burns; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cholecystitis; Cholelithiasis; Colony Count, Microbial; Humans; Immunity, Cellular; Male; Middle Aged; Surgical Wound Infection | 1998 |
Prophylactic antibiotics administration head and neck cancer surgery with major flap reconstruction: 1-day cefoperazone versus 5-day cefotaxime.
Topics: Antibiotic Prophylaxis; Cefoperazone; Cefotaxime; Cephalosporins; Double-Blind Method; Head and Neck Neoplasms; Humans; Prospective Studies; Surgical Flaps; Surgical Wound Infection; Treatment Outcome | 1998 |
A comparative study of cefixime and chloramphenicol in children with typhoid fever.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Female; Humans; Infant; Male; Treatment Outcome; Typhoid Fever | 1998 |
Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
Topics: Administration, Oral; Bronchitis; Cefixime; Cefotaxime; Cephalosporins; Chronic Disease; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Humans | 1998 |
Cefixime in the treatment of respiratory and urinary tract infections.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child; Humans; Otitis Media; Pneumococcal Infections; Respiratory Tract Infections; Treatment Outcome; Urinary Tract Infections | 1998 |
A comparative study of cefixime and chloramphenicol in children with typhoid fever.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Female; Humans; Male; Remission Induction; Safety; Time Factors; Typhoid Fever | 1998 |
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Amoxicillin; Bacteremia; Cefixime; Cefotaxime; Cephalosporins; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Pyelonephritis | 1998 |
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Lyme Disease; Penicillins; Probenecid; Renal Agents; Treatment Outcome | 1998 |
Clinical and pharmacological evaluation of a modified cefotaxime bid regimen versus traditional tid in pediatric lower respiratory tract infections.
Topics: Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Follow-Up Studies; Humans; Infant; Male; Prospective Studies; Respiratory Tract Infections | 1998 |
A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group.
Topics: Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Male; Ofloxacin; Typhoid Fever | 1999 |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Child; Exudates and Transudates; Female; Humans; Male; Otitis Media with Effusion; Time Factors | 1999 |
Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): a prospective randomized clinical trial.
Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Endoscopy; Enteral Nutrition; Enzyme Inhibitors; Female; Gastrostomy; Humans; Incidence; Intubation, Gastrointestinal; Male; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Prospective Studies; Surgical Wound Infection; Tazobactam | 1999 |
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bacteriuria; Cefotaxime; Cephalosporins; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Prostatectomy | 1999 |
[Pneumococcal meningitis: a 2-year evaluation of the cefotaxime-vancomycin combination].
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Prospective Studies; Treatment Outcome; Vancomycin | 1999 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Female; Humans; Infant; Infusions, Intravenous; Logistic Models; Male; Patient Compliance; Pyelonephritis; Recurrence; Urinary Tract Infections | 1999 |
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
Topics: Adult; Aged; Albumins; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; Female; Humans; Infusions, Intravenous; Kidney Diseases; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Plasma Volume; Renin | 1999 |
[A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
Topics: Adolescent; Adult; Bacterial Infections; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella; Male; Respiratory Tract Infections; Streptococcus pyogenes; Urinary Tract Infections | 1997 |
Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group.
Topics: Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis, Bacterial; Meropenem; Prospective Studies; Single-Blind Method; Thienamycins; Treatment Outcome | 1999 |
[Clinical evaluation and immunomodulatory study of cefodizime].
Topics: Adult; Aged; CD4-CD8 Ratio; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli; Female; Humans; Killer Cells, Natural; Male; Middle Aged; Phagocytes; Phagocytosis; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections | 1997 |
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Cephalosporins; Enteritis; Female; Humans; Infant; Male; Prospective Studies; Salmonella Infections | 1999 |
An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Netilmicin; Neutropenia; Superinfection; Treatment Outcome | 1999 |
Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Ascitic Fluid; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Peritonitis; Prospective Studies | 1999 |
The need for antibiotic prophylaxis in elective laparoscopic cholecystectomy: a prospective randomized study.
Topics: Adult; Aged; Antibiotic Prophylaxis; Bile; Cefotaxime; Cephalosporins; Cholecystectomy, Laparoscopic; Colony Count, Microbial; Elective Surgical Procedures; Female; Humans; Male; Middle Aged; Prospective Studies; Risk Factors; Surgical Wound Infection; Treatment Outcome | 2000 |
Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Penicillins; Treatment Outcome | 2000 |
Ceftriaxone and cefotaxime are equally effective in the treatment of neutropenic fever.
Topics: Adult; Aged; Antineoplastic Agents; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Fever; Hematologic Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Treatment Outcome | 2000 |
Cefodizime in skin suction blister fluid and serum following a single intravenous or intramuscular dose in adult patients.
Topics: Adult; Blister; Body Fluids; Cefotaxime; Cephalosporins; Humans; Infusions, Intravenous; Injections, Intramuscular; Kidney Function Tests; Liver Function Tests; Male; Respiratory Tract Diseases; Skin; Suction | 2000 |
Effects of intraocular cefotaxime on the human corneal endothelium.
Topics: Adult; Aged; Aged, 80 and over; Anterior Chamber; Cefotaxime; Cell Count; Cell Size; Cephalosporins; Double-Blind Method; Endophthalmitis; Endothelium, Corneal; Female; Humans; Lens Implantation, Intraocular; Male; Middle Aged; Phacoemulsification; Prospective Studies | 2001 |
[Antibiotic prophylaxis for high risk patients undergoing cholecystectomy].
Topics: Age Factors; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefamandole; Cefotaxime; Cefuroxime; Cephalosporins; Cholecystectomy; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Middle Aged; Penicillins; Postoperative Complications; Reoperation; Risk; Risk Factors; Surgical Wound Infection; Treatment Outcome | 2000 |
[Multicentre, randomized, prospective and comparative study of ceftriaxone, cefotaxime and cefuroxime in treating mild to moderate respiratory tract infection].
Topics: Adolescent; Adult; Aged; Bronchitis; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Female; Gram-Negative Bacterial Infections; Humans; Injections, Intravenous; Male; Middle Aged; Pneumonia; Prospective Studies | 1998 |
A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Utilization Review; Evidence-Based Medicine; Hospitals, Urban; Humans; Ontario; Outcome Assessment, Health Care; Pharmacists; Pharmacy Service, Hospital; Prospective Studies | 2001 |
Cefepime versus cefotaxime for empirical treatment of bacterial pneumonia in HIV-infected patients: an open, randomized trial.
Topics: Adult; Cefepime; Cefotaxime; Cephalosporins; Empiricism; Female; HIV Infections; Humans; Male; Pneumonia, Bacterial; Treatment Outcome | 2001 |
Perioperative pharmacokinetics of cefotaxime in serum and bile during continuous and intermittent infusion in liver transplant patients.
Topics: Adult; Aged; Area Under Curve; Bile; Biotransformation; Body Mass Index; Cefotaxime; Cephalosporins; Female; Half-Life; Humans; Infusions, Intravenous; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Sex Characteristics | 2004 |
Ceftriaxone and Cefotaxime Have Similar Effects on the Intestinal Microbiota in Human Volunteers Treated by Standard-Dose Regimens.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Feces; Female; Gastrointestinal Microbiome; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Healthy Volunteers; Humans; Male; Middle Aged; RNA, Ribosomal, 16S; Young Adult | 2019 |
980 other study(ies) available for cephalosporin c and cefotaxime
Article | Year |
---|---|
Molecular and biochemical characterization of the chromosome-encoded class A beta-lactamase BCL-1 from Bacillus clausii.
Topics: Amino Acid Sequence; Bacillus; Bacterial Proteins; beta-Lactamases; Chromosome Mapping; Chromosomes, Bacterial; Cloning, Molecular; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Weight; Sequence Homology, Amino Acid; Substrate Specificity | 2007 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Gentamicins; Humans; Microbial Sensitivity Tests; Netilmicin | 1979 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1992 |
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 1992 |
Comparative in vitro activity of cefepime and four extended-spectrum beta-lactams on 1,251 aminoglycoside-resistant gram-negative hospital strains.
Topics: Aminoglycosides; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Microbial Sensitivity Tests; Species Specificity | 1992 |
In vitro activities of Ro 40-6890 against 164 predominantly intestinal members of the families Enterobacteriaceae and Vibrionaceae.
Topics: Amoxicillin; Cefadroxil; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Intestines; Microbial Sensitivity Tests; Vibrionaceae | 1992 |
The patterns and transmissibility of antibiotic resistance among clinical strains of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Phenotype; Pseudomonas aeruginosa; R Factors; Tetracycline | 1992 |
[Identification of a new penicillinase in a Klebsiella pneumoniae strain of which a mutant also produces an esterase hydrolyzing cephalothin and cefotaxime].
Topics: Acetylesterase; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephalothin; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Penicillin Resistance; Penicillinase; Penicillins | 1992 |
Differential activity of bacteriocins and cefotaxime against Serratia marcescens clinical isolate SMG40 and its pigmented variant.
Topics: Amoxicillin; Bacteriocins; Cefotaxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pigments, Biological; Piperacillin; Serratia marcescens | 1992 |
In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Haemophilus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Species Specificity; Streptococcus pneumoniae | 1992 |
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cell Membrane Permeability; Cephalosporins; Ciprofloxacin; Coliphages; DNA Replication; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Porins | 1991 |
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin).
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefozopran; Cefpirome; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Moxalactam; Penicillanic Acid; Piperacillin; Tazobactam | 1991 |
H+ coupled transport of orally active cephalosporins lacking an alpha-amino group across brush-border membrane vesicles from rat small intestine.
Topics: Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Hydrogen; In Vitro Techniques; Intestine, Small; Male; Membranes; Microvilli; Rats; Rats, Inbred Strains | 1991 |
Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
Topics: Biological Transport, Active; Cefixime; Cefotaxime; Ceftibuten; Cephalexin; Cephalosporins; Glucose; Humans; Hydrogen; In Vitro Techniques; Jejunum; Microvilli | 1991 |
Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Drug Evaluation, Preclinical; Otitis Media with Effusion; Pneumococcal Infections | 1992 |
[Penetration of cefixime in the anterior chamber of the human eye].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents, Urinary; Aqueous Humor; Cataract Extraction; Cefixime; Cefotaxime; Cephalosporins; Humans; Middle Aged; Surgical Sponges | 1991 |
In vitro activity and cross resistance studies with cefpodoxime.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefixime; Cefotaxime; Cefotiam; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 1991 |
Post-antibiotic effect of beta-lactam antibiotics on gram-negative bacteria in relation to morphology, initial killing and MIC.
Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Humans; Imipenem; Luminescent Measurements; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1991 |
Immunophenotypization of cells involved in local immune response and serum antibodies in cephalosporin-treated mice.
Topics: Animals; Antibodies, Monoclonal; Antibody Formation; Antigens; Cefotaxime; Cephalosporins; Erythrocytes; Female; Hypertrophy; Immunophenotyping; Isoantibodies; Lymph Nodes; Mice; Mice, Inbred CBA; Time Factors | 1991 |
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 1991 |
Cephalosporin confusion--one simple solution?
Topics: Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cost-Benefit Analysis; Humans; Therapeutic Equivalency | 1991 |
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 1991 |
Dual-action cephalosporins: cephalosporin 3'-quinolone carbamates.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli; Mice; Pseudomonas aeruginosa; Spectrophotometry, Infrared; Staphylococcus aureus; Streptococcus pneumoniae | 1991 |
[The Norrköping study. Cephalosporins are often the implicating factors in Clostridium difficile infections].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Clostridioides difficile; Colitis; Cross Infection; Diarrhea; Drug Utilization; Humans; Middle Aged; Retrospective Studies; Sweden | 1991 |
Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
Topics: Absorption; Administration, Oral; Alkenes; Animals; Bacteria; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Chromatography; Drug Evaluation, Preclinical; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats | 1991 |
In vitro antibacterial activity of KP-736, a new cephem antibiotic.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Hexosyltransferases; Hydrolysis; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Time Factors | 1991 |
[Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Cefixime; Cefotaxime; Cephalosporins; Esters; Female; Half-Life; Humans; Male; Molecular Structure; Prodrugs; Solutions; Suspensions; Tablets | 1990 |
[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Drug Stability; Molecular Structure | 1990 |
Inhibitory and bactericidal activity of cefpirome and cefotaxime against blood culture isolates.
Topics: Bacterial Infections; Bacteriological Techniques; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Enterobacter; Escherichia coli; Klebsiella; Pseudomonas aeruginosa; Staphylococcus aureus | 1990 |
Comparison of cefodizime with various cephalosporins for their indirect effect on the human neutrophil oxidative burst in vitro.
Topics: Cefotaxime; Cephalosporins; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neutrophils; Oxidation-Reduction; Pseudomonas aeruginosa | 1990 |
[Concentration of cefotaxime in the exudate from ischemic ulcer after systemic and regional administration].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Exudates and Transudates; Female; Humans; Infusions, Intravenous; Leg Ulcer; Male; Middle Aged | 1990 |
Cephalosporin 3'-quinolone esters with a dual mode of action.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
Characterisation of a unique ceftazidime-hydrolysing beta-lactamase, TEM-E2.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Conjugation, Genetic; Drug Resistance, Microbial; Escherichia coli; Humans; Hydrolysis; Infant, Newborn; Klebsiella; Penicillins; Plasmids | 1990 |
[Comparative antibacterial activity of ceftibuten (SH 39 720) against 150 K. pneumoniae strains producing different beta-lactamases].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Dose-Response Relationship, Drug; In Vitro Techniques; Klebsiella pneumoniae | 1990 |
In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Helicobacter pylori; Microbial Sensitivity Tests | 1990 |
Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins.
Topics: Animals; Cefotaxime; Cefpirome; Cephalosporins; Cytosol; Gluconeogenesis; Glutathione; In Vitro Techniques; Kidney Cortex; Kidney Diseases; L-Lactate Dehydrogenase; Male; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds | 1990 |
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Male; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1990 |
New orally active cephalosporin esters.
Topics: Absorption; Administration, Oral; Animals; Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Esters; Mice; Rats | 1990 |
Therapeutic studies of cefepime (BMY 28142) in murine meningitis and pharmacokinetics in neonatal rats.
Topics: Animals; Animals, Newborn; Bacteria; Cefepime; Cefotaxime; Cephalosporins; Male; Meningitis; Mice; Microbial Sensitivity Tests; Moxalactam; Rats; Rats, Inbred Strains | 1990 |
Comparative chemotherapeutic activity of cefpirome and imipenem in experimental infections.
Topics: Abscess; Animals; Bacterial Infections; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Granuloma; Imipenem; Male; Mice; Mice, Hairless; Mice, Inbred C3H; Pneumonia; Rats; Rats, Inbred Strains; Sepsis; Staphylococcal Skin Infections; Staphylococcus aureus; Streptococcal Infections | 1990 |
Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels.
Topics: Bacterial Infections; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cell Membrane Permeability; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Gram-Negative Bacteria; Isoelectric Focusing; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 1989 |
[Antibiotics used for paratyphi B infections resistant to classical treatment and the results of their use].
Topics: Amikacin; Ampicillin Resistance; Cefotaxime; Cephalosporins; Child, Preschool; Chloramphenicol; Drug Resistance, Microbial; Humans; Infant; Paratyphoid Fever; Salmonella; Salmonella paratyphi B; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
[Structure-activity relationship of oral cephalosporins].
Topics: Absorption; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Structure-Activity Relationship | 1989 |
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
Topics: Ampicillin; Bacterial Proteins; Carrier Proteins; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Haemophilus influenzae; Hexosyltransferases; Kinetics; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Phenotype | 1989 |
Interaction of cefpirome and a cephalosporinase from Citrobacter freundii GN7391.
Topics: beta-Lactamases; Cefotaxime; Cefotiam; Cefpirome; Ceftazidime; Cephalosporinase; Cephalosporins; Citrobacter; Hydrolysis; Kinetics | 1989 |
Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamases; Cefepime; Cefmenoxime; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Immunosuppression Therapy; Mice; Microbial Sensitivity Tests | 1989 |
Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime.
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria | 1989 |
Characterization of a plasmid coding for resistance to broad-spectrum cephalosporins in Salmonella typhimurium.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Humans; Isoelectric Focusing; Kinetics; Penicillin G; Phenotype; Plasmids; Salmonella typhimurium; Transformation, Genetic | 1989 |
Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
Topics: Amoxicillin; Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Escherichia coli; Escherichia coli Infections; Female; Metronidazole; Mice; Microbial Sensitivity Tests | 1989 |
Mode of action of the dual-action cephalosporin Ro 23-9424.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Ciprofloxacin; DNA Replication; DNA, Bacterial; Enterobacter; Escherichia coli; Fleroxacin; Fluoroquinolones; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1989 |
Penetration of third-generation cephalosporins into human peritoneal tissue.
Topics: Ascitic Fluid; Bacteroides fragilis; Cefoperazone; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Middle Aged; Peritoneum; Tissue Distribution | 1989 |
Interaction of E1040 with cephalosporinase from Citrobacter freundii GN7391.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Citrobacter; Kinetics | 1989 |
Synthesis and antimicrobial properties of substituted beta-aminoxypropionyl penicillins and cephalosporins.
Topics: Ampicillin; Cefotaxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Penicillin G; Penicillins | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |
Stimulatory effect of cefodizime on macrophage-mediated phagocytosis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Dose-Response Relationship, Drug; Female; Macrophages; Mice; Mice, Inbred BALB C; Phagocytosis | 1989 |
Transport of cefodizime, a novel third generation cephalosporin antibiotic, in isolated rat choroid plexus.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Cefotaxime; Cephalosporins; Choroid Plexus; Kinetics; Penicillin G; Rats; Tritium | 1989 |
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pseudomonas | 1989 |
[Cephalosporins and enzymuria].
Topics: Acetylglucosaminidase; Adolescent; Adult; Aged; Alkaline Phosphatase; Cefotaxime; Cefotetan; Cefotiam; Cefoxitin; Ceftriaxone; Cephalosporins; Cephamycins; Cephradine; Child; Enzymes; Female; gamma-Glutamyltransferase; Humans; Kidney; Male; Middle Aged | 1986 |
Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae.
Topics: Amikacin; beta-Lactamases; Cefotaxime; Cephalosporins; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella Infections; Klebsiella pneumoniae; Paris; Recurrence; Urinary Tract Infections | 1987 |
Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Quinolines | 1985 |
Inducing capacity and selection of resistant variants of cefpirome (HR 810) in comparison with other beta-lactam compounds.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillinase | 1988 |
[A case of bronchiolitis obliterans organizing pneumonia in a patient with long-term administration of antibiotics and bone graft].
Topics: Bone Transplantation; Bronchiolitis Obliterans; Cefotaxime; Cephalosporins; Cephapirin; Dibekacin; Drug Therapy, Combination; Humans; Kanamycin; Lung; Male; Middle Aged; Pulmonary Fibrosis; Tibial Fractures | 1988 |
Comparative study of a novel plasmid-mediated beta-lactamase, CAZ-2, and the CTX-1 and CAZ-1 enzymes conferring resistance to broad-spectrum cephalosporins.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Escherichia coli; Genetic Vectors; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype; Plasmids | 1988 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
[Comparative study of cefuzonam (CZON) with cefotiam in bacterial pneumonia and pulmonary suppuration].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Female; Humans; Lung Diseases; Male; Middle Aged; Pneumonia; Suppuration | 1986 |
In vitro activity of BMY-28142, a new cephalosporin.
Topics: Bacteria; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1987 |
Biological activity of BO-1236, a new antipseudomonal cephalosporin.
Topics: Animals; Bacterial Infections; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Gram-Negative Bacteria; Gram-Positive Bacteria; Isoindoles; Male; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1987 |
Enzyme kinetic studies with beta-lactamases against cefotaxime and other cephalosporins.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Humans; Kinetics; Klebsiella pneumoniae | 1987 |
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
Topics: Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefazolin; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hexosyltransferases; Humans; Methicillin; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa | 1988 |
In vitro activity and beta-lactamase stability of LY163892.
Topics: Administration, Oral; Bacteria; beta-Lactamases; Cefaclor; Cefotaxime; Cephalexin; Cephalosporins; Enzyme Stability | 1988 |
Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Sisomicin | 1988 |
Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime.
Topics: Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Pseudomonas aeruginosa; Selection, Genetic | 1988 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
Effects of cefotetan disodium, cefoxitin, cefazolin, and cefotaxime in vitro on polymorphonuclear leukocytes from patients with leukopenia and severe pelvic inflammatory disease.
Topics: Cefazolin; Cefotaxime; Cefotetan; Cefoxitin; Cephalosporins; Cephamycins; Chemotaxis, Leukocyte; Female; Humans; Leukopenia; Neutrophils; Pelvic Inflammatory Disease | 1988 |
Phase I clinical studies of 7432-S: effect of 7432-S on platelet aggregation and blood coagulation.
Topics: Adenosine Diphosphate; Adult; Animals; Anti-Bacterial Agents; Blood Coagulation; Cefaclor; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalexin; Cephalosporins; Collagen; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Male; Moxalactam; Partial Thromboplastin Time; Platelet Aggregation; Prothrombin Time; Rats; Rats, Inbred Strains; Time Factors | 1988 |
[Third generation cephalosporins, monobactams and carbapenems].
Topics: Aztreonam; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Imipenem; Thienamycins | 1988 |
[Once again: the perioperative antibiotic prophylaxis in cesarean section].
Topics: Cefotaxime; Cefotiam; Cephalosporins; Dose-Response Relationship, Drug; Female; Gentamicins; Humans; Infusions, Intravenous; Pregnancy; Premedication; Puerperal Infection; Reoperation; Surgical Wound Infection | 1988 |
H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Administration, Oral; Animals; Biological Transport; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Mucosa; Male; Microvilli; Rabbits; Structure-Activity Relationship | 1988 |
In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefotaxime; Cefoxitin; Cephalosporins; Clindamycin; Clostridium; Moxalactam; Peptococcaceae; Propionibacterium acnes | 1988 |
Determination of cefotaxime, desacetylcefotaxime, cefmenoxime and ceftizoxime in biological samples by fluorescence detection after separation by thin-layer chromatography.
Topics: Cefmenoxime; Cefotaxime; Ceftizoxime; Cephalosporins; Chromatography, Thin Layer; Humans; Spectrometry, Fluorescence | 1988 |
An in vitro evaluation of HRE 664, a novel penem antibiotic.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Drug Stability; Lactams; Microbial Sensitivity Tests; Quality Control; Temperature | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Plasmids | 1988 |
Use of cefotaxime in brain abscess.
Topics: Adolescent; Adult; Aged; Brain Abscess; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged | 1988 |
Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.
Topics: beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Citrobacter; Enterobacter; Hydrolysis; Kinetics | 1988 |
[Changes in the phagocytic activity of human polymorphonuclear neutrophils induced in vitro by cefotiam vs 6 other antibiotics].
Topics: Adult; Cefoperazone; Cefotaxime; Cefotiam; Ceftazidime; Cephalosporins; Female; Gentamicins; Humans; Luminescent Measurements; Male; Middle Aged; Neutrophils; Phagocytosis; Piperacillin; Rifampin | 1987 |
In vitro antibacterial activity and beta-lactamase stability of CL 118523, an aminothiazolyl iminomethoxy cephalosporin.
Topics: Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Stability; Enterobacteriaceae; Enzyme Induction; Imipenem; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1987 |
[Susceptibility of some bacteria isolated from clinical samples to third-generation cephalosporins].
Topics: Bacteria; Cefoperazone; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Escherichia coli; Humans; Klebsiella; Proteus; Pseudomonas; Staphylococcus aureus; Staphylococcus epidermidis | 1987 |
Carrier-mediated transport of cefixime, a new cephalosporin antibiotic, via an organic anion transport system in the rat renal brush-border membrane.
Topics: Animals; Biological Transport, Active; Cefixime; Cefotaxime; Cephalosporins; Hydrogen-Ion Concentration; Kidney; Male; Microvilli; Potassium; Rats; Rats, Inbred Strains; Valinomycin | 1988 |
[Initial results of perioperative antibiotic premedication with halospor and gentamycin in cesarean section].
Topics: Cefotaxime; Cefotiam; Cephalosporins; Cesarean Section; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Parenteral; Pregnancy; Premedication; Surgical Wound Infection | 1986 |
[Antibiotic activities of cefuzoname and the representative cephalosporins against clinically isolated methicillin resistant strains of Staphylococcus].
Topics: Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Drug Resistance; In Vitro Techniques; Methicillin; Staphylococcus aureus; Staphylococcus epidermidis | 1986 |
Comparative in vitro activity of cefetamet (RO 15-8074).
Topics: Ampicillin; Cefaclor; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Enterobacteriaceae | 1987 |
Antibiotic- and method-dependent variation in susceptibility testing results of Bacteroides fragilis group isolates.
Topics: Bacteroides; Bacteroides fragilis; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Clindamycin; Culture Media; Metronidazole; Microbial Sensitivity Tests; Quality Control | 1987 |
The synthesis and biological evaluation of 7 beta-[2-(2-aminooxazol-4-yl)-2-Z-methoximinoacetamido]-cep halosporin antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefotaxime; Cephalosporins; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests | 1986 |
Antibiotic susceptibility of Haemophilus influenzae isolated from cerebrospinal fluid and blood.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Chloramphenicol; Drug Resistance, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Netilmicin; Rifampin; Sepsis | 1986 |
In vitro microbiological properties of mezlocillin compared with four cephalosporins.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Hydrolysis; Mezlocillin; Microbial Sensitivity Tests; Mutation | 1986 |
Factors affecting antimicrobial susceptibility of Fusobacterium species.
Topics: beta-Lactamases; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Clindamycin; Culture Media; Fusobacterium; L Forms; Microbial Sensitivity Tests; Penicillins | 1987 |
Beta-lactamase hydrolysis and inhibition studies of the new 1-carbacephem LY163892.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Cefotaxime; Cephaloridine; Cephalosporins; Hydrolysis | 1987 |
Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Topics: Bacteria, Aerobic; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Microbial Sensitivity Tests; Sulbactam | 1987 |
Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates.
Topics: Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Ceftizoxime; Ceftriaxone; Cephalosporinase; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1987 |
Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action.
Topics: Animals; Bacteriolysis; beta-Lactamases; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli; Glucuronidase; Humans; Neutrophils; Phagocytosis; Rabbits | 1986 |
Inhibitory and bactericidal activity of cefmetazole and seven other beta-lactams against different bacterial inocula.
Topics: Bacteria; Cefamandole; Cefmetazole; Cefotaxime; Cefoxitin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Citrobacter; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Proteus; Pseudomonas; Staphylococcus; Streptococcus | 1986 |
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
Topics: Aztreonam; Bacteria; beta-Lactamase Inhibitors; beta-Lactamases; Carbenicillin; Cefotaxime; Ceftazidime; Cephalosporins; Gentamicins; Humans; Imipenem; Microbial Sensitivity Tests; Penicillin Resistance; Thienamycins | 1986 |
Therapeutic effect of SF-2103A, a novel carbapenem antibiotic, in combination with cefotaxime, cefoperazone and other cephalosporins.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Cefotaxime; Cephalosporins; Drug Stability; Drug Synergism; Drug Therapy, Combination; Escherichia coli Infections; Kinetics; Proteus Infections; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |
[In vitro antibacterial activity of a new cephalosporin: cefpirome (HR 810). Comparison with ceftriaxone, cefotaxime, latamoxef and ceftazidime].
Topics: Bacteria; Cefotaxime; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Moxalactam | 1986 |
In vitro activity of DQ-2556, a new cephalosporin.
Topics: Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1986 |
Antibacterial activity of BMY-28142, a novel broad-spectrum cephalosporin.
Topics: Animals; Bacterial Infections; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry; Male; Mice; Microbial Sensitivity Tests; Penicillin Resistance | 1986 |
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Topics: Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1987 |
Comparative in-vitro activity of cefodizime, cefpirome, carumonam and RU-28965 with other antimicrobials against anaerobes.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Cephalosporins; Leucomycins; Microbial Sensitivity Tests | 1987 |
Consensus report: antimicrobial therapy for bacterial meningitis in infants and children.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis; Meningitis, Haemophilus; Meningitis, Listeria; Meningitis, Meningococcal; Meningitis, Pneumococcal | 1987 |
Endemic emergence of cephalosporin-resistant Enterobacter: relation to prior therapy.
Topics: Aged; Anti-Bacterial Agents; Cardiac Surgical Procedures; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Mutation | 1986 |
Strategies in aminoglycoside use and impact upon resistance.
Topics: Acinetobacter; Amikacin; Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Interactions; Drug Therapy, Combination; Enterobacteriaceae; Gentamicins; Humans; Penicillin Resistance; Pseudomonas; R Factors; Risk; Staphylococcus | 1986 |
Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
Topics: Cefaclor; Cefadroxil; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reference Values | 1987 |
Experimental pneumococcus infection in mice: comparative in vitro and in vivo effect of cefuroxime, cefotaxime and ceftriaxone.
Topics: Animals; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Female; Mice; Microbial Sensitivity Tests; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1987 |
In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Topics: Bacteria; Cefixime; Cefotaxime; Cephalosporins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria | 1987 |
Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
Topics: Bacteria; Blood; Cefoperazone; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Diffusion; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Species Specificity | 1986 |
[In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
Topics: Bacteria; Cefamandole; Cefonicid; Cefotaxime; Cefoxitin; Cephaloridine; Cephalosporins; Cross Infection; Humans; Microbial Sensitivity Tests | 1986 |
[In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
Topics: Cefotaxime; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Moxalactam; Species Specificity | 1986 |
[In vitro activity of 4 cephalosporins on gram-negative bacteria and Staphylococcus aureus of hospital origin].
Topics: Cefotaxime; Cephalexin; Cephalosporins; Cephalothin; Cephradine; Gram-Negative Bacteria; In Vitro Techniques; Microbial Sensitivity Tests; Staphylococcus aureus | 1985 |
New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.
Topics: Animals; Cefepime; Cefotaxime; Cefpirome; Cephalosporins; Meningitis, Pneumococcal; Rabbits; Streptococcus pneumoniae | 1985 |
[Treatment of purulent meningitis with ceftriaxone].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Brain Edema; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Humans; Infant; Kinetics; Meningitis; Penicillins; Shock | 1985 |
Cephem antibiotics and alcohol metabolism.
Topics: Acetaldehyde; Alcohol Deterrents; Animals; Bile Ducts; Cefazolin; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Ethanol; Injections, Intravenous; Ligation; Rats; Rats, Inbred Strains | 1985 |
[Intraocular penetration of systemically administered cephalosporins under steady-state conditions in animal experiments].
Topics: Animals; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Chromatography, High Pressure Liquid; Eye; Injections, Intravenous; Rabbits; Time Factors | 1985 |
Stability of clindamycin phosphate and ceftizoxime sodium, cefoxitin sodium, cefamandole nafate, or cefazolin sodium in two intravenous solutions.
Topics: Cefamandole; Cefazolin; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Clindamycin; Drug Stability; Infusions, Parenteral; Time Factors | 1985 |
Comparative activity of ceftizoxime and four other cephalosporins against gram negative bacteria and their sensitivity to beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Hydrolysis; Microbial Sensitivity Tests | 1985 |
In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
Topics: Ampicillin; Cefmenoxime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Methicillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
Cephalosporin-induced immune neutropenia.
Topics: Adult; Agranulocytosis; Antibodies; Cefotaxime; Cefuroxime; Cephalosporins; Female; Fluorescent Antibody Technique; Granulocytes; Humans; Leukocyte Count; Neutropenia | 1985 |
Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Biological Availability; Blood Proteins; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Mice; Microbial Sensitivity Tests; Moxalactam; Protein Binding | 1985 |
Transferable resistance to cefotaxime and cefuroxime is regulated by the same plasmid gene.
Topics: Cefotaxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Genes, Bacterial; Klebsiella pneumoniae; Plasmids | 1985 |
Inhibitory activity of cefpiramide on beta-lactamase.
Topics: beta-Lactamase Inhibitors; Cefotaxime; Cephaloridine; Cephalosporins; Citrobacter; Drug Synergism; Enterobacter; Escherichia coli; Hydrolysis; Proteus | 1985 |
Which cephalosporin for wound prophylaxis? An experimental comparison of three drugs.
Topics: Animals; Cefamandole; Cefazolin; Cefotaxime; Cephalosporins; Escherichia coli Infections; Feces; Female; Mice; Staphylococcal Infections; Surgical Wound Infection | 1985 |
Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefepime; Cefoperazone; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Stability; Hydrolysis; Microbial Sensitivity Tests | 1985 |
Role of cephalosporins in the treatment of bacterial meningitis in adults. Overview with special emphasis on ceftazidime.
Topics: Adult; Animals; Bacterial Infections; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Disease Models, Animal; Humans; Meningitis | 1985 |
Comparative in-vitro activity of Sch 34343, imipenem, cefpirome and cefotaxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefpirome; Cephalosporins; Escherichia coli; Haemophilus influenzae; Imipenem; Lactams; Microbial Sensitivity Tests; Pseudomonas; Staphylococcus; Streptococcus; Thienamycins | 1985 |
[In vitro antibacterial activity of cefodizime (HR 221) on 323 hospital strains of Gram negative bacilli. Comparison with cefotiam, cefoperazone, cefotetan and cefotaxime].
Topics: Cefoperazone; Cefotaxime; Cefotetan; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria | 1985 |
Efficacy of BMY-28142 in experimental bacteremia and meningitis caused by Escherichia coli and group B streptococci.
Topics: Animals; Cefepime; Cefotaxime; Cephalosporins; Escherichia coli; Female; Meningitis; Microbial Sensitivity Tests; Penicillin G; Pregnancy; Rats; Rats, Inbred Strains; Sepsis; Streptococcal Infections; Streptococcus agalactiae | 1985 |
Pharmacokinetic properties of the newer cephalosporins. A valid basis for drug selection?
Topics: Bile; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Half-Life; Humans; Kinetics; Moxalactam | 1985 |
[Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
Topics: Bacteria; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotetan; Ceftazidime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 1985 |
Emergence of beta-lactam multiresistant variants of gram-negative bacilli in the presence of cefotaxime.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Pseudomonas | 1985 |
The influence of some cephalosporins on immunological response.
Topics: Animals; Antibody Formation; Cefotaxime; Cells, Cultured; Cephalosporins; Cephradine; Hemolysin Proteins; Hemolytic Plaque Technique; Immunity, Cellular; Immunosuppression Therapy; Injections, Intramuscular; Macrophages; Mice; Rabbits; Spleen | 1985 |
Cephalosporin resistance in Pseudomonas aeruginosa, with special reference to the proposed trapping of antibiotics by beta-lactamase.
Topics: beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Models, Biological; Pseudomonas aeruginosa | 1985 |
The in vitro antibacterial activity of ceftriaxone in comparison with nine other antibiotics.
Topics: Anti-Bacterial Agents; Bacteria; Bacteria, Anaerobic; Cefotaxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus; Microbial Sensitivity Tests; Neisseria; Penicillin G; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus | 1985 |
Antibacterial activity in vitro and regression studies for ceftazidime and ceftriaxone.
Topics: Acinetobacter; Campylobacter fetus; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Enterococcus faecalis; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Regression Analysis; Streptococcus | 1985 |
Comparative in vitro inhibitory and killing activity of cefpirome, ceftazidime, and cefotaxime against Pseudomonas aeruginosa, enterococci, Staphylococcus epidermidis, and methicillin-susceptible and -resistant and tolerant and nontolerant Staphylococcus
Topics: Bacteria; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Enterococcus faecalis; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus aureus; Staphylococcus epidermidis | 1985 |
Interaction of third generation cephalosporins combined with amikacin against Pseudomonas aeruginosa.
Topics: Amikacin; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Synergism; Kanamycin; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa | 1985 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |
In vitro activity of cefpiramide (SM-1652) against gram-negative bacilli.
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Pseudomonas | 1986 |
Antimicrobial activity of HR810 against 419 strict anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1985 |
Pharmacokinetics of cefaronide, ceftriaxone and cefoperazone in sheep.
Topics: Animals; Cefamandole; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Female; Injections, Intravenous; Kinetics; Sheep; Spectrophotometry, Ultraviolet | 1985 |
In vitro comparative antimicrobial activity of cefpimizole against clinical isolates from five medical centers.
Topics: Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests | 1985 |
[Interference of cephalosporins in creatinine determination].
Topics: Cefotaxime; Cephalexin; Cephalosporins; Cephalothin; Creatinine; Drug Interactions; Humans | 1985 |
Impact of injectable cephalosporins on the gastrointestinal microflora: observations in healthy volunteers and hospitalized patients.
Topics: Bacteria; Bile; Cefotaxime; Cephalosporins; Cross Infection; Digestive System; Hospitalization; Humans; Injections | 1985 |
The influence of third-generation cephalosporins on the aerobic intestinal flora.
Topics: Bacteria, Aerobic; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Feces; Humans; Infant; Intestines | 1985 |
Positioning of the beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Humans | 1985 |
Respiratory superinfections after the use of third-generation cephem antibiotics.
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Gram-Positive Bacteria; Humans; Lung; Pneumonia; Respiratory Tract Infections; Sputum | 1985 |
Use of third-generation cephalosporins for treatment of neonatal infections.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Humans; Infant, Newborn | 1985 |
Relationship between protein binding and renal clearance of a new oral cephalosporin in the dog.
Topics: Animals; Cefixime; Cefotaxime; Cephalosporins; Dogs; Kidney; Kinetics; Protein Binding | 1985 |
The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Enterobacteriaceae; Haemophilus; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Neisseria; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Pseudomonas; Streptococcus | 1984 |
New cephalosporins: in-vitro activity against gram-negative bacilli and suggestions for possible clinical use.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Humans; Moxalactam; Tobramycin | 1984 |
[Nonparametric approach to the determination of critical diameters. Comparison with conventional methods].
Topics: Ampicillin; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Dibekacin; Escherichia coli; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus | 1984 |
[Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram].
Topics: Adult; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Combinations; Female; Humans; Injections, Intravenous; Kinetics; Male | 1984 |
Lack of interference with creatinine assays by four cephalosporin-like antibiotics.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Creatinine; False Positive Reactions; Humans; Moxalactam | 1984 |
Quaternary heterocyclylamino beta-lactams. II. The in vitro antibacterial properties of L-640,876, a new type of beta-lactam antibiotic.
Topics: Amdinocillin; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Culture Media; Microbial Sensitivity Tests; Osmolar Concentration | 1983 |
Quaternary heterocyclylamino beta-lactams. IV. Comparison of the in vivo antibacterial activities of L-640,876, mecillinam, cefoxitin and cefotaxime.
Topics: Amdinocillin; Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Gram-Negative Bacteria; Kinetics; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Sepsis; Tissue Distribution | 1983 |
Comparative study of ceftriaxone and cefuroxime for perioperative prophylaxis in orthopedic surgery.
Topics: Adult; Aged; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infection Control; Male; Middle Aged; Orthopedics; Postoperative Complications; Risk; Wound Healing | 1984 |
Comparative pharmacokinetics of YM-13115, ceftriaxone, and ceftazidime in rats, dogs, and rhesus monkeys.
Topics: Animals; Anti-Bacterial Agents; Bile; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Dogs; Injections, Intravenous; Kinetics; Macaca mulatta; Male; Rats; Rats, Inbred Strains | 1984 |
Diffusibility of the newer cephalosporins into human interstitial fluids.
Topics: Adolescent; Adult; Blood Proteins; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Diffusion; Extracellular Space; Humans; Male; Middle Aged; Moxalactam; Protein Binding | 1984 |
Influence of third-generation cephalosporins on aerobic intestinal flora.
Topics: Bacteria, Aerobic; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Feces; Humans; Infant; Intestines | 1984 |
[Clinical studies on combination therapy of cephem antibiotics in chronic complicated urinary tract polymicrobial infections due to Pseudomonas aeruginosa and other bacteria].
Topics: Aged; Bacterial Infections; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pseudomonas Infections; Urinary Tract Infections | 1984 |
Affinity of cefmenoxime for beta-lactamases: an analysis.
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Cefotaxime; Cephalosporinase; Cephalosporins; Hydrolysis; Kinetics; Moxalactam; Penicillinase | 1984 |
Repeated exposition to subinhibitory concentrations of antibiotic in vitro readily decreases susceptibility of Neisseria gonorrhoeae to rifampicin, but not to new cephalosporins and penicillin G.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotiam; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin G; Penicillin Resistance; Rifampin; Time Factors | 1984 |
Cefodizime, an aminothiazolyl cephalosporin. III. Therapeutic activity against experimentally induced pneumonia in mice.
Topics: Animals; Cefotaxime; Cephalosporins; Mice; Pneumonia; Sepsis | 1984 |
[Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Escherichia coli; Humans; Klebsiella pneumoniae; Salmonella; Staphylococcus aureus | 1982 |
[Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Topics: Acinetobacter; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus | 1982 |
Cefotaxime, cephalothin, and cephapirin: antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations.
Topics: Bacteria; Cefotaxime; Cephalosporins; Cephalothin; Cephapirin; Drug Synergism; Humans; Microbial Sensitivity Tests | 1984 |
In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Citrobacter; Enterobacteriaceae; Gram-Negative Bacteria; Microbial Sensitivity Tests; Proteus; Pseudomonas aeruginosa; Salmonella; Serratia | 1982 |
Cefotaxime and meningitis.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Meningitis | 1980 |
Effects of cefotaxime on the proximal tubules of the human kidney.
Topics: Adult; Aminopeptidases; CD13 Antigens; Cefotaxime; Cephalosporins; Female; Humans; Kidney Tubules, Proximal; Male; Microvilli | 1980 |
Cefotaxime for chloramphenicol/ampicillin resistant haemophilus infections.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Chloramphenicol; Haemophilus Infections; Haemophilus influenzae; Humans; Penicillin Resistance | 1981 |
Elimination of brush border membrane protein in urine caused by toxic alterations of the tubular cell.
Topics: Adolescent; Adult; Amikacin; Aminopeptidases; Anti-Bacterial Agents; CD13 Antigens; Cefotaxime; Cell Membrane; Cephalosporins; Cisplatin; Female; Humans; Kidney Tubules, Proximal; Kinetics; Male; Membrane Proteins; Microvilli; Middle Aged; Netilmicin; Sulfonylurea Compounds | 1981 |
Cefotaxime metabolism and renal function.
Topics: Cefotaxime; Cephalosporins; Humans; Kidney; Kidney Failure, Chronic | 1981 |
Cefotaxime for spectinomycin resistant Neisseria gonorrhoeae.
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Gonorrhea; Humans; Neisseria gonorrhoeae; Spectinomycin | 1981 |
Cefotaxime, frusemide, and urinary gamma-glutamyltranspeptidase.
Topics: Adult; Cefotaxime; Cephalosporins; Drug Synergism; Furosemide; gamma-Glutamyltransferase; Humans; Kidney Tubules, Proximal; Male | 1981 |
Ceftizoxime and ceftazidime.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Humans | 1984 |
Comparative in vitro activity of cefotaxime (HR 756).
Topics: Aminoglycosides; Bacteria; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Penicillins | 1980 |
Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses.
Topics: Adult; Bacteria; Bacterial Infections; Cefazolin; Cefotaxime; Cephalosporins; Drug Tolerance; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male | 1980 |
Enterobacter cloacae outer membrane permeability to ceftizoxime (FK 749) and five other new cephalosporin derivatives.
Topics: beta-Lactamases; Cefmetazole; Cefotaxime; Cefotiam; Cefoxitin; Ceftizoxime; Cefuroxime; Cell Membrane Permeability; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae | 1980 |
[Effectiveness of cefotaxime and other antibiotics to the typhoid and paratyphoid B carriers with gall stones and typhoid fever (author's transl)].
Topics: Adult; Aged; Ampicillin; Carrier State; Cefotaxime; Cephalosporins; Cholelithiasis; Female; Humans; Middle Aged; Paratyphoid Fever; Typhoid Fever | 1980 |
Biosynthesis of peptidoglycan in Pseudomonas aeruginosa: comparison of the inhibitory effects of cefotaxime, its anti isomer, and the syn S-oxide compound.
Topics: Alanine; Anti-Bacterial Agents; Cefotaxime; Cell Wall; Cephalosporins; Lactams; Peptidoglycan; Pseudomonas aeruginosa; Stereoisomerism; Structure-Activity Relationship | 1980 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative activities of the oxa-beta-lactam LY127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Staphylococcus; Streptococcus; Ticarcillin | 1980 |
In vitro efficacy of cefoperazone compared with cefotaxime, LY127935, and thienamycin.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Lactams; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Thienamycins | 1980 |
Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Topics: Cefoperazone; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1980 |
Antibacterial activity of HR-756, cefoxitin and cefuroxine against multiply antibiotic-resistant strains of Enterobacteriaceae and Pseudomonas aeruginosa.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1980 |
[Availability of cefotaxime. Pharmacokinetic studies on the distribution in central and various peripheral compartments (author's transl)].
Topics: Ascitic Fluid; Bile; Biological Availability; Bone and Bones; Cefotaxime; Cephalosporins; Humans; Tissue Distribution | 1980 |
[Cephotaxim treatment in gynecology and obstetrics. Clinical experiences].
Topics: Abscess; Adolescent; Adult; Cefotaxime; Cephalosporins; Endometritis; Female; Humans; Middle Aged; Pelvic Inflammatory Disease; Sepsis | 1980 |
In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Topics: Azlocillin; beta-Lactamases; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1980 |
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria.
Topics: Anaerobiosis; Bacteria; Bacteroides; Carbenicillin; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1980 |
[Antimicrobial chemotherapy in severe infections. Experience with a new beta-lactam antibiotic].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Female; Humans; Male; Middle Aged | 1980 |
Hydrolysis of Cefotaxime by a beta-lactamase from Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamases; Cefotaxime; Cephalosporins; Hydrolysis; Kinetics; Substrate Specificity | 1980 |
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Fermentation; Microbial Sensitivity Tests; Moxalactam; Pseudomonas | 1980 |
Concentrations of cefotaxime in skin.
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Female; Humans; Injections, Intravenous; Male; Middle Aged; Skin; Skin Diseases, Infectious | 1980 |
Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function.
Topics: Aged; Cefotaxime; Cephalosporins; Creatinine; Drug Administration Schedule; Humans; Injections, Intravenous; Male; Middle Aged; Uremia | 1980 |
[Diffusion of cefotaxime in different tissues of the urogenital tract (author's transl)].
Topics: Adenoma; Aged; Cefotaxime; Cephalosporins; Genitalia, Male; Humans; Kidney; Male; Prostate; Prostatic Neoplasms; Testis; Tissue Distribution; Ureter; Urinary Tract | 1980 |
Chemotherapy with cefotaxime: how to avoid selection of Pseudomonas aeruginosa.
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Pseudomonas aeruginosa | 1980 |
In vitro antimicrobial activity of cefotaxime, a new cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests; Staphylococcus aureus | 1980 |
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testing.
Topics: Bacteria; Cefotaxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Pseudomonas; Regression Analysis | 1980 |
Cefotaxime: a new cephalosporin antibiotic.
Topics: Animals; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Humans | 1980 |
Pharmacokinetics of cefotaxime in subjects with normal and impaired renal function.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Humans; Kidney Failure, Chronic; Kinetics | 1980 |
Pharmacokinetics of cefotaxime in neonates and children: clinical aspects.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Child, Preschool; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Kinetics | 1980 |
Cefotaxime concentration in cerebrospinal fluid.
Topics: Cefotaxime; Cephalosporins; Escherichia coli; Humans; Injections, Intravenous; Microbial Sensitivity Tests; Staphylococcus aureus | 1980 |
Cefotaxime concentrations in ascites.
Topics: Ascitic Fluid; Cefotaxime; Cephalosporins; Female; Half-Life; Humans; Liver Cirrhosis, Alcoholic; Male | 1980 |
Concentrations of cefotaxime in bronchial secretions.
Topics: Bronchi; Cefotaxime; Cephalosporins; Humans; Kinetics; Respiratory Tract Infections; Saliva | 1980 |
Cefotaxime concentration in the bile and wall of the gallbladder.
Topics: Adult; Aged; Bile; Cefotaxime; Cephalosporins; Female; Gallbladder; Humans; Kinetics; Liver; Male; Middle Aged | 1980 |
beta-Lactamase stability of cefotaxime.
Topics: beta-Lactamases; Cefotaxime; Cephalosporinase; Cephalosporins; Drug Stability; Hydrolysis; Kinetics | 1980 |
Cefotaxime concentrations in otitis media effusions.
Topics: Cefotaxime; Cephalosporins; Child; Child, Preschool; Exudates and Transudates; Humans; Infant; Otitis Media | 1980 |
Determination of cefotaxime concentrations in non-infected human bone [proceedings].
Topics: Bone and Bones; Cefotaxime; Cephalosporins; Humans | 1980 |
Transfer of cefotaxime in human milk and from mother to foetus.
Topics: Cefotaxime; Cephalosporins; Female; Fetus; Half-Life; Humans; Maternal-Fetal Exchange; Milk, Human; Pregnancy; Tissue Distribution | 1980 |
Concentrations of cefotaxime in the anterior chamber of the eye in rabbits and humans.
Topics: Animals; Anterior Chamber; Aqueous Humor; Cefotaxime; Cephalosporins; Escherichia coli; Humans; Kinetics; Rabbits; Species Specificity | 1980 |
Clinical pharmacology of cefotaxime including penetration into bile, sputum, bone and cerebrospinal fluid.
Topics: Bile; Bone and Bones; Bronchitis; Cefotaxime; Cephalosporins; Humans; Sputum | 1980 |
Allergic and immunological aspects of therapy with cefotaxime and other cephalosporins.
Topics: Animals; Cefotaxime; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Guinea Pigs; Humans; Passive Cutaneous Anaphylaxis; Penicillins | 1980 |
Cefotaxime in the treatment of lower respiratory tract infections.
Topics: Cefotaxime; Cephalosporins; Humans; Respiratory Tract Infections; Trachea | 1980 |
Some bacterial proteins with affinity for cefotaxime.
Topics: Bacterial Proteins; Cefotaxime; Cephalosporinase; Cephalosporins; Escherichia coli; Kinetics; Protein Binding | 1980 |
Cefotaxime in bronchopulmonary infections--a clinical and pharmacological study.
Topics: Bronchial Diseases; Cefotaxime; Cephalosporins; Female; Humans; Lung Diseases; Male; Pleural Effusion; Respiratory Tract Infections; Sputum | 1980 |
Cefotaxime for urinary tract infections.
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Escherichia coli; Humans; Urinary Tract Infections | 1980 |
Elimination kinetics of cefotaxime in patients with renal insufficiency requiring dialysis.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Female; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Male; Middle Aged; Renal Dialysis | 1980 |
Cefotaxime therapy of urinary tract infections.
Topics: Adolescent; Adult; Aged; Bacteria; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Female; Gentamicins; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Urinary Tract Infections | 1980 |
Cefotaxime in children: efficacy, tolerance and effect on the intestinal bacterial flora.
Topics: Adolescent; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infant, Newborn; Intestines | 1980 |
Cefotaxime in the treatment of severe paediatric infections.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Surgical Wound Infection | 1980 |
Cefotaxime therapy in children with serious infections associated with reduced host defense mechanisms.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Immunity; Infant; Infant, Newborn; Male | 1980 |
Antibacterial activity of cefotaxime and other newer cephalosporins (in vitro and in vivo).
Topics: Animals; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporinase; Cephalosporins; Enterobacteriaceae; Kinetics; Mice | 1980 |
Evaluation of cefotaxime in a hospital with high antibiotic resistance rates.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged | 1980 |
Cefotaxime in the treatment of septicaemia and endocarditis.
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Sepsis | 1980 |
Management of severe systemic infections caused by multiple resistant organisms.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Male; Meningitis; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1980 |
The treatment of bone and joint infections with cefotaxime.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Diseases; Cefotaxime; Cephalosporins; Female; Humans; Joint Diseases; Male; Middle Aged | 1980 |
Cefotaxime in septicaemia including typhoid fever.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Humans; Male; Middle Aged; Sepsis; Typhoid Fever | 1980 |
Study of cefotaxime in the treatment of obstetric and gynaecological infections.
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Genital Diseases, Female; Humans; Microbial Sensitivity Tests; Middle Aged; Pregnancy; Pregnancy Complications, Infectious | 1980 |
Treatment of gonococcal urethritis in males with a single dose of cefotaxime [proceedings].
Topics: Cefotaxime; Cephalosporins; Gonorrhea; Humans; Male; Urethritis | 1980 |
The treatment of gonococcal urethritis with cefotaxime [proceedings].
Topics: Cefotaxime; Cephalosporins; Drug Therapy, Combination; Gonorrhea; Humans; Male; Probenecid; Urethritis | 1980 |
The evaluation of efficacy and safety of cefotaxime: a review of 2500 cases.
Topics: Adolescent; Adult; Age Factors; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Meningitis; Middle Aged; Respiratory Tract Infections; Sepsis; Sex Factors | 1980 |
Sensitivity testing and synergy.
Topics: Azlocillin; Bacteria; Cefotaxime; Cephalosporins; Culture Media; Drug Synergism; Microbial Sensitivity Tests; Penicillins; Tobramycin | 1980 |
Antibacterial activity of cefotaxime.
Topics: Bacteria; Cefotaxime; Cephalosporinase; Cephalosporins; Drug Stability; Escherichia coli; Microbial Sensitivity Tests; Penicillins; Protein Binding; Pseudomonas aeruginosa | 1980 |
In vitro activity of cefotaxime and other cephalosporins against Neisseria gonorrhoeae.
Topics: Cefotaxime; Cephalosporinase; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1980 |
In vitro and in vivo activity of cefotaxime on gonococcal strains.
Topics: Cefazolin; Cefotaxime; Cephalosporins; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1980 |
Cefotaxime and amikacin: results of in vitro and in vivo studies against Gram-negative bacteria and Staphylococcus aureus. EORTC International Antimicrobial Therapy Project Group.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Synergism; Humans; Kanamycin; Mice; Staphylococcus aureus | 1980 |
Chemistry of cefotaxime.
Topics: Acylation; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Drug Stability | 1980 |
Metabolism of cefotaxime in animals and man.
Topics: Animals; Bile; Biotransformation; Cefotaxime; Cephalosporins; Dogs; Half-Life; Humans; Intestinal Absorption; Rats; Species Specificity; Tissue Distribution | 1980 |
Toxicology of cefotaxime in comparison to other cephalosporins.
Topics: Animals; Cefotaxime; Cephalosporins; Dogs; Drug Interactions; Female; Furosemide; Kidney Diseases; Lethal Dose 50; Male; Mice; Mutagens; Pregnancy; Rats; Reproduction | 1980 |
Pharmacokinetics of cefotaxime in normal human volunteers.
Topics: Adult; Cefotaxime; Cefuroxime; Cephaloridine; Cephalosporins; Drug Interactions; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Kinetics; Lidocaine; Male; Middle Aged | 1980 |
Human metabolism of cefotaxime.
Topics: Adult; Bile; Biotransformation; Cefotaxime; Cephalosporins; Humans; Kidney Failure, Chronic; Kinetics; Male | 1980 |
[Clinical experiences with cefotaxim].
Topics: Acute Disease; Adult; Aged; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Respiratory Tract Diseases; Sepsis; Urinary Tract Infections | 1980 |
[Kinetics of bactericidial function of cefotaxim against Pseudomonas aeruginosa alone and in combination with tobramycin].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin | 1980 |
Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.
Topics: Bacteria; Cefotaxime; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Culture Media; Drug Resistance, Microbial; Escherichia coli; Humans; Models, Biological; Species Specificity; Urinary Bladder | 1980 |
Activity of cefotaxime-aminoglycoside combinations against aminoglycoside-resistant Pseudomonas.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Gentamicins; Humans; Kanamycin; Pseudomonas aeruginosa; Tobramycin | 1980 |
Comparison of cefoperazone, cefotaxime, and moxalactam (LY127935) against aerobic gram-negative bacilli.
Topics: Aerobiosis; Bacteria; Blood; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Culture Media; Drug Resistance, Microbial; Humans; Moxalactam; Pseudomonas aeruginosa; Species Specificity; Staphylococcus aureus | 1980 |
In vitro activities of cefotaxime and moxalactam (LY127935) against Haemophilus influenzae.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Haemophilus influenzae; Moxalactam; Penicillin Resistance; Species Specificity | 1980 |
Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels.
Topics: Adult; Blister; Body Fluids; Cefotaxime; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Male; Moxalactam | 1980 |
In vitro susceptibility of gram-negative bacilli from pediatric patients to moxalactam, cefotaxime, Ro 13-9904, and other cephalosporins.
Topics: Bacteria; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Drug Resistance, Microbial; Humans; Moxalactam | 1980 |
HR 756--a new cephalosporin in the treatment of gonorrhoea caused by ordinary and penicillinase-producing strains of Neisseria gonorrhoeae.
Topics: Cefotaxime; Cephalosporins; Drug Tolerance; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillinase | 1980 |
Antibacterial activity of a new cephalosporin, cefotaxime.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Klebsiella pneumoniae; Pseudomonas aeruginosa; Serratia marcescens; Species Specificity | 1980 |
Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Cefsulodin; Cephalosporins; Dibekacin; Drug Synergism; Gentamicins; Mezlocillin; Penicillin Resistance; Penicillins; Pseudomonas aeruginosa; Sisomicin; Tobramycin | 1980 |
The in vitro antibacterial activity of cefotaxime compared with that of cefuroxime and cefoxitin.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1980 |
In vitro evaluation of LY127935 (6050S) compared with cefotaxime, eight other beta-lactams and two aminoglycosides.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam | 1980 |
Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli.
Topics: Aminoglycosides; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
Topics: Cefaclor; Cefotaxime; Cefuroxime; Cephacetrile; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1980 |
A bacterial test in liquid culture for the detection of mutagenic activity of antibacterial compounds: studies with cephalosporine HR 756.
Topics: Animals; Cefotaxime; Cephalosporins; Culture Media; In Vitro Techniques; Mutagenicity Tests; Rats; Salmonella typhimurium | 1980 |
Cefotaxime treatment of patients who failed to respond to previous antibiotics.
Topics: Adult; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Drug Evaluation; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn | 1980 |
[Studies on antibacterial activity of cephotaxime (HR 756), a new antibiotic of the cephalosporin group (author's transl)].
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Injections, Intravenous; Microbial Sensitivity Tests | 1980 |
[Pharmacokinetics of cefotaxim in geriatric patients (author's transl)].
Topics: Aged; Cefotaxime; Cephalosporins; Half-Life; Humans; Injections, Intramuscular; Injections, Intravenous; Urinary Tract Infections | 1980 |
[Cefotaxime: a semi-synthetic cephalosporin of the new generation (author's transl)].
Topics: Bacteria; Cefotaxime; Cephalosporins; Structure-Activity Relationship | 1981 |
[Cefotaxime, syn isomer of a new methoxyimino cephalosporin with unusual activity (author's transl)].
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillins; Stereoisomerism | 1981 |
[In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)].
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Neutropenia | 1981 |
[Value of cefotaxime in the treatment of female asymptomatic N. gonorrhoeae carriers (author's transl)].
Topics: Adult; Carrier State; Cefotaxime; Cephalosporins; Cervix Mucus; Female; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Saliva | 1981 |
[Effects of cefotaxime on the intestinal bacterial ecosystem in children (author's transl)].
Topics: Cefotaxime; Cephalosporins; Enterococcus faecalis; Escherichia coli; Feces; Humans; Infant; Intestines | 1981 |
[In vitro activity of cefotaxime on anaerobes (author's transl)].
Topics: Anaerobiosis; Bacteria; Bacteroides fragilis; Cefotaxime; Cephalosporins; Clostridium perfringens; Microbial Sensitivity Tests; Peptococcus | 1981 |
[Kinetics of cefotaxime in healthy subjects (author's transl)].
Topics: Adult; Blood Proteins; Cefotaxime; Cephalosporins; Humans; Infusions, Parenteral; Injections, Intramuscular; Injections, Intravenous; Kinetics; Middle Aged; Protein Binding | 1981 |
[Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
Topics: Adult; Aged; Biological Assay; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Half-Life; Humans; Kidney Failure, Chronic; Kinetics; Middle Aged; Models, Biological | 1981 |
[Cefotaxime CSF levels in children with purulent meningitis (author's transl)].
Topics: Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Meningitis; Meningitis, Haemophilus | 1981 |
[Comparative study of cefotaxime serum and lung concentrations in 6 patients with thoracotomy (author's transl)].
Topics: Cefotaxime; Cephalosporins; Humans; Lung; Male; Pneumonectomy | 1981 |
[A study of the transplacental passage of cefotaxime (author's transl)].
Topics: Amniotic Fluid; Cefotaxime; Cephalosporins; Female; Humans; Kinetics; Maternal-Fetal Exchange; Pregnancy | 1981 |
[Diffusion of cefotaxime in the interstitial fluid of rabbits. Comparison with cefazolin, cefoxitin and cefamandole (author's transl)].
Topics: Animals; Cefamandole; Cefazolin; Cefotaxime; Cefoxitin; Cephalosporins; Diffusion; Extracellular Space; Rabbits | 1981 |
[The use of cefotaxime against infections (author's transl)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Female; Humans; Male; Middle Aged; Sepsis; Urinary Tract Infections | 1981 |
[Place of cefotaxime in the treatment of septicaemias due to enterobacteriaceae (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Middle Aged; Sepsis | 1981 |
[Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Meningitis; Middle Aged; Pseudomonas Infections; Respiratory Tract Infections; Sepsis; Urinary Tract Infections | 1981 |
[Clinical experience of cefotaxime (author's transl)].
Topics: Adolescent; Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia; Sepsis; Urinary Tract Infections | 1981 |
[Treatment of Gram-negative septicaemia with cefotaxime: 16 cases (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Humans; Middle Aged; Sepsis | 1981 |
[Cefotaxime treatment of 25 cases of severe enterobacteriaceae infections in an intensive care unit (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Critical Care; Enterobacteriaceae Infections; Humans; Infusions, Parenteral; Middle Aged | 1981 |
[Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
Topics: Acinetobacter Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pneumonia; Urinary Tract Infections | 1981 |
[Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Child; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1981 |
[Cefotaxime in childhood infections (author's transl)].
Topics: Adolescent; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Lymphadenitis; Male; Osteoarthritis; Pneumonia; Skin Diseases, Infectious; Urinary Tract Infections | 1981 |
[Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Humans; Infant; Infant, Newborn; Male; Meningitis; Meningitis, Haemophilus; Pseudomonas Infections; Salmonella Infections | 1981 |
[Cefotaxime and Gram-negative infections in children. Effectiveness and tolerance (author's transl)].
Topics: Adolescent; Cefotaxime; Cephalosporins; Child; Child, Preschool; Enterobacteriaceae Infections; Fusobacterium Infections; Haemophilus Infections; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous | 1981 |
[Cefotaxime in digestive tract infections (author's transl)].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Digestive System Diseases; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Pseudomonas Infections; Staphylococcal Infections | 1981 |
[Cefotaxime in bronchopulmonary infections (author's transl)].
Topics: Adolescent; Adult; Aged; Bronchitis; Cefotaxime; Cephalosporins; Enterobacteriaceae Infections; Female; Haemophilus Infections; Humans; Male; Middle Aged; Pneumonia; Staphylococcal Infections; Streptococcal Infections | 1981 |
[Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Kanamycin; Leukemia; Middle Aged | 1981 |
[Cefotaxime in infections caused by multi-resistant microorganisms].
Topics: Adult; Aged; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Infant; Male; Middle Aged; Sepsis | 1981 |
In vitro comparison of three new cephalosporins: LY-127935, cefotaxime and cefoperazone.
Topics: Bacteria; Cefoperazone; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Interactions; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
A note on the anti-Pseudomonas activity of cephalosporins with chlorhexidine.
Topics: Cefotaxime; Cefoxitin; Cefuroxime; Cephaloridine; Cephalosporins; Chlorhexidine; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1980 |
Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis.
Topics: Ampicillin; Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Escherichia coli; Humans; Kinetics; Listeria monocytogenes; Male; Meningitis; Moxalactam; Penicillin Resistance; Rabbits; Streptococcus agalactiae | 1981 |
[The use of cefotaxime in pediatrics: clinical and bacteriological experience].
Topics: Cefotaxime; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Female; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Male | 1980 |
Comparative determination of cefotaxime and desacetyl cefotaxime in serum and bile by bioassay and high-performance liquid chromatography.
Topics: Adult; Animals; Bile; Biological Assay; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Male; Microbial Sensitivity Tests; Rats | 1981 |
Assay of cefotaxime by high-pressure-liquid chromatography.
Topics: Biological Assay; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Kinetics; Microbial Sensitivity Tests | 1981 |
Cefotaxime kinetics after multiple-dose intramuscular study in healthy volunteers.
Topics: Adult; Cefotaxime; Cephalosporins; Half-Life; Humans; Injections, Intramuscular; Kinetics; Male | 1981 |
In vivo and in vitro interference due to cefotaxime on the assay of creatinine.
Topics: Cefotaxime; Cephalosporins; Creatinine; Humans; Time Factors | 1981 |
Bactericidal activity of antibiotics against Campylobacter fetus subspecies intestinalis.
Topics: Ampicillin; Campylobacter; Campylobacter fetus; Cefoperazone; Cefotaxime; Cephalosporins; Cephalothin; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Streptomycin | 1981 |
Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
Topics: Adult; Cefotaxime; Cephalosporins; Humans; Injections, Intravenous; Kidney Failure, Chronic; Kinetics; Renal Dialysis | 1981 |
Influence of inoculum size on activity of cefoperazone, cefotaxime, moxalactam, piperacillin, and N-formimidoyl thienamycin (MK0787) against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1980 |
Susceptibility of Neisseria gonorrhoeae to cefotaxime and ceftizoxime.
Topics: Cefotaxime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillinase | 1981 |
[Chemotherapy with fosfomycin, cefoxitin, and cefotaxime in experimental E. coli-pleuropneumonia (author's transl)].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli Infections; Female; Fosfomycin; Kinetics; Pleuropneumonia; Rats | 1981 |
[Comparative study of the effectiveness of cefotaxime and cefazolin on respiratory tract infection (author's transl)].
Topics: Adolescent; Adult; Aged; Cefazolin; Cefotaxime; Cephalosporins; Drug Evaluation; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1980 |
Suction skin blister, skin window, and skin chamber techniques to determine extravascular passage of cefotaxime in humans.
Topics: Adolescent; Adult; Aged; Biological Transport; Blister; Cefotaxime; Cephalosporins; Humans; Middle Aged; Skin; Skin Window Technique; Suction | 1981 |
In vitro activity of N-formimidoyl thienamycin in comparison with cefotaxime, moxalactam, and ceftazidime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative in vitro studies of Ro 13-9904, a new cephalosporin derivative.
Topics: Bacteria; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Moxalactam | 1981 |
Antimicrobial activity of cefmenoxime (SCE-1365).
Topics: Animals; Bacteria; Bacterial Infections; Cefamandole; Cefazolin; Cefmenoxime; Cefotaxime; Cefoxitin; Cephalosporins; Drug Synergism; Female; Mice | 1981 |
Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease.
Topics: Cefotaxime; Cephalosporins; Female; Half-Life; Humans; Kidney Diseases; Kidney Failure, Chronic; Kinetics; Liver Diseases; Male; Middle Aged | 1981 |
[Preliminary clinico-therapeutic trials of new cephalosporin: cefotaxime].
Topics: Abscess; Adult; Aged; Arthritis, Infectious; Bacterial Infections; Cefotaxime; Cephalosporins; Cholangitis; Female; Humans; Male; Middle Aged; Otitis Media; Pelvic Inflammatory Disease; Pharyngitis; Urinary Tract Infections | 1981 |
Study of the in vitro activity of new cephalosporins on strains of Neisseria gonorrhoeae of the Toulouse region.
Topics: Ampicillin; Cefazolin; Cefotaxime; Cefotiam; Cefoxitin; Ceftriaxone; Cephalosporins; Cephalothin; Cephamycins; Female; France; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Penicillins | 1981 |
Comparative in vitro activity of 8 cephalosporins on 109 strains of Neisseria gonorrhoeae and 60 strains of Neisseria meningitidis.
Topics: Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftriaxone; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Moxalactam; Neisseria gonorrhoeae; Neisseria meningitidis | 1981 |
In-vitro activity of the novel oxa-beta-lactam antibiotic moxalactam (LY 127935) against dense populations of selected Gram-negative bacilli.
Topics: Ampicillin; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Time Factors | 1981 |
N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Moxalactam | 1981 |
Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture.
Topics: Bacteria; Blood; Cefotaxime; Cephalosporins; Cephamycins; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and sulphamethoxazole in experimental meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis; Moxalactam; Rabbits; Sulfamethoxazole; Trimethoprim | 1981 |
Serratia endocarditis in a pediatric burn patient. Cure with cefotaxime.
Topics: Burns; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Endocarditis, Bacterial; Enterobacteriaceae Infections; Female; Humans; Sepsis; Serratia marcescens; Tricuspid Valve | 1981 |
The use of cefotaxime in serious and problem surgical infections.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Surgical Wound Infection | 1980 |
Antibacterial activity of moxalactam (LY-127935) compared with cefotaxime and other beta-lactam antibiotics against clinical isolates of enterobacteriacea and non-fermenters.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae; Enterobacteriaceae Infections; Fermentation; Humans; Microbial Sensitivity Tests; Moxalactam | 1981 |
Bactericidal activity of erythromycin in the respiratory system.
Topics: Amoxicillin; Ampicillin; Cefotaxime; Cephalosporins; Erythromycin; Haemophilus influenzae; Humans; In Vitro Techniques; Kinetics; Microbial Sensitivity Tests; Mucus; Respiratory System; Sputum; Staphylococcus aureus; Streptococcus pyogenes; Time Factors | 1981 |
[An enzymic method for the determination of cefotaxim in serum and urine (author's transl)].
Topics: Cefotaxime; Cephalosporins; Humans; Methods | 1981 |
New drugs for enteric gram-negative bacillary meningitis in adults.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Meningitis; Meningitis, Haemophilus; Moxalactam | 1981 |
Sensitivity of gram-negative organisms to cefotaxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests | 1981 |
Drugs & dosages: Claforan (cefotaxime sodium).
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Humans | 1981 |
Cefotaxime: binding affinity to penicillin-binding proteins and morphological changes of Escherichia coli and Pseudomonas aeruginosa.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas aeruginosa | 1981 |
Synergistic activity of cefoperazone in combination with beta-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; beta-Lactams; Cefoperazone; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Synergism; Penicillanic Acid; Sulbactam | 1981 |
In vitro comparison of N-formimidoyl thienamycin, piperacillin, cefotaxime, and cefoperazone.
Topics: Aerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Humans; Imipenem; Lactams; Penicillins; Piperacillin; Species Specificity | 1981 |
Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefmenoxime; Cefotaxime; Cephalosporinase; Cephalosporins; Drug Stability; Microbial Sensitivity Tests; Proteus vulgaris | 1981 |
Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime.
Topics: Animals; Bacteria; beta-Lactamases; Cefotaxime; Cefuroxime; Cephalosporinase; Cephalosporins; Cross Reactions; Hydrolysis; Rabbits | 1981 |
Potential value of cefoperazone in bacterial meningitis: experimental studies.
Topics: Animals; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Kinetics; Meningitis, Haemophilus; Moxalactam; Rabbits | 1981 |
Comparative in-vitro activity and mode of action of ceftriaxone (Ro 13-9904), a new highly potent cephalosporin.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Haemophilus influenzae; Kinetics; Pseudomonas aeruginosa; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1981 |
Susceptibility of Pseudomonas aeruginosa to cefoperazone, cefotaxime and moxalactam, with special reference to isolates resistant to aminoglycosides, carbenicillin and ticarcillin.
Topics: Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Ticarcillin | 1981 |
Activity of moxalactam and cefotaxime alone and in combination with ampicillin or penicillin against group B streptococci.
Topics: Ampicillin; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Humans; Moxalactam; Penicillin G; Penicillin Resistance; Streptococcal Infections; Streptococcus agalactiae | 1981 |
In vitro susceptibility of Haemophilus influenzae and neisseria gonorrhoeae to Ro 13-9904 in comparison with other beta-lactam antibiotics.
Topics: beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Cerebrospinal Fluid; Haemophilus influenzae; Humans; Neisseria gonorrhoeae; Penicillins; Sputum | 1981 |
Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. VI. Alternative syntheses of 7 beta-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]cephalosporin derivatives.
Topics: Cefmenoxime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry | 1981 |
Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Topics: beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa | 1981 |
Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Topics: Bacteroides fragilis; beta-Lactamases; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Cephamycins; In Vitro Techniques; Moxalactam | 1981 |
Pharmacology of ceftizoxime compared with that of cefamandole.
Topics: Adult; Cefamandole; Cefotaxime; Ceftizoxime; Cephalosporins; Humans; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male | 1981 |
Comparative in vitro activity of first, second and third generation cephalosporins.
Topics: Bacteria; Cefamandole; Cefoperazone; Cefotaxime; Cefoxitin; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Cephamycins; Dose-Response Relationship, Drug; Moxalactam; Structure-Activity Relationship | 1981 |
[Moxalactam and cefotaxime--two new beta-lactam antibiotics compared with three well-known cephalosporins].
Topics: Bacteria; Cefazolin; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1981 |
Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
Topics: Aminohippuric Acids; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephaloridine; Cephalosporins; Inulin; Kidney; Male; p-Aminohippuric Acid; Protein Binding; Rabbits | 1981 |
Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
Topics: Animals; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Cephalosporins; Half-Life; Kidney; Kidney Tubules; Male; Metabolic Clearance Rate; Protein Binding; Rabbits; Rats; Rats, Inbred Strains | 1981 |
Resistance to cefamandole: a collaborative study of emerging clinical problems.
Topics: Adult; Aged; Bacteroides Infections; beta-Lactamases; Cefamandole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Escherichia coli Infections; Female; Humans; Isoelectric Focusing; Male; Middle Aged; Moxalactam; Penicillin Resistance; Penicillins | 1982 |
Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.
Topics: beta-Lactamases; Cefmenoxime; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1981 |
Comparative in vitro activity of ceftizoxime, cefoperazone, and cefoxitin against anaerobic bacteria.
Topics: Anaerobiosis; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1981 |
In vitro antimicrobial activity evaluation of cefodizime (HR221), a new semisynthetic cephalosporin.
Topics: Bacteria; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Stability; Enterobacteriaceae; Hydrolysis; Microbial Sensitivity Tests | 1981 |
Comparative activity of N-formimidoyl thienamycin with third generation cephalosporins and ureido penicillins against multiple resistant Serratia marcescens.
Topics: Azlocillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Imipenem; Lactams; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin; Serratia marcescens | 1981 |
[In vitro susceptibility of Listeria monocytogenes with special reference to newer beta lactam antibiotics (author's transl)].
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Doxycycline; Gentamicins; Listeria monocytogenes; Mezlocillin; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1981 |
[Comparison of antibacterial activity of cefmenoxime with other cephalosporins against clinically isolated bacteria (author's transl)].
Topics: Bacteria; Bacteroides; Cefmenoxime; Cefotaxime; Cephalosporins; Clostridium; Drug Resistance, Microbial; Escherichia coli; Haemophilus influenzae; Klebsiella; Proteus; Streptococcus | 1981 |
The new cephalosporins and penicillins.
Topics: Azlocillin; Bacterial Infections; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Humans; Mezlocillin; Moxalactam; Penicillins; Piperacillin | 1982 |
Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
Topics: Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Gentamicins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin | 1982 |
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
Topics: Animals; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephamycins; Dose-Response Relationship, Drug; Infusions, Parenteral; Kinetics; Male; Meningitis, Haemophilus; Meningitis, Pneumococcal; Moxalactam; Rabbits; Streptococcus pneumoniae | 1982 |
Comparative in vitro bactericidal activity of cefonicid, ceftizoxime, and penicillin against group B streptococci.
Topics: Cefamandole; Cefonicid; Cefotaxime; Ceftizoxime; Cephalosporins; Dose-Response Relationship, Drug; Penicillin G; Penicillin Resistance; Streptococcus agalactiae | 1982 |
Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins | 1982 |
Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography.
Topics: Cefotaxime; Cefotiam; Cefsulodin; Cefuroxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Microchemistry; Structure-Activity Relationship | 1982 |
In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; beta-Lactams; Cefotaxime; Cefoxitin; Cefsulodin; Cephalosporins; Cephamycins; Imipenem; Lincomycin; Metronidazole; Moxalactam | 1981 |
Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Culture Media; Humans; Injections, Intravenous; Moxalactam; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1981 |
Activities of new beta-lactam antibiotics against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Cystic Fibrosis; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections | 1981 |
Susceptibility of gram-positive cocci to various antibiotics, including cefotaxime, moxalactam, and N-formimidoyl thienamycin.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1981 |
Anion-exchange extraction of cephapirin, cefotaxime, and cefoxitin from serum for liquid chromatography.
Topics: Bacillus subtilis; Biological Assay; Blood Proteins; Cefotaxime; Cefoxitin; Cephalosporins; Cephapirin; Chromatography, Ion Exchange; Chromatography, Liquid; Humans; Protein Binding | 1982 |
Prophylactic cephalosporin in prostatic surgery.
Topics: Cefotaxime; Cephalosporins; Cephradine; Humans; Male; Premedication; Prostatectomy | 1982 |
A very precise high-performance liquid chromatographic procedure for the determination of cefmenoxime, a new cephalosporin antibiotic, in plasma.
Topics: Cefmenoxime; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Reference Values; Time Factors | 1982 |
Resistance of Listeria to cefotaxime and moxalactam.
Topics: Cefotaxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Listeriosis; Moxalactam | 1982 |
High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
Topics: Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Chromatography, High Pressure Liquid; Humans | 1982 |
The comparative activities of N-formimidoyl theinamycin (MK0787), moxalactam, cefotaxime and cefoperazone against Yersinia enterocolitica and Listeria monocytogenes.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Imipenem; Lactams; Listeria monocytogenes; Moxalactam; Yersinia | 1982 |
[Sensitivity to second-generation cephem agents of clinically isolated strains of bacteria in otorhinolaryngological field (author's transl)].
Topics: Bacteria; Bacterial Infections; Cefazolin; Cefmetazole; Cefotaxime; Cefotiam; Cefuroxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Otorhinolaryngologic Diseases | 1982 |
[Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Topics: Bacteria; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Gentamicins; Moxalactam; Structure-Activity Relationship | 1982 |
[Efficacy of the new cephalosporin antibiotics cefotaxime, cefoperazone and lamoxactam].
Topics: Bacteria; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Microbial Sensitivity Tests; Moxalactam | 1982 |
Effects of moxalactam and cefotaxime on rabbit renal tissue.
Topics: Acetylglucosaminidase; Animals; Cefotaxime; Cephalosporins; Cephamycins; Creatine; Kidney; Kidney Glomerulus; Male; Moxalactam; Rabbits | 1982 |
In vitro susceptibility of Clostridium difficile isolates to cefotaxime, moxalactam, and cefoperazone.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Clostridium; Microbial Sensitivity Tests; Moxalactam | 1982 |
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Topics: Acinetobacter; Bacteria; Bacteroides fragilis; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Enterobacter; Enterobacteriaceae; Microbial Sensitivity Tests; Moxalactam; Providencia; Pseudomonas aeruginosa | 1982 |
[Statistical regression analysis for four new cephalosporins (author's transl)].
Topics: Bacteria; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Microbial Sensitivity Tests; Moxalactam; Regression Analysis | 1982 |
Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.
Topics: Bacteria; Cefmenoxime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests | 1982 |
Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
Topics: Azlocillin; Cefotaxime; Cefsulodin; Cephalosporins; Cephamycins; Mezlocillin; Microbial Sensitivity Tests; Moxalactam; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
Cefotaxime and moxalactam: the new third-generation cephalosporins.
Topics: Cefotaxime; Cephalosporins; Humans | 1982 |
[In vitro activity of ceftazidime compared with five beta-lactamase stable compounds against clinical strains of Acinetobacter calcoaceticus ].
Topics: Acinetobacter; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Humans | 1982 |
[Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Topics: Bacteria; beta-Lactamases; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Gentamicins; Microbial Sensitivity Tests; Moxalactam | 1982 |
Comparative synergistic activity of cefoperazone, cefotaxime, moxalactam, and carbenicillin, combined with tobramycin, against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Carbenicillin; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Pseudomonas aeruginosa; Tobramycin | 1981 |
Aminoglycoside-resistant gram-negative bacilli in a community hospital: comparative in vitro activity of cefotaxime, moxalactam, cefoperazone, and piperacillin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefoperazone; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Humans; Moxalactam; Penicillin Resistance; Penicillins; Piperacillin | 1982 |
[Cephem antibiotics and alcohol metabolism: (1) Disulfiram-like reaction resulting from intravenous administration of cephem antibiotics].
Topics: Acetaldehyde; Administration, Oral; Animals; Cefamandole; Cefazolin; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Cephamycins; Disulfiram; Drug Interactions; Ethanol; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1982 |
[Clinical bacteriological studies on cefotiam and cefsulodin in the field of otorhinolaryngology].
Topics: Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Humans; Middle Aged; Otorhinolaryngologic Diseases | 1982 |
Bacteriological comparison of the activities of ceftriaxone, a new long-acting cephalosporin, with those of other new cephalosporins.
Topics: Bacteria; Cefotaxime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests | 1982 |
The newest cephalosporins: how to use them?
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Cephamycins; Enterobacteriaceae Infections; Humans; Moxalactam | 1982 |
[Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1982 |
In vitro activity of N-formimidoyl-thienamycin in comparison to that of moxalactam and cefotaxime against gentamicin-resistant gram-negative bacteria.
Topics: Acinetobacter; Bacteria; Cefotaxime; Cephalosporins; Cephamycins; Cross Infection; Drug Resistance, Microbial; Enterobacter; Escherichia coli; Gentamicins; Imipenem; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia; Thienamycins | 1982 |
In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Topics: Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Cefoxitin; Cephalosporins; Cephalothin; Cephamycins; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam | 1982 |
Ceftizoxime and other third-generation cephalosporins: structure-activity relationships.
Topics: Acylation; Bacteria; Cefotaxime; Ceftizoxime; Cephalosporins; Chemical Phenomena; Chemistry; Molecular Conformation; Oximes; Structure-Activity Relationship | 1982 |
Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefamandole; Cefazolin; Cefotaxime; Ceftizoxime; Cephalosporins; Humans; Respiratory Tract Infections; Skin Diseases, Infectious; Tobramycin; Urinary Tract Infections | 1982 |
In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.
Topics: Anaerobiosis; Bacteria; Bacteroides; Bacteroides fragilis; Cefotaxime; Ceftizoxime; Cephalosporins; Clostridium perfringens | 1982 |
Synergism and antagonism of ceftizoxime and other new cephalosporins.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; beta-Lactamase Inhibitors; Cefotaxime; Ceftizoxime; Cephalosporins; Culture Media; Drug Antagonism; Drug Synergism; Microbial Sensitivity Tests; Pseudomonas | 1982 |
Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans.
Topics: Adolescent; Adult; Aged; Cefoperazone; Cefotaxime; Ceftizoxime; Cephalosporins; Cephamycins; Humans; Kinetics; Middle Aged; Models, Biological; Moxalactam; Myelography; Protein Binding; Time Factors | 1982 |
Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.
Topics: Animals; Cefazolin; Cefotaxime; Ceftazidime; Cephalosporins; Female; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Rats | 1982 |
In-vitro and in-vivo efficacy of ceftriaxone, moxalactam, and chloramphenicol against Haemophilus influenzae type b.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Chloramphenicol; Haemophilus Infections; Haemophilus influenzae; Microbial Sensitivity Tests; Moxalactam; Rats | 1982 |
The in vitro activity of ceftazidime against resistant clinical isolates.
Topics: Bacteria; Cefotaxime; Ceftazidime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1983 |
Ceftazidime, ceftizoxime, cefotaxime and HR 221 in experimental chronic Escherichia coli pyelonephritis in rats.
Topics: Animals; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Chronic Disease; Drug Evaluation, Preclinical; Escherichia coli Infections; Pyelonephritis; Rats | 1983 |
Kinetics and significance of the activity of the Sabath and Abrahams' beta-lactamase of Pseudomonas aeruginosa against cefotaxime and cefsulodin.
Topics: beta-Lactamases; Cefotaxime; Cefsulodin; Cephaloridine; Cephalosporinase; Cephalosporins; Drug Resistance, Microbial; Enzyme Induction; Kinetics; Mutation; Pseudomonas aeruginosa | 1983 |
[Activity of new cephalosporins against polyresistant bacterial strains].
Topics: Bacteria; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Drug Resistance, Microbial | 1983 |
Cefotetan: antimicrobial activity in-vitro compared with that of cefotaxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cefotetan; Cephalosporins; Cephamycins; Microbial Sensitivity Tests | 1983 |
[Clinical investigation of combined therapy (cefotiam, sulbenicillin and cefsulodin) against infections complicated by acute leukemia].
Topics: Acute Disease; Adult; Bacterial Infections; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia; Male; Middle Aged; Penicillin G; Sulbenicillin | 1983 |
Comparative in vitro activity of cefodizime, ceftazidime, aztreonam, and other selected antimicrobial agents against Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Aztreonam; Cefotaxime; Ceftazidime; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1983 |
Penicillin-binding proteins in Bacteroides fragilis and their affinities for several new cephalosporins.
Topics: Bacterial Proteins; Bacteroides fragilis; Carrier Proteins; Cefotaxime; Cephalosporins; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin G; Penicillin-Binding Proteins; Peptidyl Transferases | 1983 |
[The studies on distributions of cefsulodin and cefotiam to human aqueous humor and cornea].
Topics: Aged; Aqueous Humor; Cataract; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Cornea; Female; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged | 1982 |
[The antibacterial activity of new cephem antibiotics against clinical isolates. A comparison of the antibacterial activity of cefotaxime with 6 other antibiotics].
Topics: Bacteria; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacter; Haemophilus influenzae; Klebsiella; Microbial Sensitivity Tests; Moxalactam; Proteus; Streptococcus pneumoniae | 1983 |
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Cefmenoxime; Cefotaxime; Cefotetan; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1983 |
Efficacy of ceftriaxone in treatment of serious childhood infections.
Topics: Adolescent; Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Humans; Infant; Infant, Newborn | 1983 |
Ceftriaxone--and more to come.
Topics: Bacterial Infections; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephamycins; Child; Humans; Microbial Sensitivity Tests; Moxalactam | 1983 |
A beta-lactamase from Proteus vulgaris that hydrolyses newly introduced cephalosporins.
Topics: beta-Lactamases; Cefamandole; Cefotaxime; Cefuroxime; Cephalosporinase; Cephalosporins; Proteus vulgaris | 1983 |
Drugs recently released in Belgium.
Topics: Acyclovir; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Humans | 1983 |
Effect of storage temperature and time on stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
Topics: Cefmenoxime; Cefotaxime; Cefotetan; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Drug Storage; Freezing; Glucose; Temperature; Time Factors | 1983 |
Antimicrobial activity of cefmenoxime compared with those of other cephalosporins.
Topics: Bacteria; Cefmenoxime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests | 1983 |
Systematic approach to the determination of cephalosporins in biological fluids by reversed-phase liquid chromatography.
Topics: Bile; Cefotaxime; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Female; Humans; Hydrogen-Ion Concentration; Male; Microchemistry; Milk, Human; Osmolar Concentration | 1983 |
[In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Cephamycins; Drug Synergism; Enterobacteriaceae; Moxalactam | 1983 |
[Comparative clinical efficacy of cephotaxim and cefuroxime against the pathogens of inflammation in obstetrics and gynecology].
Topics: Bacterial Infections; Cefotaxime; Cefuroxime; Cephalosporins; Endometritis; Enterococcus faecalis; Escherichia coli; Female; Humans; Infant, Newborn; Infant, Newborn, Diseases; Kinetics; Klebsiella; Pregnancy; Pseudomonas aeruginosa; Puerperal Infection; Pyelonephritis; Staphylococcus aureus | 1983 |
Synthesis and biological properties of sodium (5R, 6S, 8R)-6 alpha-hydroxyethyl-2-carbamoyloxymethyl-2-penem-3-carboxylate (FCE 22101) and its orally absorbed esters FCE 22553 and FCE 22891.
Topics: Administration, Oral; Animals; Cefotaxime; Cephalosporins; Cephamycins; Indicators and Reagents; Injections, Intravenous; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Moxalactam; Structure-Activity Relationship | 1983 |
A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Enterobacter; Enterobacteriaceae; Escherichia coli; Oxacillin; Penicillin Resistance | 1983 |
[In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
Topics: beta-Lactamases; Cefotaxime; Cephalosporinase; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Enterobacteriaceae; Enzyme Induction; Hydrolysis; Moxalactam | 1983 |
Susceptibility of 324 nonfermentative gram-negative rods to 6 cephalosporins and azthreonam.
Topics: Acinetobacter; Alcaligenes; Anti-Bacterial Agents; Aztreonam; Bordetella; Cefamandole; Cefotaxime; Cefoxitin; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Flavobacterium; Gram-Negative Aerobic Bacteria; Moraxella; Pseudomonas | 1983 |
[Animal experiment studies on the effect of vitrectomy on the intraocular penetration of systemically applied cephalosporins].
Topics: Animals; Aqueous Humor; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Therapy, Combination; Eye; Permeability; Rabbits; Vitreous Body | 1983 |
Simultaneous determinations of cefsulodin and cefotiam in serum and bone marrow blood by high-performance liquid chromatography.
Topics: Biological Assay; Bone Marrow; Cefazolin; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Chromatography, High Pressure Liquid; Humans | 1983 |
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam | 1983 |
[In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
Topics: Bacteria; Cefotaxime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Moxalactam; Staphylococcus aureus | 1983 |
In vitro activity of ceftazidime and ceftriaxone.
Topics: Bacteria; Bacteria, Anaerobic; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Chemical Phenomena; Chemistry; Drug Resistance, Microbial; Microbial Sensitivity Tests | 1983 |
In vitro activity of HR 810, a new broad-spectrum cephalosporin.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Dose-Response Relationship, Drug; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Humans; Neisseriaceae; Penicillin Resistance; Piperacillin; Staphylococcus aureus | 1983 |
Relation between beta-lactamase production and antimicrobial activity: comparison of the new compound HR 810 with cefotaxime.
Topics: beta-Lactamases; Cefotaxime; Cefpirome; Cephalosporins; Enterobacteriaceae; Humans | 1983 |
Penetration of cefotaxime into the aqueous humour of the human eye after intravenous application.
Topics: Aqueous Humor; Bacterial Infections; Cataract Extraction; Cefotaxime; Cephalosporins; Endophthalmitis; Humans; Injections, Intravenous; Kinetics | 1983 |
Effect of broad-spectrum cephalosporins on the microbial flora of recipients.
Topics: Adult; Aged; Bacterial Infections; Bacteroides; Candidiasis; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Feces; Female; Humans; Male; Middle Aged; Neoplasms; Pharynx; Staphylococcus; Streptococcus | 1983 |
HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum.
Topics: Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Chemical Phenomena; Chemistry | 1983 |
Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.
Topics: Alcaligenes; Bacteria; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Cephalothin; Chloramphenicol; Deferoxamine; Drug Synergism; Enterobacteriaceae; Ferric Compounds; Gentamicins; Pseudomonas; Staphylococcus | 1983 |
Pharmacokinetic and microbial susceptibility studies of ceftriaxone.
Topics: Anti-Bacterial Agents; Bile; Cefotaxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Humans; Kinetics; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Synovial Fluid | 1983 |
New beta-lactamase-resistant cephem treatment of guinea pigs infected with Legionella pneumophila.
Topics: Animals; Cefotaxime; Cefotiam; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Evaluation, Preclinical; Erythromycin; Guinea Pigs; Legionnaires' Disease; Moxalactam | 1983 |
[Clinical use of new cephalosporins for severe infections in internal medicine].
Topics: Bacteroides Infections; Cefotaxime; Cefoxitin; Cephalosporins; Cross Infection; Drug Therapy, Combination; Enterobacteriaceae Infections; Gentamicins; Humans; Pseudomonas Infections; Staphylococcal Infections; Structure-Activity Relationship | 1983 |
[Chemotherapy of severe bacterial infections in pediatrics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Clindamycin; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Newborn, Diseases; Infant, Premature; Infant, Premature, Diseases; Meningitis; Metronidazole; Penicillin G; Pseudomonas Infections; Streptococcal Infections | 1983 |
[In-vitro activity of cefotaxime].
Topics: Cefotaxime; Cefoxitin; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Moxalactam; Penicillin Resistance; Penicillins; Streptococcal Infections; Streptococcus | 1983 |
In vitro antimicrobial activity of ceftizoxime.
Topics: Bacteria; Cefotaxime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1983 |
Lack of interference of five new beta-lactam antibiotics with serum creatinine determination.
Topics: Anti-Bacterial Agents; Autoanalysis; Aztreonam; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Creatinine; Humans; Male | 1983 |
[Comparison of sensitivity patterns of bacteria isolated from clinical materials to the 2d generation cephamycins and cephalosporins and clinical application of these antibiotics].
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Cefmetazole; Cefotaxime; Cefotiam; Cefoxitin; Cephalosporins; Cephamycins; Penicillin Resistance; Penicillins; Tetracyclines | 1983 |
In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
Topics: Amikacin; Anti-Bacterial Agents; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Drug Synergism; Imipenem; Kanamycin; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1983 |
Entry of four cephalosporins into the ovine lung.
Topics: Albumins; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Female; Humans; Lung; Lymph; Moxalactam; Proteins; Sheep | 1984 |
Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Topics: Bacteroides fragilis; beta-Lactamases; Cefmetazole; Cefotaxime; Cefoxitin; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam | 1984 |
Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Chloramphenicol; Haemophilus influenzae; Humans; Imipenem; Infant; Kinetics; Male; Meningitis, Haemophilus; Penicillin Resistance; Rabbits; Thienamycins | 1984 |
Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
Topics: Adult; Aged; Blister; Body Fluids; Cefoperazone; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Female; Humans; Kinetics; Male; Middle Aged; Skin; Tissue Distribution | 1983 |
[Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Azlocillin; Cefoperazone; Cefotaxime; Cefsulodin; Cephalosporins; Mezlocillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas; Pseudomonas fluorescens | 1984 |
Population analysis in strains of Staphylococcus aureus and Staphylococcus epidermidis. II. Cefuroxime and cefotaxime.
Topics: Cefotaxime; Cefuroxime; Cephalosporins; Dose-Response Relationship, Drug; Methicillin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Staphylococcus aureus; Staphylococcus epidermidis | 1983 |
[Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Cefotaxime; Cefotetan; Cefsulodin; Cephalosporins; Cephamycins; Dibekacin; Drug Resistance, Microbial; Drug Synergism; Escherichia coli; Kanamycin; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens; Sisomicin | 1983 |
[Sensitivity of the recent bacterial isolates to cefotaxime and other cephem antibiotics].
Topics: Bacteria; Cefotaxime; Cephalosporins; Drug Resistance, Microbial | 1983 |
Liquid chromatographic assay of ceftizoxime in sera of normal and uremic patients.
Topics: Cefotaxime; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Uremia | 1984 |
Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Azlocillin; beta-Lactamases; Carbenicillin; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Chromosomes, Bacterial; Isoelectric Point; Penicillin Resistance; Penicillins; Plasmids; Pseudomonas aeruginosa; United Kingdom | 1984 |
Interference of third-generation cephalosporins with theophylline assay by high-performance liquid chromatography.
Topics: Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Theophylline | 1984 |
Enhanced in vitro bactericidal activity of amikacin or gentamicin combined with three new extended-spectrum cephalosporins against cephalothin-resistant members of the family Enterobacteriaceae.
Topics: Amikacin; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Drug Synergism; Enterobacteriaceae; Gentamicins; Kanamycin; Time Factors | 1984 |
The role of penicillin-proteins in the action of cephalosporins against Escherichia coli and Salmonella typhimurium.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Salmonella typhimurium | 1981 |
[The pharmacokinetics and pharmacodynamics of cefotaxime in experimental diabetic rats].
Topics: Animals; Cefotaxime; Cephalosporins; Diabetes Mellitus, Experimental; Male; Pneumococcal Infections; Rats; Rats, Sprague-Dawley | 1995 |
In vivo activity and pharmacodynamics of cefotaxime or ceftriaxone in combination with fosfomycin in fibrin clots infected with highly penicillin-resistant Streptococcus pneumoniae.
Topics: Animals; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Fibrin; Fosfomycin; Male; Microbial Sensitivity Tests; Multivariate Analysis; Rabbits; Streptococcus pneumoniae | 1995 |
Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Evaluation Studies as Topic; Microbial Sensitivity Tests; Penicillins; Sensitivity and Specificity; Streptococcus pneumoniae | 1995 |
Effect of membrane surface potential on the uptake of anionic compounds by liposomes.
Topics: Anions; Cefixime; Cefotaxime; Ceftibuten; Cell Membrane Permeability; Cephalosporins; Hydroxyindoleacetic Acid; Liposomes; Membrane Potentials; Phosphatidylserines | 1994 |
Failure of cefotaxime treatment in two children with meningitis caused by highly penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Imipenem; Infant; Male; Meningitis, Pneumococcal; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Thienamycins | 1995 |
[Resistant pneumococcal meningitis revealing sickle cell anemia: efficacy of cefotaxime-vancomycin combination].
Topics: Anemia, Sickle Cell; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Pneumococcal; Penicillin Resistance; Vancomycin | 1995 |
Stability of cefotaxime sodium and metronidazole in 0.9% sodium chloride injection or in ready-to-use metronidazole bags.
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Metronidazole; Sodium Chloride | 1995 |
Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci.
Topics: Agar; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Cefotaxime; Cephalosporins; Clavulanic Acids; Culture Media; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1995 |
Extended-spectrum beta-lactamases conferring resistance to monobactams and oxyimino-cephalosporins in clinical isolates of Serratia marcescens.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Humans; Isoelectric Focusing; Monobactams; Plasmids; Serratia marcescens | 1995 |
[In vitro activity of six beta-lactams against 295 strains of enterobacteriaceae and P. aeruginosa isolated from neutropenic patients].
Topics: Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Humans; Imipenem; In Vitro Techniques; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tazobactam; Thienamycins | 1995 |
Genetic analysis of clinical isolates of Streptococcus pneumoniae with high-level resistance to expanded-spectrum cephalosporins.
Topics: Amino Acid Sequence; Base Sequence; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mosaicism; Mutagenesis, Site-Directed; Penicillin G; Streptococcus pneumoniae; Transformation, Bacterial | 1995 |
Failure of cefotaxime treatment in a patient with penicillin-resistant pneumococcal meningitis and confirmation of nosocomial spread by random amplified polymorphic DNA analysis.
Topics: Base Sequence; Cefotaxime; Cephalosporins; Cross Infection; DNA Primers; DNA, Bacterial; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant; Meningitis, Pneumococcal; Molecular Sequence Data; Penicillin Resistance; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1995 |
Multicentre comparative study on the antibacterial activity of FK-037, a new parenteral cephalosporin.
Topics: Aztreonam; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Ceftizoxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Microbial Sensitivity Tests; Sensitivity and Specificity | 1995 |
The in vitro activity of beta-lactamase inhibitors in combination with cephalosporins against M. tuberculosis.
Topics: beta-Lactamase Inhibitors; Cefamandole; Cefotaxime; Ceftriaxone; Cephalosporins; Cephapirin; Drug Synergism; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Sulbactam | 1995 |
Transferable resistance to cefotaxime in nosocomial Klebsiella pneumoniae and Escherichia coli strains due to their production of extended-spectrum beta-lactamase in Slovakia.
Topics: beta-Lactamases; Cefotaxime; Ceftibuten; Cephalosporins; Conjugation, Genetic; Cross Infection; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Humans; Hydrolysis; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Slovakia | 1995 |
In-vitro and in-vivo activity of DWC-751, a new cephalosporin.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1994 |
Antibiotic resistant organisms in a NICU.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal | 1995 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
Radical mechanisms of cephalosporins: a pulse radiolysis study.
Topics: Azides; Bromine; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Free Radicals; Hydroxyl Radical; Kinetics; Oxygen; Pulse Radiolysis; Superoxides | 1995 |
[Microbiological aspects of antibiotics with immunomodulating action].
Topics: Adjuvants, Immunologic; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Humans; Multicenter Studies as Topic | 1994 |
Intestinal brush-border transport of the oral cephalosporin antibiotic, cefdinir, mediated by dipeptide and monocarboxylic acid transport systems in rabbits.
Topics: Acetates; Animals; Biological Transport, Active; Carboxylic Acids; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Male; Membrane Potentials; Microvilli; Rabbits | 1993 |
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
Topics: Bacterial Proteins; Biological Transport; Carrier Proteins; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cell Membrane; Cell Membrane Permeability; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1994 |
TEM beta-lactamase mutants hydrolysing third-generation cephalosporins. A kinetic and molecular modelling analysis.
Topics: Aztreonam; beta-Lactamases; Binding Sites; Catalysis; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Escherichia coli; Hydrolysis; Kinetics; Mutation; Penicillins; Plasmids; Stereoisomerism; Substrate Specificity | 1994 |
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure | 1994 |
Synthesis and antibacterial properties of 7 beta-[2-(5-substituted-or unsubstituted-2-furyl)acetamido]cephalosporanic acid derivatives.
Topics: Anti-Bacterial Agents; Bacteria; Cefazolin; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet | 1994 |
Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Leukocyte Count; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 1994 |
Changes in the permeation rate of organic anions through the intestinal brush-border membrane with membrane surface potential.
Topics: Anilino Naphthalenesulfonates; Animals; Anions; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Diffusion; Fluorescent Dyes; Hydrogen-Ion Concentration; Intestinal Mucosa; Membrane Potentials; Microvilli; Penicillin G; Permeability; Rats | 1994 |
[Cephalosporins as possible methods of etiotropic therapy of tuberculosis].
Topics: Animals; Cefazolin; Cefotaxime; Cells, Cultured; Cephalosporins; Culture Media; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Mice; Microbial Sensitivity Tests; Rifampin; Tuberculosis | 1993 |
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
Topics: Adenocarcinoma; Amino Acids; Biological Transport; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Colonic Neoplasms; Dipeptides; Drug Antagonism; Energy Metabolism; Humans; Intestinal Absorption; Tumor Cells, Cultured | 1994 |
[Polyresistant Streptococcus pneumoniae causing cumulative diseases in infants and young children].
Topics: Age Factors; Ampicillin; Cefotaxime; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Oxacillin; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae | 1993 |
Comparison of endotoxin release by different antimicrobial agents and the effect on inflammation in experimental Escherichia coli meningitis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Chloramphenicol; Endotoxins; Escherichia coli Infections; Gentamicins; Inflammation; Male; Meningitis, Bacterial; Meropenem; Rabbits; Thienamycins | 1993 |
Comparison of the in vitro effects of several cephalosporins on the oxidative burst of human phagocytes.
Topics: Cefotaxime; Cefsulodin; Ceftazidime; Ceftriaxone; Cephalosporins; Humans; In Vitro Techniques; Kinetics; Neutrophils; Oxidation-Reduction; Phagocytes; Respiratory Burst | 1993 |
Nanoscale packed capillary liquid chromatography-electrospray ionization mass spectrometry: analysis of penicillins and cephems.
Topics: Cefotaxime; Cephalosporins; Cephamycins; Chromatography, Liquid; Humans; Mass Spectrometry; Penicillins; Piperacillin; Reference Standards | 1993 |
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.
Topics: Amines; Anti-Infective Agents; Bacterial Proteins; Carrier Proteins; Cefotaxime; Ceftriaxone; Cell Nucleus; Cephalosporins; Ciprofloxacin; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1993 |
Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling.
Topics: Amino Acid Sequence; Bacillus; Base Sequence; beta-Lactamases; Binding Sites; Cefotaxime; Ceftazidime; Cephalosporins; Citrobacter freundii; Hydrolysis; Lysine; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Oligodeoxyribonucleotides; Protein Structure, Secondary; Recombinant Proteins; Serine; Streptomyces | 1993 |
Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study.
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Haemophilus Infections; Haemophilus influenzae; Otitis Media; Random Allocation | 1993 |
Susceptibility of 170 penicillin-susceptible and penicillin-resistant pneumococci to six oral cephalosporins, four quinolones, desacetylcefotaxime, Ro 23-9424 and RP 67829.
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Culture Media; Fleroxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 1993 |
[Clinical efficacy of flomoxef in neonatal bacterial infection].
Topics: Ampicillin; Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn | 1993 |
[Protein binding of oral cephems in patients with chronic renal failure].
Topics: Carrier Proteins; Cefdinir; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Humans; Kidney Failure, Chronic; Palmitic Acid; Palmitic Acids; Renal Dialysis | 1993 |
Use of cefotaxime and metronidazole for treating cerebral abscesses.
Topics: Adult; Antitrichomonal Agents; Brain Abscess; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Metronidazole | 1995 |
Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Humans; Male; Respiratory Tract Infections | 1995 |
Assessment of the use of cefixime for switch therapy.
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Humans; Injections; Patient Compliance | 1995 |
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis.
Topics: Amoxicillin; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Drug Synergism; Enterococcus faecalis; Gram-Positive Bacterial Infections; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases | 1995 |
Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Base Sequence; beta-Lactamases; Campylobacter jejuni; Cefotaxime; Cephalosporins; Drug Resistance, Multiple; Molecular Sequence Data; Mutation; Pefloxacin; Polymerase Chain Reaction | 1995 |
Extracorporeal membrane oxygenation for refractory shock in fulminant meningococcal sepsis.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Child, Preschool; Extracorporeal Membrane Oxygenation; Female; Humans; Infant; Meningococcal Infections; Shock, Septic | 1996 |
Comparative perilymph permeability of cephalosporins and its significance in the treatment and prevention of suppurative labyrinthitis.
Topics: Animals; Cefotaxime; Cefuroxime; Cephalosporins; Chromatography, High Pressure Liquid; Female; Guinea Pigs; Labyrinthitis; Male; Perilymph; Permeability | 1996 |
In vivo acquisition of extended-spectrum beta-lactamase in Salmonella enteritidis during antimicrobial therapy.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Child, Preschool; Female; Humans; Microbial Sensitivity Tests; Salmonella enteritidis; Salmonella Infections | 1995 |
Criteria for testing the susceptibility of Streptococcus pneumoniae to cefotaxime and its desacetyl metabolite using 1 microgram or 30 micrograms cefotaxime disks.
Topics: Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Interactions; Humans; Microbial Sensitivity Tests; Regression Analysis; Streptococcus pneumoniae | 1995 |
Multidrug-resistant Salmonella typhi in Pakistani children: clinical features and treatment.
Topics: Ampicillin Resistance; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Multiple; Female; Humans; Infant; Male; Ofloxacin; Pakistan; Salmonella typhi; Trimethoprim Resistance; Typhoid Fever | 1996 |
Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease.
Topics: Anemia, Sickle Cell; Bacteremia; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1995 |
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Disease Outbreaks; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Rifampin | 1995 |
Genetic competence and susceptibility to beta-lactam antibiotics in Streptococcus pneumoniae R6 are linked via a two-component signal-transducing system cia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Genes, Bacterial; Hexosyltransferases; Histidine Kinase; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Phenotype; Protein Kinases; Signal Transduction; Streptococcus pneumoniae | 1995 |
Meningitis and septicemia due to Neisseria cinerea.
Topics: Adolescent; Bacteremia; Cefotaxime; Cephalosporins; Humans; Male; Meningitis, Bacterial; Neisseria; Neisseriaceae Infections; Species Specificity; Tooth Avulsion; Virulence | 1995 |
Non-typhoid Salmonella spp. resistant to cefotaxime.
Topics: Ampicillin; Argentina; beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Electrophoresis; Humans; Isoelectric Point; Microbial Sensitivity Tests; Salmonella; Salmonella Infections | 1995 |
The choice of antibacterial drugs.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Cross Infection; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Gram-Negative Bacteria; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Neutropenia; Penicillins; Pneumonia, Mycoplasma; Pneumonia, Staphylococcal; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1996 |
Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Female; Gonorrhea; Humans; Injections, Intramuscular; Treatment Outcome; Uterine Cervicitis | 1996 |
Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Cefotaxime compares favourably with other third generation cephalosporins.
Topics: Cefotaxime; Cephalosporins; Diarrhea; Enterocolitis, Pseudomembranous; Humans | 1996 |
Risk of diarrhoea due to Clostridium difficile during cefotaxime treatment. Mortality due to C difficile colitis in elderly people has been underestimated.
Topics: Aged; Cefotaxime; Cephalosporins; Diarrhea; Enterocolitis, Pseudomembranous; Female; Humans; Male | 1996 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
Third generation oral cephalosporins: comparative in vitro kinetics.
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalosporins; Escherichia coli; Haemophilus influenzae; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes | 1995 |
In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Topics: Cefotaxime; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 1995 |
Cloning and sequence of the gene encoding a cefotaxime-hydrolyzing class A beta-lactamase isolated from Escherichia coli.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporins; Cloning, Molecular; Escherichia coli; Hydrolysis; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Homology, Amino Acid | 1995 |
Streptococcus pneumoniae susceptible to benzylpenicillin but with reduced susceptibility to both cefotaxime and ceftriaxone.
Topics: Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Switch therapy in community-acquired pneumonia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Hospitalization; Humans; Infusions, Intravenous; Pneumonia; Treatment Outcome; United Kingdom | 1996 |
Synthesis and biological activity of C-3 direct heterocyclylcarbon-substituted novel cephalosporins.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles | 1996 |
Treatment failure due to extended spectrum beta-lactamase.
Topics: Adolescent; beta-Lactamases; Cefotaxime; Cephalosporins; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Failure | 1996 |
In-vitro effects of cefodizime on leucocyte functions and colony formation from granulocyte-monocyte progenitors.
Topics: Antibody-Dependent Cell Cytotoxicity; Cefotaxime; Cephalosporins; Dose-Response Relationship, Drug; Hematopoietic Stem Cells; Humans; Leukocytes; Lymphocyte Activation; Neutrophils; Phagocytosis | 1996 |
Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis.
Topics: Adolescent; Antigens, CD; Cefotaxime; Ceftazidime; Cephalosporins; Child; Child, Preschool; Cytokines; Female; Humans; Infant; Interleukin-10; Male; Meningitis, Bacterial; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Receptors, Tumor Necrosis Factor, Type II; Tumor Necrosis Factor-alpha | 1996 |
[The sensitivity to the preparation cefotaxime of bacteria isolated from newborn infants].
Topics: Bacteria; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Drug Resistance, Microbial; Humans; Infant, Newborn; Microbial Sensitivity Tests; Mucous Membrane; Skin | 1995 |
[Immunotropic activity of antimicrobial agents used in tuberculosis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Cefotaxime; Cephalosporins; Erythromycin; Isoniazid; Macrophages; Mice; Ofloxacin; Time Factors; Tuberculosis | 1996 |
Cefotaxime in the treatment of spontaneous bacterial peritonitis.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Drug Administration Schedule; Humans; Peritonitis | 1996 |
Meningitis in infancy caused by Pasteurella multocida.
Topics: Cefotaxime; Cephalosporins; Humans; Infant; Male; Meningitis, Bacterial; Pasteurella Infections; Pasteurella multocida; Penicillins | 1995 |
Analytical investigation of beta-lactam antibiotics in pharmaceutical preparations. IX. Colorimetric determination of six cephalosporins of second and third generation in the range of micromolar concentrations.
Topics: Cefaclor; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Colorimetry; Indicators and Reagents; Molecular Structure; Sensitivity and Specificity | 1996 |
Our experience with Lyme arthritis.
Topics: Adult; Amoxicillin; Arthritis; Cefotaxime; Cephalosporins; Humans; Lyme Disease; Male; Middle Aged; Recurrence | 1996 |
[Bacteremic peritonitis caused by Aeromonas hydrophila in a woman with cirrhosis].
Topics: Aeromonas hydrophila; Bacteremia; Cefotaxime; Cephalosporins; Chronic Disease; Female; Gram-Negative Bacterial Infections; Humans; Liver Cirrhosis; Middle Aged; Peritonitis | 1996 |
[Variation in transfer resistance to cefotaxime, ceftazidime and aztreonam in strains of Acinetobacter sp., Enterobacter sp. and Citrobacter sp. isolated from the same university hospitals].
Topics: Acinetobacter; Aztreonam; Cefotaxime; Ceftazidime; Cephalosporins; Citrobacter; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterobacter; Hospitals, University; Humans; Monobactams; R Factors | 1996 |
Second attack of acute tubulointerstitionephritis induced by cefataxim and pregnancy.
Topics: Acute Disease; Adult; Cefotaxime; Cephalosporins; Cystitis; Female; Humans; Kidney; Nephritis, Interstitial; Pregnancy; Pregnancy Complications; Recurrence; Risk Factors | 1996 |
Shigella sonnei meningitis.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Dysentery, Bacillary; Humans; Infant; Male; Meningitis, Bacterial; Shigella sonnei | 1996 |
[Bacteremia caused by Capnocytophaga sp: presentation of 2 cases, one with endocarditis. Review of the literature].
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Capnocytophaga; Cefotaxime; Ceftazidime; Cephalosporins; Endocarditis, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Male | 1996 |
[Acute bacterial parotitis caused by Serratia marcescens].
Topics: Acute Disease; Aztreonam; Cefotaxime; Cephalosporins; Child; Diagnosis, Differential; Female; Humans; Middle Aged; Monobactams; Parotitis; Serratia Infections; Serratia marcescens; Time Factors; Tomography, X-Ray Computed | 1996 |
Therapeutic arterial embolization for control of severe hepatic haemorrhage.
Topics: Adult; Angiography, Digital Subtraction; Catheterization, Peripheral; Cefotaxime; Cephalosporins; Child; Embolization, Therapeutic; Gelatin Sponge, Absorbable; Hemorrhage; Hemostatics; Hepatic Artery; Humans; Liver Diseases; Male; Radiography, Interventional | 1995 |
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Penetration and bactericidal activity of cefixime in synovial fluid.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli; Female; Haemophilus influenzae; Humans; Joint Diseases; Male; Middle Aged; Rheumatic Diseases; Synovial Fluid; Time Factors | 1996 |
In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Meropenem; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae; Thienamycins | 1996 |
Evaluation of commercial methods for determining antimicrobial susceptibility of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol Resistance; Drug Resistance, Microbial; Erythromycin; Evaluation Studies as Topic; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Tetracycline Resistance; Trimethoprim Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
In vitro activity of ceftizoxime, ceftazidime, cefuroxime, ceftriaxone, cefotaxime, and penicillin against Streptococcus pneumoniae as determined by three quantitative methods.
Topics: Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 1996 |
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins | 1996 |
[Antimicrobial activities of meropenem against clinically isolated strains. The result against strains isolated from blood and cerebrospinal fluid].
Topics: Ampicillin; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Escherichia coli; Humans; Imipenem; Listeria monocytogenes; Meningitis, Bacterial; Meropenem; Penicillins; Sepsis; Streptococcus agalactiae; Streptococcus pneumoniae; Thienamycins | 1996 |
Invasive non-typeable Haemophilus influenzae diseases in children.
Topics: Cefotaxime; Cephalosporins; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant | 1996 |
Antibiotic prophylaxis in severe acute pancreatitis.
Topics: Acute Disease; Antibiotic Prophylaxis; Cefotaxime; Cefuroxime; Cephalosporins; Humans; Pancreatitis; Randomized Controlled Trials as Topic | 1996 |
Failure of cefotaxime therapy in a child with shigellosis.
Topics: Cefotaxime; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Dysentery, Bacillary; Feces; Humans; Male; Microbial Sensitivity Tests; Shigella flexneri; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Direct application of Etest to gram-positive cocci from blood cultures: quick and reliable minimum inhibitory concentration data.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Culture Media; Erythromycin; Gentamicins; Gram-Positive Cocci; Imipenem; Microbial Sensitivity Tests; Penicillin G; Penicillins; Thienamycins; Vancomycin | 1996 |
The use of capillary electrophoresis to monitor the stability of a dual-action cephalosporin in solution.
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Stability; Electrophoresis, Capillary; Fleroxacin; Fluoroquinolones; Half-Life; Kinetics; Solutions; Water | 1995 |
Assessment of two penicillins plus beta-lactamase inhibitors versus cefotaxime in treatment of murine Klebsiella pneumoniae infections.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Female; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pneumonia, Bacterial; Tazobactam; Ticarcillin | 1996 |
MIC and time-kill study of activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, cefotaxime, imipenem, and vancomycin against nine penicillin-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cell Division; Cephalosporins; Drug Resistance, Microbial; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Quinolones; Streptococcus pneumoniae; Thienamycins; Time Factors; Vancomycin | 1996 |
Decrease in surface charge density of Klebsiella pneumoniae treated with cefodizime and enhancement of the phagocytic function of human polymorphonuclear leucocytes stimulated by the drug-treated bacteria.
Topics: Cefotaxime; Cephalosporins; Electrophoresis; Humans; Klebsiella pneumoniae; Luminescent Measurements; Microbial Sensitivity Tests; Neutrophils; Phagocytosis; Surface Properties | 1995 |
Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
Topics: Aged; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Practice Guidelines as Topic; Streptococcus pneumoniae | 1996 |
[Pathogen spectrum and antibiotic resistance in peritonsillar abscess].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Infant; Male; Middle Aged; Peritonsillar Abscess | 1996 |
Acute interstitial nephritis due to cefotaxime.
Topics: Acute Disease; Adult; Cefotaxime; Cephalosporins; Humans; Kidney; Male; Nephritis, Interstitial; Renal Dialysis | 1996 |
Cefotaxime failure in pneumococcal meningitis caused by a susceptible isolate.
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Infant; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1996 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Costs and Cost Analysis; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Scotland | 1996 |
A case of penicillin-resistant pneumococcal meningitis.
Topics: Aged; Cefotaxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Meningitis, Pneumococcal; Penicillin Resistance; Streptococcus pneumoniae | 1996 |
An engineered Staphylococcus aureus PC1 beta-lactamase that hydrolyses third-generation cephalosporins.
Topics: Base Sequence; beta-Lactamases; Binding Sites; Cefotaxime; Ceftazidime; Cephaloridine; Cephalosporins; Cloning, Molecular; Computer Simulation; Crystallography, X-Ray; Escherichia coli; Gene Expression Regulation; Hydrolysis; Kinetics; Models, Molecular; Molecular Sequence Data; Molecular Structure; Mutagenesis, Site-Directed; Protein Engineering; Staphylococcus aureus; Substrate Specificity | 1995 |
Correlation of in-vitro activity and pharmacokinetic parameters with in-vivo effect of amoxycillin, co-amoxiclav and cefotaxime in a murine model of pneumococcal pneumonia.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Cefotaxime; Cephalosporins; Clavulanic Acids; Disease Models, Animal; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1996 |
Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent.
Topics: Adult; Cefotaxime; Ceftizoxime; Cephalosporin Resistance; Cephalosporins; Costs and Cost Analysis; Cross Infection; Female; Humans; Length of Stay; Male; Middle Aged; Pneumococcal Infections; Streptococcus pneumoniae; Treatment Outcome | 1996 |
Antipneumococcal activities of cefpirome and cefotaxime, alone and in combination with vancomycin and teicoplanin, determined by checkerboard and time-kill methods.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Teicoplanin; Time Factors; Vancomycin | 1996 |
MIC and time-kill study of antipneumococcal activities of RPR 106972 (a new oral streptogramin), RP 59500 (quinupristin-dalfopristin), pyostacine (RP 7293), penicillin G, cefotaxime, erythromycin, and clarithromycin against 10 penicillin-susceptible and -
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clarithromycin; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae; Time Factors; Virginiamycin | 1996 |
Surrogate disks for predicting cefotaxime and ceftriaxone susceptibilities of Streptococcus pneumoniae.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Humans; Predictive Value of Tests; Streptococcus pneumoniae | 1996 |
Infections due to drug-resistant pneumococci, enterococci, and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Mycobacterium tuberculosis; Pneumococcal Infections; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; Vancomycin | 1996 |
Activity of penicillin and three third-generation cephalosporins against US isolates of Streptococcus pneumoniae: a 1995 surveillance study.
Topics: Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Effect of RO 23-9424, cefotaxime and fleroxacin on functions of human polymorphonuclear cells and cytokine production by human monocytes.
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Fleroxacin; Fluoroquinolones; Humans; Interleukin-1; Interleukin-8; Lipopolysaccharides; Monocytes; Neutrophils; Phagocytosis; Superoxides; Tumor Necrosis Factor-alpha | 1996 |
Penicillin-resistant Streptococcus pneumoniae.
Topics: Adult; Age Factors; Amoxicillin; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Humans; Incidence; Infant; Infant, Newborn; Penicillin Resistance; Penicillins; Pneumococcal Infections; Risk Factors; Streptococcus pneumoniae | 1996 |
[Antimicrobial activity of cefodizime against clinical isolates].
Topics: Bacteria; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Neisseria gonorrhoeae; Proteus mirabilis; Streptococcus pyogenes | 1996 |
Spontaneous bacterial peritonitis caused by Citrobacter diversus: case report.
Topics: Aged; Alcohol Drinking; Ascites; Cefotaxime; Cephalosporins; Citrobacter; Diagnosis, Differential; Diuretics; Enterobacteriaceae Infections; Fever; Humans; Jaundice; Male; Peritonitis; Spironolactone | 1997 |
Reduced anti-Pseudomonas aeruginosa activity of a cephalosporin, cefodizime, in rats whose neutrophils were selectively depleted by a monoclonal antibody.
Topics: Animals; Antibodies, Monoclonal; Blood Bactericidal Activity; Cefotaxime; Cephalosporins; Female; Granulocyte Colony-Stimulating Factor; Leukocyte Count; Neutrophils; Pseudomonas aeruginosa; Rats; Rats, Wistar | 1996 |
Acute bacterial peritonitis: permeability of cephalosporins in the peritoneal cavity.
Topics: Acute Disease; Animals; Bacterial Infections; Cefazolin; Cefonicid; Cefotaxime; Cephalosporins; Drug Evaluation, Preclinical; Drug Monitoring; Peritoneal Cavity; Peritonitis; Random Allocation; Rats; Rats, Wistar; Tissue Distribution | 1996 |
The effect of cefodizime on phagocyte function in non-patient volunteers and patients with chronic renal failure. In vitro and ex vivo studies.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Cefotaxime; Cell Polarity; Cephalosporins; Dose-Response Relationship, Drug; Female; Humans; In Vitro Techniques; Kidney Failure, Chronic; Luminescent Measurements; Male; Middle Aged; Phagocytes; Receptors, Cell Surface | 1996 |
[Disseminated liver abscesses in yersiniosis: diagnosis by ultrasound and spiral CT].
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Female; Humans; Liver Abscess; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Yersinia Infections | 1996 |
Adrenobronchial fistula complicating a neonatal adrenal abscess: treatment by percutaneous aspiration and antibiotics.
Topics: Abscess; Adrenal Gland Diseases; Anti-Bacterial Agents; Bronchial Fistula; Cefotaxime; Cephalosporins; Contrast Media; Escherichia coli Infections; Fistula; Gentamicins; Humans; Infant, Newborn; Injections, Intravenous; Lung Diseases; Male; Needles; Netilmicin; Suction; Tomography, X-Ray Computed | 1997 |
Spontaneous ascitic infection in different cirrhotic groups: prevalence, risk factors and the efficacy of cefotaxime therapy.
Topics: Adult; Ascitic Fluid; Bacteria; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Hospital Mortality; Humans; Infusions, Intravenous; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Prevalence; Prospective Studies; Recurrence; Risk Factors; Treatment Outcome; Turkey | 1997 |
Cefodizime: effects of sub-inhibitory concentrations on adhesiveness and bacterial morphology of Staphylococcus aureus and Escherichia coli: comparison with cefotaxime and ceftriaxone.
Topics: Bacterial Adhesion; Cefotaxime; Ceftriaxone; Cells, Cultured; Cephalosporins; Escherichia coli; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Mouth Mucosa; Staphylococcus aureus | 1997 |
[The use of endolymphatic antibacterial therapy to prevent suppurative complications after heart operations under artificial blood circulation].
Topics: Adult; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefazolin; Cefotaxime; Cephalosporins; Extracorporeal Circulation; Female; Humans; Injections, Intralymphatic; Male; Middle Aged; Surgical Wound Infection; Time Factors | 1996 |
[Third generation cephalosporins (cefoperazone, cefotaxime, ceftazidime and ceftriaxone) in the prevention and treatment of experimental plague in albino mice].
Topics: Animals; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Evaluation, Preclinical; Mice; Microbial Sensitivity Tests; Plague; Treatment Outcome; Yersinia pestis | 1996 |
Bactericidal activity of cefodizime on Enterobacteriaceae in an in-vitro model simulating plasma pharmacokinetics in humans.
Topics: Cefotaxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Models, Biological | 1997 |
Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Culture Media; Half-Life; Lung; Male; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Rats; Rats, Wistar; Streptococcus pneumoniae; Vancomycin | 1997 |
A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods.
Topics: Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactam Resistance; Cefotaxime; Cefoxitin; Ceftizoxime; Ceftriaxone; Cephalosporins; Clindamycin; Clostridium; Drug Resistance, Microbial; Eubacterium; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptostreptococcus; Piperacillin; Prevotella; Veillonella | 1997 |
Cefepime and amikacin synergy against a cefotaxime-susceptible strain of Enterobacter cloacae in vitro and in vivo.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae Infections; Kidney; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rats; Rats, Wistar | 1997 |
Application of capillary zone electrophoresis in cephalosporin analysis.
Topics: Cefotaxime; Cefpirome; Cefuroxime; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration | 1997 |
Alternative continuous infusion method for analysis of enterohepatic circulation and biliary excretion of cefixime in the rat.
Topics: Animals; Bile; Cefixime; Cefotaxime; Cephalosporins; Enterohepatic Circulation; Male; Rats; Rats, Wistar | 1994 |
Pharmacokinetics of antibiotics in neonates.
Topics: Anti-Bacterial Agents; Birth Weight; Cefotaxime; Ceftriaxone; Cephalosporins; Gentamicins; Humans; Infant, Newborn; Kidney; Protein Binding | 1997 |
Development of experimental pneumonia by infection with penicillin-insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem.
Topics: Amoxicillin; Animals; Cefotaxime; Cephalosporins; Colony Count, Microbial; Disease Models, Animal; Female; Guinea Pigs; Lung; Meropenem; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Thienamycins | 1996 |
Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
Topics: Amoxicillin; Animals; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Disease Models, Animal; Female; Lung; Mice; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1996 |
Activities against Streptococcus pneumoniae of amoxicillin and cefotaxime at physiological concentrations: in vitro pharmacodynamic simulation.
Topics: Amoxicillin; Cefotaxime; Cephalosporins; Colony Count, Microbial; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Simultaneous radical prostatectomy and partial rectum resection without colostomy.
Topics: Anastomosis, Surgical; Antitrichomonal Agents; Cefotaxime; Cephalosporins; Humans; Male; Metronidazole; Middle Aged; Neoplasms, Multiple Primary; Prostatectomy; Prostatic Neoplasms; Rectal Neoplasms; Rectum; Surgical Wound Infection; Treatment Outcome | 1997 |
Spontaneous bacterial peritonitis: clinical study, microbiological findings and clinical course.
Topics: Aged; Bacteria; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Male; Middle Aged; Peritonitis; Retrospective Studies; Time Factors | 1997 |
A mutation in the D,D-carboxypeptidase penicillin-binding protein 3 of Streptococcus pneumoniae contributes to cefotaxime resistance of the laboratory mutant C604.
Topics: Bacterial Proteins; Base Sequence; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Hexosyltransferases; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Point Mutation; Streptococcus pneumoniae | 1997 |
In vitro evaluation of contemporary beta-lactam drugs tested against viridans group and beta-haemolytic streptococci.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus; Ticarcillin | 1997 |
[Studies on enrichment broth for verotoxin-producing Escherichia coli (VTEC) O157].
Topics: Aeromonas; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Escherichia coli O157; Novobiocin; Pseudomonas; Shiga Toxin 1; Tellurium; Temperature; Vancomycin | 1997 |
[A case of isolated lung contusion].
Topics: Adult; Cefotaxime; Cephalosporins; Contusions; Humans; Lung; Lung Injury; Male; Radiography; Remission Induction; Wounds, Nonpenetrating | 1996 |
Infected abdominal aortic aneurysm due to penicillin-, ceftriaxone-, and cefotaxime-resistant Streptococcus pneumoniae.
Topics: Aortic Aneurysm, Abdominal; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Meningitis, Bacterial; Middle Aged; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1997 |
Penicillin-binding proteins as resistance determinants in clinical isolates of Streptococcus pneumoniae.
Topics: Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Drug Resistance, Multiple; Genes, Bacterial; Hexosyltransferases; Humans; Hungary; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptide Synthases; Peptidyl Transferases; Pneumococcal Infections; Polymerase Chain Reaction; Streptococcus pneumoniae | 1996 |
Penicillin-binding proteins 2x and 2b as primary PBP targets in Streptococcus pneumoniae.
Topics: Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin; Polymerase Chain Reaction; Streptococcus pneumoniae; Transformation, Bacterial | 1996 |
Five-year survey of cefotaxime resistance in Spain.
Topics: Bacterial Infections; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae; Humans; Respiratory Tract Infections; Spain | 1995 |
[Recurrent meningitis caused by Escherichia coli].
Topics: Ampicillin; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Escherichia coli; Female; Humans; Infant, Newborn; Meningitis; Penicillins; Recurrence | 1997 |
Influence of changes in pancreatic tissue morphology and capillary blood flow on antibiotic tissue concentrations in the pancreas during the progression of acute pancreatitis.
Topics: Acute Disease; Animals; Anti-Bacterial Agents; Capillaries; Cefotaxime; Cephalosporins; Disease Progression; Imipenem; Male; Necrosis; Pancreas; Pancreatitis, Acute Necrotizing; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Thienamycins | 1997 |
Otitic hydrocephalus.
Topics: Anti-Bacterial Agents; Antitrichomonal Agents; Cefotaxime; Cephalosporins; Child; Humans; Hydrocephalus; Male; Mastoid; Metronidazole; Otitis Media, Suppurative; Sinus Thrombosis, Intracranial; Tomography, X-Ray Computed | 1997 |
[The use of cefotaxime on patients admitted to the internal medicine service of a general hospital. An analysis from the viewpoint of health economics].
Topics: Adult; Aged; Aged, 80 and over; Cefotaxime; Cephalosporins; Drug Utilization; Female; Hospital Departments; Hospitals, General; Humans; Internal Medicine; Male; Middle Aged; Retrospective Studies; Spain | 1997 |
[Discitis in childhood: integrated neuroradiological imaging in diagnosis and follow-up study of one case].
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Discitis; Female; Humans; Lumbosacral Region; Magnetic Resonance Imaging; Teicoplanin | 1997 |
beta-Lactamase bioassay: a simplified method to determine extended-spectrum beta-lactamases (ESBL) in enterobacteria.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biological Assay; Cefotaxime; Cephalosporins; Enterobacteriaceae; Escherichia coli; Isoelectric Focusing; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sensitivity and Specificity | 1997 |
In vitro reduction of endotoxin concentrations with the 5S fragment of immunoglobulin G.
Topics: Cefotaxime; Cephalosporins; Colony Count, Microbial; Escherichia coli; Humans; Immunoglobulin Fragments; Immunoglobulin G; Kinetics; Lipopolysaccharides; Microbial Sensitivity Tests | 1997 |
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Fallopian Tubes; Female; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Organ Culture Techniques | 1997 |
[The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
Topics: Acinetobacter; Bacteria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Drug Resistance, Multiple; Flavobacterium; Imipenem; Pseudomonas; R Factors; Thienamycins; Xanthomonas | 1997 |
Evolution of extended spectrum cephalosporin resistance in the pneumococcus.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Imipenem; Penicillin Resistance; Streptococcus pneumoniae; Thienamycins | 1997 |
Morganella morganii: a newly reported, rare cause of neonatal sepsis.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Penicillins; Sepsis | 1997 |
[A multicenter study shows alarming results. High antibiotic resistance within Swedish intensive care].
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Sweden | 1997 |
Cost comparison of single daily i.v. doses of ceftriaxone versus continuous infusion of cefotaxime.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Costs and Cost Analysis; Health Care Costs; Humans; Infusions, Intravenous; Injections, Intravenous; Nurses; Pharmacists; Time and Motion Studies | 1997 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1997 |
[Infections in childhood; from respiratory infections to tropical medicine].
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Dexamethasone; Humans; Meningitis; Otitis Media; Respiratory Tract Infections | 1993 |
Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion.
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Ear, Middle; Humans; Infant; Otitis Media with Effusion | 1997 |
Surgical management of complicated colonic diverticulitis.
Topics: Anastomosis, Surgical; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Diverticulitis, Colonic; Humans; Treatment Outcome | 1997 |
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins | 1997 |
In vitro activity of cefixime versus ceftizoxime against Salmonella typhi.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 1997 |
TEM-8: a paradoxical ceftazidimase that owes its uniqueness to the presence of serine residues at positions 164 and 238.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Escherichia coli; Penicillin G | 1997 |
Bactericidal activity against intermediately cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with bacterial meningitis treated with high doses of cefotaxime and vancomycin.
Topics: Adolescent; Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Infant; Meningitis, Bacterial; Microbial Sensitivity Tests; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 1997 |
Protein carbonyl formation in blood plasma by cephalosporins.
Topics: Antioxidants; Ascorbic Acid; Blood Proteins; Cefotaxime; Cephalosporins; Chelating Agents; Cysteine; Glutathione; Humans; Metals; Moxalactam; Oxidation-Reduction | 1997 |
Genetic studies of cefotaxime resistance in Streptococcus pneumoniae.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Genes, Bacterial; Hexosyltransferases; Humans; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Serotyping; Signal Transduction; Streptococcus pneumoniae | 1997 |
Relapsing infection due to Enterobacter species: lessons of heterogeneity.
Topics: Abscess; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Humans; Mutation; Pneumonia, Bacterial | 1997 |
In vitro synergism between cefotaxime and minocycline against Vibrio vulnificus.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Colony Count, Microbial; Drug Synergism; Kinetics; Microbial Sensitivity Tests; Minocycline; Time Factors; Vibrio | 1997 |
A global gene pool for high-level cephalosporin resistance in commensal Streptococcus species and Streptococcus pneumoniae.
Topics: Amino Acid Sequence; Base Sequence; Berlin; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Gene Expression; Gene Transfer Techniques; Genes, Bacterial; Humans; Hungary; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Penicillin Resistance; Penicillin-Binding Proteins; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Sequence Homology, Nucleic Acid; Spain; Streptococcal Infections; Streptococcus; Streptococcus oralis; Streptococcus pneumoniae; Transformation, Genetic | 1997 |
[Stage-oriented antibiotic therapy of peritonitis. Prospective study].
Topics: Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Metronidazole; Ofloxacin; Peritoneal Lavage; Peritonitis; Prognosis; Prospective Studies; Surgical Wound Infection; Survival Analysis | 1997 |
Neonatal sepsis due to nonencapsulated Haemophilus influenzae biotype IV.
Topics: Ampicillin; Bacterial Typing Techniques; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant, Newborn; Male; Meconium Aspiration Syndrome; Oxygen Inhalation Therapy; Penicillins; Pregnancy; Respiratory Insufficiency; Sepsis | 1997 |
Transferable resistance to cefotaxime, ceftazidime, and aztreonam and production of extended-spectrum beta-lactamase in a strain of Salmonella enteritidis.
Topics: Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Multiple; Humans; Infant; Monobactams; Plasmids; Salmonella enteritidis; Transformation, Bacterial | 1997 |
Antimicrobial interactions (synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against gram-positive isolates from Germany and the United States.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Resistance, Multiple; Drug Synergism; Germany; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Teicoplanin; United States | 1997 |
[Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Male; Meningitis, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 1997 |
Meningococcal meningitis during penicillin therapy for meningococcemia.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Child; Female; Humans; Meningitis, Meningococcal; Penicillin Resistance; Penicillins | 1997 |
Spinal abscess of Haemophilus paraphrophilus. A case report.
Topics: Abscess; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Haemophilus; Haemophilus Infections; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Middle Aged; Spinal Diseases | 1997 |
Penicillin-resistant pneumococcal meningitis in Israel.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Humans; Infant; Israel; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcus pneumoniae; Vancomycin | 1997 |
[The reasons for the application of endolymphatic therapy in the treatment of purulent lung diseases, complicated by empyema of the pleura].
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Empyema, Pleural; Female; Humans; Injections, Intralymphatic; Lung Diseases; Male; Middle Aged; Suppuration | 1997 |
Atomic force microscopy: application to investigation of Escherichia coli morphology before and after exposure to cefodizime.
Topics: Cefotaxime; Cephalosporins; Escherichia coli; Microscopy, Atomic Force | 1998 |
Postantibiotic effect in Escherichia coli determined with real-time metabolic monitoring.
Topics: Anti-Bacterial Agents; Biotransformation; Cefotaxime; Cephalosporins; Computer Systems; Escherichia coli; Microbial Sensitivity Tests; Penicillins; Piperacillin | 1998 |
Multicenter evaluation of antimicrobial resistance to six broad-spectrum beta-lactams in Colombia using the Etest method. The Colombian Antimicrobial Resistance Study Group.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporinase; Cephalosporins; Cohort Studies; Colombia; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Reproducibility of Results; Staphylococcus; Sulbactam | 1997 |
Community-acquired Legionnaires' disease following minimal exposure to a contaminated source.
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Community-Acquired Infections; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Fluorescent Antibody Technique, Indirect; Humans; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Rifampin; Water Microbiology; Water Supply | 1997 |
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed | 1997 |
Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
Topics: Bacteremia; Cefotaxime; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple; Humans; Infant; Infusions, Intravenous; Male; Meningitis, Pneumococcal; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 1998 |
[Septic arthritis caused by Streptococcus pneumoniae].
Topics: Aged; Aged, 80 and over; Arthritis, Infectious; Cefotaxime; Cephalosporins; Hip Joint; Humans; Immunosuppression Therapy; Knee Joint; Male; Middle Aged; Pneumococcal Infections; Risk Factors | 1997 |
[Maternal and neonatal Pasteurella multocida infection].
Topics: Adult; Amoxicillin; Animals; Bites and Stings; Cefotaxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Dogs; Drug Therapy, Combination; Female; Gentamicins; Humans; Infant, Newborn; Male; Netilmicin; Pasteurella Infections; Pasteurella multocida; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Zoonoses | 1997 |
[Pneumococcal infections: penicillin resistance and therapeutic implications].
Topics: Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Erythromycin; Humans; Imipenem; Patient Care Planning; Penicillin G; Penicillin Resistance; Penicillins; Pleural Effusion; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Tetracycline Resistance; Thienamycins; Tracheal Diseases | 1995 |
A plasmid-mediated beta-lactamase conferring resistance to cefotaxime in a Salmonella typhimurium clone found in St Petersburg, Russia.
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Plasmids; Russia; Salmonella typhimurium | 1998 |
Ototoxicity resulting from intracochlear perfusion of Streptococcus pneumoniae in the guinea pig is modified by cefotaxime or amoxycillin pretreatment.
Topics: Amoxicillin; Animals; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Ear Diseases; Electrophysiology; Escherichia coli; Escherichia coli Infections; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Central; Microscopy, Electron, Scanning; Penicillins; Pneumococcal Infections; Scala Tympani; Streptococcus pneumoniae | 1998 |
[Usefulness of the disk diffusion method for evaluating the sensitivity of Neisseria meningitidis to penicillin and cefotaxime].
Topics: Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Neisseria meningitidis; Oxacillin; Penicillin Resistance; Penicillins | 1997 |
Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone.
Topics: Aged; Cardiac Tamponade; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Penicillin Resistance; Pericarditis; Streptococcus pneumoniae | 1998 |
[Salmonella meningitis in children in Libreville. Retrospective study of 9 cases].
Topics: Cefotaxime; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gabon; Humans; Infant; Male; Meningitis, Bacterial; Retrospective Studies; Salmonella Infections | 1997 |
The choice of antibacterial drugs.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporins; Community-Acquired Infections; Costs and Cost Analysis; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Macrolides; Meningitis, Bacterial; Meningitis, Meningococcal; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Neutropenia; Pneumococcal Infections; Pneumonia, Bacterial; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 1998 |
Cefotaxime-resistant Enterobacteriaceae isolates from a hospital in Warsaw, Poland: identification of a new CTX-M-3 cefotaxime-hydrolyzing beta-lactamase that is closely related to the CTX-M-1/MEN-1 enzyme.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Poland; Polymerase Chain Reaction | 1998 |
A case of pseudolymphoma leukaemia syndrome following cefixime.
Topics: Cefixime; Cefotaxime; Cephalosporins; Diagnosis, Differential; Female; Humans; Leukemia; Middle Aged; Pseudolymphoma; Sezary Syndrome | 1998 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
[Empirical treatment with cephotaxim in Echovirus type 3 meningitis].
Topics: Cefotaxime; Cephalosporins; Echovirus Infections; Humans; Meningitis | 1997 |
Sequence of the gene encoding a plasmid-mediated cefotaxime-hydrolyzing class A beta-lactamase (CTX-M-4): involvement of serine 237 in cephalosporin hydrolysis.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Genes, Bacterial; Hydrolysis; Molecular Sequence Data; Plasmids; Salmonella typhimurium; Serine | 1998 |
[Pathomorphological changes in albino mice infected with plague and treated with cefotaxime].
Topics: Animals; Cefotaxime; Cephalosporins; Liver; Lung; Lymph Nodes; Mice; Plague; Spleen | 1998 |
In vitro activity and clinical evaluation of cefixime in urinary tract infection.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 1998 |
Congenital endophthalmitis following maternal shellfish ingestion.
Topics: Animals; Bacteremia; Cefotaxime; Cephalosporins; Cyclopentolate; Endophthalmitis; Eye Infections, Bacterial; Female; Food Microbiology; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Male; Maternal-Fetal Exchange; Meningitis, Bacterial; Mydriatics; Ostreidae; Plesiomonas; Pregnancy; Pregnancy Complications, Infectious | 1998 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1998. A 70-year-old man with diarrhea, polyarthritis, and a history of Reiter's syndrome.
Topics: Aged; Arthritis; Arthritis, Reactive; Cefixime; Cefotaxime; Cephalosporins; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male | 1998 |
In vitro activity of cefpirome against Streptococcus pneumoniae strains with decreased susceptibility to cefotaxime.
Topics: Cefotaxime; Cefpirome; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Species Specificity; Streptococcus pneumoniae | 1998 |
Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Respiratory System; Streptococcus pneumoniae | 1998 |
Clinical outcome of invasive infections by penicillin-resistant Streptococcus pneumoniae in Korean children.
Topics: Adolescent; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Vancomycin | 1998 |
Cardiff repair of incisional hernia: a university hospital experience.
Topics: Adolescent; Adult; Aged; Cefotaxime; Cephalosporins; Female; Hernia, Ventral; Hospitals, University; Humans; Male; Middle Aged; Prospective Studies; Suture Techniques; Treatment Outcome | 1998 |
Pathogenesis of early operative site infections after orthotopic liver transplantation.
Topics: Amoxicillin; Bacteria; Bile; Cefotaxime; Cephalosporins; Humans; Intraoperative Period; Liver Transplantation; Penicillins; Peritoneum; Surgical Wound Infection | 1998 |
Bactericidal activities of ceftizoxime and cefotaxime against Streptococcus pneumoniae.
Topics: Cefotaxime; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 1998 |
[Meningitis caused by Pseudomonas aeruginosa. Treatment with meropenem].
Topics: Aged; Blood-Brain Barrier; Cefepime; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Hydrocephalus; Male; Meningitis, Bacterial; Meropenem; Postoperative Complications; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Further studies of transferable antibiotic resistance in strains of Pseudomonas aeruginosa from four clinical settings in three countries.
Topics: Antibiotics, Antitubercular; Cefotaxime; Ceftazidime; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Drug Resistance, Multiple; Escherichia coli; Humans; Imipenem; Proteus mirabilis; Pseudomonas aeruginosa; Rifampin; Thienamycins | 1998 |
Perioperative antibiotic prophylaxis in abdominal surgery for hernia repair: retrospective study of 1,524 consecutive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Herniorrhaphy; Humans; Male; Middle Aged; Pefloxacin; Retrospective Studies; Surgical Wound Infection; Treatment Outcome | 1998 |
Management of acute otitis media caused by resistant pneumococci in infants.
Topics: Acute Disease; Administration, Oral; Amoxicillin; Cefotaxime; Ceftriaxone; Cephalosporins; Humans; Infant; Injections, Intravenous; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Penicillins; Pneumococcal Infections; Retrospective Studies; Streptococcus pneumoniae; Treatment Failure | 1998 |
CTX-M-5, a novel cefotaxime-hydrolyzing beta-lactamase from an outbreak of Salmonella typhimurium in Latvia.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporins; Disease Outbreaks; Hydrolysis; Latvia; Microbial Sensitivity Tests; Molecular Sequence Data; Salmonella Infections; Salmonella typhimurium | 1998 |
Transfer of resistance to oxy-imino-cephalosporins and of extended-spectrum beta-lactamase productions in Klebsiella pneumoniae strains from infected neonates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Drug Resistance, Multiple; Escherichia coli; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Proteus mirabilis | 1998 |
Bacterial orchitis in a baby with imperforate anus.
Topics: Anus, Imperforate; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli Infections; Humans; Infant; Male; Orchitis; Recurrence; Ultrasonography, Doppler, Color | 1998 |
Haemophilus paraphrophilus; a rare cause of intracranial abscess.
Topics: Adult; Brain; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Haemophilus; Haemophilus Infections; Humans; Male; Stereotaxic Techniques; Tomography, X-Ray Computed | 1998 |
Listeria monocytogenes meningitis in a penicillin-allergic paediatric renal transplant patient.
Topics: Amoxicillin-Potassium Clavulanate Combination; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Child; Drug Hypersensitivity; Female; Humans; Immunocompromised Host; Kidney Transplantation; Listeria monocytogenes; Meningitis, Listeria; Meropenem; Thienamycins | 1998 |
Influence of ciprofloxacin and other antimicrobial drugs on different Escherichia coli strains in continuous-flow cultures under aerobic and anaerobic conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Culture Media; Escherichia coli; Feces; Gentamicins; Mezlocillin; Penicillins | 1998 |
Two novel plasmid-mediated cefotaxime-hydrolyzing beta-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Salmonella typhimurium; Sequence Analysis, DNA | 1998 |
Reduction by cefodizime of the pulmonary inflammatory response induced by heat-killed Streptococcus pneumoniae in mice.
Topics: Animals; Cefotaxime; Cephalosporins; Cytokines; Female; Inflammation Mediators; Mice; Neutrophils; Phagocytosis; Pneumonia, Pneumococcal | 1998 |
Description of two new isolates of Streptococcus pneumoniae in spain that are highly resistant to cefotaxime.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Humans; Male; Microbial Sensitivity Tests; Spain; Streptococcus pneumoniae | 1998 |
[Elective treatment in meningitis due to Neisseria meningitidis].
Topics: Cefotaxime; Cephalosporins; Humans; Meningitis, Bacterial; Neisseria meningitidis; Neisseriaceae Infections | 1998 |
Rate of decline of cefotaxime and ceftazidime in milk following intramammary administration to healthy and mastitic dairy cows.
Topics: Animals; Cattle; Cefotaxime; Ceftazidime; Cephalosporins; Dairying; Female; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Milk | 1998 |
Overview of the clinical features of cefixime.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemistry, Pharmaceutical; Drug Administration Schedule; Humans | 1998 |
Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Topics: Amoxicillin; Animals; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Cefixime in the treatment of upper respiratory tract infections and otitis media.
Topics: Cefixime; Cefotaxime; Cephalosporins; Humans; Otitis Media; Patient Compliance; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Treatment Outcome | 1998 |
Cefixime for switch therapy.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Drug Administration Schedule; Humans; Infusions, Intravenous; Practice Guidelines as Topic; Treatment Outcome | 1998 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections | 1998 |
Clinical role of cefixime in community-acquired infections.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Intravenous; Treatment Outcome | 1998 |
[Current status of pneumococcal resistance].
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Child; Drug Resistance, Microbial; Humans; Penicillin G; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1998 |
Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients.
Topics: Adult; Cefotaxime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cost-Benefit Analysis; Humans; Pneumonia, Bacterial; Treatment Outcome | 1998 |
Anodic voltammetry of cefotaxime.
Topics: Cefotaxime; Cephalosporins; Chemistry Techniques, Analytical; Electrochemistry; Electrodes; Hydrogen-Ion Concentration; Regression Analysis; Reproducibility of Results | 1998 |
Resistance to cefotaxime and peptidoglycan composition in Enterococcus faecalis are influenced by exogenous sodium chloride.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Chromatography, High Pressure Liquid; Dimerization; Disaccharides; Enterococcus faecalis; Hexosyltransferases; Humans; Mass Spectrometry; Microbial Sensitivity Tests; Models, Biological; Molecular Weight; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptides; Peptidoglycan; Peptidyl Transferases; Phenotype; Sodium Chloride | 1998 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Control of an outbreak of a highly beta-lactam-resistant Enterobacter cloacae strain in a neonatal special care unit.
Topics: Ampicillin; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Disease Outbreaks; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Male; Penicillin G; Penicillins; Sweden | 1998 |
New spectrophotometric procedure for determining cefotaxime based on derivatization with 1,2-naphthoquinone-4-sulphonate into solid-phase extraction cartridges--application to pharmaceutical and urine samples.
Topics: Adult; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Naphthoquinones; Pharmaceutical Preparations; Sensitivity and Specificity; Spectrophotometry | 1998 |
[Modifications to the technic of cesarean section after Stark].
Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Cesarean Section; Cesarean Section, Repeat; Female; Humans; Pregnancy; Time Factors | 1998 |
Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefotaxime; Cephalosporins; Colony Count, Microbial; Culture Media; Helicobacter pylori; Microbial Sensitivity Tests; Penicillins | 1998 |
Effect of substitution of Asn for Arg-276 in the cefotaxime-hydrolyzing class A beta-lactamase CTX-M-4.
Topics: Amino Acid Substitution; Arginine; Asparagine; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Mutagenesis | 1998 |
Effectiveness of antibiotic prophylaxis in critically ill patients. Antibiotic prophylaxis can lead to contamination with Clostridium difficile.
Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Humans | 1998 |
Contribution of in vivo 1H spectroscopy to the diagnosis of deep-seated brain abscess.
Topics: Anti-Inflammatory Agents; Brain Abscess; Cefotaxime; Cephalosporins; Female; Haemophilus Infections; Humans; Magnetic Resonance Spectroscopy; Methylprednisolone; Middle Aged; Streptococcal Infections | 1999 |
Antibiotic prophylaxis--Hobson's choice in burns management.
Topics: Adult; Anaphylaxis; Antibiotic Prophylaxis; Burns; Cefotaxime; Cephalosporins; Disseminated Intravascular Coagulation; Drug Hypersensitivity; Female; Humans; Injections, Intravenous; Postoperative Hemorrhage; Skin Transplantation | 1998 |
[Prophylaxis of purulent complications in operations on large joints by endolymphatic infusion of drugs].
Topics: Adjuvants, Immunologic; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intralymphatic; Knee; Knee Injuries; Male; Middle Aged; Peptides; Suppuration; Surgical Wound Infection; Thymus Extracts | 1998 |
Derivative spectrophotometric determination of the triethylammonium salt of cefotaxime in presence of related compounds from the synthesis.
Topics: Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Atomic | 1998 |
HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dosage Forms; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Spectrophotometric and atomic absorption spectrometric determination of certain cephalosporins.
Topics: Benzoquinones; Cefotaxime; Cefuroxime; Cephalosporins; Indicators and Reagents; Lead; Nitriles; Spectrophotometry, Atomic; Spectrophotometry, Ultraviolet; Spin Labels | 1999 |
Multicenter survey of the in vitro activity of four expanded-spectrum beta-lactams against consecutive contemporary clinical isolates.
Topics: Anti-Bacterial Agents; Aztreonam; Bacteria; beta-Lactams; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests; Monobactams | 1998 |
Infectious dermatitis in a ball python (Python regius) colony.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Boidae; Cefotaxime; Cephalosporins; Dermatitis; Disease Outbreaks; Fatal Outcome; Female; Male; Proteus Infections; Proteus vulgaris; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Infectious | 1998 |
[Meningitis by Streptococcus pneumoniae: resistant to cefotaxime?].
Topics: Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Female; Humans; Meningitis, Pneumococcal; Middle Aged | 1999 |
Radiation induced effects on cephalosporins: an ESR study.
Topics: Cefixime; Cefotaxime; Cefpodoxime; Cefsulodin; Ceftizoxime; Cephalosporins; Electron Spin Resonance Spectroscopy; Free Radicals; Gamma Rays | 1999 |
[A strain of Nocardia asteroides isolated from a patient with acute leukemia].
Topics: Cefotaxime; Cephalosporins; Child; Humans; Male; Nocardia asteroides; Nocardia Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1997 |
Drug interference in amino acid analysis of urines: a graphic presentation on selected pediatric antibiotics.
Topics: Amikacin; Amino Acids; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, Ion Exchange; Drug Contamination; Gentamicins; Humans; Infant, Newborn; Tobramycin | 1995 |
A case of cerebrospinal fluid eosinophilia associated with shunt malfunction.
Topics: Anti-Inflammatory Agents; Cefotaxime; Cephalosporins; Eosinophilic Granuloma; Equipment Failure; Female; Humans; Hydrocephalus; Infant; Lumbosacral Region; Meningomyelocele; Postoperative Complications; Prednisolone; Ultrasonography; Ventriculoperitoneal Shunt | 1999 |
[Human urinary myiasis caused by Fannia canicularis (Diptera, Muscidae) larvae in Algeria].
Topics: Adult; Cefotaxime; Cephalosporins; Female; Humans; Larva; Myiasis; Time Factors; Urinary Tract Infections | 1999 |
Brain abscess caused by Salmonella enteritidis in an immunocompetent adult patient: successful treatment with cefotaxime and ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Enteritis; Humans; Immunocompetence; Male; Salmonella Infections | 1998 |
Extended-spectrum beta-lactamase producing strains of Enterobacter cloacae transferring resistance to cefotaxime and ceftazidime.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Conjugation, Genetic; Drug Resistance, Microbial; Enterobacter cloacae; Escherichia coli; Humans; Microbial Sensitivity Tests | 1999 |
Cholesteatoma extending into the internal auditory meatus.
Topics: Adult; Cefotaxime; Cephalosporins; Cholesteatoma, Middle Ear; Facial Paralysis; Fistula; Humans; Labyrinth Diseases; Labyrinthitis; Male; Meningitis, Bacterial; Tomography, X-Ray Computed | 1999 |
Ochrobactrum anthropi meningitis in a pre-term neonate.
Topics: Alcaligenes; Cefotaxime; Cephalosporins; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Meningitis, Bacterial; Respiratory Distress Syndrome, Newborn | 1999 |
In-vitro activity of 29 antimicrobial agents against penicillin-resistant and -intermediate isolates of Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Carbapenems; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Glycopeptides; Macrolides; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Streptococcus pneumoniae | 1999 |
Penicillin-nonsusceptible pneumococcus in acute otitis media in New York City.
Topics: Acute Disease; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Microbial Sensitivity Tests; New York City; Otitis Media; Penicillins; Streptococcus pneumoniae | 1999 |
[Osteoarticular infection by Kingella kingae: two case reports].
Topics: Amoxicillin; Arthritis, Infectious; Cefotaxime; Cephalosporins; Female; Humans; Infant; Kingella kingae; Magnetic Resonance Imaging; Neisseriaceae Infections; Osteoarthritis; Penicillins; Tibia; Tomography, X-Ray Computed | 1999 |
Limiting cefotaxime pediatric dosing to adult standards: a pharmacokinetic simulation study.
Topics: Adult; Area Under Curve; Cefotaxime; Cephalosporins; Child; Computer Simulation; Dose-Response Relationship, Drug; Humans; Microbial Sensitivity Tests; Reference Standards | 1999 |
Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae.
Topics: Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae | 1999 |
Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis.
Topics: Albumins; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; Humans; Infusions, Intravenous; Kidney Diseases; Liver Cirrhosis; Paracentesis; Peritonitis; Plasma Volume | 1999 |
[The antibacterial activity of cefmetazole and other antibiotics to 463 isolates].
Topics: Cefmetazole; Cefotaxime; Ceftazidime; Cephalosporins; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus vulgaris | 1997 |
[Selected lymphocyte subsets in Lime borreliosis: a preliminary study].
Topics: Adolescent; Adult; Ampicillin; Antibodies, Monoclonal; Antibody Specificity; Cefotaxime; Ceftriaxone; Cephalosporins; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Lyme Disease; Male; Middle Aged; Penicillins; Phenotype; Retrospective Studies; T-Lymphocyte Subsets; Time Factors; Treatment Outcome | 1999 |
[Interesting case no. 25. Cervical tuberculous lymphadenitis].
Topics: Adult; Amoxicillin; Cefotaxime; Cephalosporins; Clavulanic Acid; Clindamycin; Diagnostic Techniques, Surgical; Drug Combinations; Humans; Male; Tuberculosis, Lymph Node | 1999 |
[An analysis of bacterial resistance to antimicrobial agents in a burn centre].
Topics: Burns; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Humans; Pseudomonas aeruginosa; Wound Infection | 1998 |
Genetic and physiological studies of the CiaH-CiaR two-component signal-transducing system involved in cefotaxime resistance and competence of Streptococcus pneumoniae.
Topics: Amino Acid Sequence; Bacterial Proteins; Blotting, Northern; Calcium; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Gene Expression Regulation, Bacterial; Histidine Kinase; Molecular Sequence Data; Mutation; Operon; Protein Kinases; Signal Transduction; Streptococcus pneumoniae; Transcription, Genetic; Transformation, Bacterial | 1999 |
Development of bacterial resistance to the third generation cephalosporins and their clinical use.
Topics: Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Czech Republic; Gram-Negative Bacteria; Hospitals; Humans | 1999 |
Influence of cefodizime on pulmonary inflammatory response to heat-killed Klebsiella pneumoniae in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Cefotaxime; Cephalosporins; Inflammation; Injections, Subcutaneous; Interleukins; Klebsiella Infections; Klebsiella pneumoniae; Lung; Macrophages, Alveolar; Mice; Neutrophils; Tumor Necrosis Factor-alpha | 1999 |
Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Humans; Infant; Lung; Male; Pneumonia, Pneumococcal; Radiography; Streptococcus pneumoniae; Treatment Failure; Vancomycin | 1999 |
Selective type-1 hypersensitivity to cefixime.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Drug Hypersensitivity; Female; Humans; Urticaria | 1999 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden | 1999 |
[Chronic meningococcal meningitis: a case report and literature review].
Topics: Cefotaxime; Cephalosporins; Chronic Disease; Humans; Infant; Injections, Intravenous; Male; Meningococcal Infections; Neisseria meningitidis | 1999 |
Association of IgA nephropathy with Clostridium difficile colitis.
Topics: Acute Kidney Injury; Adult; Cefixime; Cefotaxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Glomerulonephritis, IGA; Humans; Kidney | 1999 |
[Liver abscess caused by Klebsiella pneumoniae in diabetic patients].
Topics: Aged; Cefotaxime; Cephalosporins; Diabetes Complications; Follow-Up Studies; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess; Male; Middle Aged; Time Factors; Tomography, X-Ray Computed | 1999 |
Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria, Anaerobic; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Prevotella; Retrospective Studies; Treatment Outcome | 1999 |
An uncommon cause of ophthalmia neonatorum: Neisseria meningitidis.
Topics: Cefotaxime; Cephalosporins; Conjunctiva; Diagnosis, Differential; Humans; Infant, Newborn; Injections, Intravenous; Meningococcal Infections; Neisseria meningitidis; Ophthalmia Neonatorum | 1999 |
Detection of borreliacidal antibodies in Lyme borreliosis patient sera containing antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Blotting, Western; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Doxycycline; Erythromycin; False Positive Reactions; Humans; Immunoglobulin G; Immunoglobulin M; In Vitro Techniques; Lyme Disease; Penicillins | 1999 |
Comparative bacteriostatic and bactericidal activities of cefodizime against Borrelia burgdorferi sensu lato.
Topics: Borrelia burgdorferi Group; Cefotaxime; Ceftriaxone; Cephalosporins; Humans; Lyme Disease; Microbial Sensitivity Tests | 1999 |
Cefotaxime-hydrolysing beta lactamases in Morganella morganii.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Hydrolysis; Microbial Sensitivity Tests; Morganella morganii | 1999 |
Bacteremia with CDC group IV c-2 in an immunocompetent infant.
Topics: Bacteremia; Cefotaxime; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunocompetence; Infant | 1999 |
[Cefotaxime in sequential therapy of community acquired pneumonia].
Topics: Adult; Bacterial Infections; Cefotaxime; Cephalosporins; Community-Acquired Infections; Humans; Pneumonia, Bacterial | 1999 |
Major related sets of antibiotic-resistant Pneumococci in the United States as determined by pulsed-field gel electrophoresis and pbp1a-pbp2b-pbp2x-dhf restriction profiles.
Topics: Amino Acid Sequence; Aminoacyltransferases; Bacterial Capsules; Bacterial Proteins; beta-Lactam Resistance; Carrier Proteins; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Genes, Switch; Genotype; Hexosyltransferases; Humans; Lactams; Molecular Epidemiology; Molecular Sequence Data; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Predictive Value of Tests; Sequence Homology, Amino Acid; Serotyping; Streptococcus pneumoniae; Tetrahydrofolate Dehydrogenase; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2000 |
Intravenous albumin in patients with cirrhosis and spontaneous bacterial peritonitis.
Topics: Albumins; Bacterial Infections; Cefotaxime; Central Venous Pressure; Cephalosporins; Fluid Therapy; Humans; Infusions, Intravenous; Kidney Diseases; Liver Cirrhosis; Paracentesis; Peritonitis | 1999 |
Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance.
Topics: Adolescent; Adult; Age Distribution; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Female; Humans; Incidence; Infant; Infant, Newborn; Male; Meningitis, Pneumococcal; Middle Aged; Population Surveillance; Risk Factors; Streptococcus pneumoniae; Vancomycin | 2000 |
[Extended-spectrum beta-lactamase (ESBL) produced by Escherichia coli and Klebsiella pneumoniae isolated from Teikyou University Hospital--the first report].
Topics: beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Humans; Klebsiella pneumoniae | 1999 |
[The effect of the regimen for administering antibacterial therapy on the manifestations of endogenous intoxication in patients operated on for lung cancer].
Topics: Antibiotic Prophylaxis; Biomarkers; Cefotaxime; Cephalosporins; Humans; Lung Neoplasms; Malondialdehyde; Postoperative Care; Preoperative Care; Retrospective Studies; Sepsis; Superoxide Dismutase; Time Factors | 1999 |
Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence.
Topics: Bacterial Adhesion; Cefotaxime; Cells, Cultured; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli; Hemagglutination; Humans; Microbial Sensitivity Tests; Mouth Mucosa; Movement; Phagocytosis; Respiratory Burst; Virulence | 2000 |
Effect of cefodizime on peritoneal mononuclear- and polymorphonuclear-cell chemotaxis.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Chemotaxis, Leukocyte; Humans; Middle Aged; Monocytes; Neutrophils; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Peritonitis | 1998 |
[Acute epiglottitis. Study of 23 cases].
Topics: Acute Disease; Cefotaxime; Cephalosporins; Child, Preschool; Epiglottitis; Female; Humans; Infant; Infusions, Intravenous; Male | 1999 |
Gonococcal bacteremia in a neonate.
Topics: Adult; Bacteremia; Cefotaxime; Cephalosporins; Female; Gonorrhea; Humans; Infant, Newborn; Neisseria gonorrhoeae; Pregnancy; Pregnancy Complications, Infectious; Synovitis; Treatment Outcome | 2000 |
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefotaxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Microbial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Pneumonia, Pneumococcal; United States | 2000 |
[Prophylaxis and therapy of infectious complications of lung surgery].
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Humans; Lung Diseases; Pneumonectomy; Postoperative Complications; Surgical Wound Infection | 1999 |
Inactivation of the ampD gene in Pseudomonas aeruginosa leads to moderate-basal-level and hyperinducible AmpC beta-lactamase expression.
Topics: Ampicillin; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Enzyme Induction; Genetic Complementation Test; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; N-Acetylmuramoyl-L-alanine Amidase; Penicillins; Phenotype; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2000 |
[Bacteremia and Pasteurella multocida pneumonia revealing HIV infection].
Topics: Adult; Amoxicillin; Animals; Anti-Infective Agents; Bacteremia; Bites and Stings; Cats; Cefotaxime; Cephalosporins; HIV Infections; HIV Seropositivity; Humans; Male; Pasteurella Infections; Pasteurella multocida; Pefloxacin; Penicillins; Pneumonia, Bacterial; Time Factors | 1999 |
[Acute Salmonella typhi meningitis in a 25-day-old newborn infant complicated by obstruction of the sylvian artery].
Topics: Brain Ischemia; Cefotaxime; Cephalosporins; Cerebral Arteries; Cerebral Infarction; Gentamicins; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Netilmicin; Typhoid Fever | 2000 |
Spectrophotometric determination of certain cephalosporins through oxidation with cerium(IV) and 1-chlorobenzotriazole.
Topics: Benzaldehydes; Cefotaxime; Cefuroxime; Cephalosporins; Cerium; Evaluation Studies as Topic; Indicators and Reagents; Oxidation-Reduction; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Sulfates; Triazoles | 1999 |
Fibrin glue-antibiotic mixture in the treatment of anal fistulae: experience with 69 cases.
Topics: Adult; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Electrocoagulation; Female; Fibrin Tissue Adhesive; Gentamicins; Humans; Male; Metronidazole; Middle Aged; Rectal Fistula; Therapeutic Irrigation; Tissue Adhesives | 2000 |
TLA-1: a new plasmid-mediated extended-spectrum beta-lactamase from Escherichia coli.
Topics: Amino Acid Sequence; Base Sequence; beta-Lactamases; Cefotaxime; Cephalosporins; Cloning, Molecular; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Isoelectric Focusing; Kinetics; Mexico; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids | 2000 |
Treatment of gram-negative bacterial meningitis in term neonates with third generation cephalosporins plus amikacin.
Topics: Amikacin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Infant, Newborn; Male; Meningitis, Bacterial; Morbidity; Retrospective Studies | 2000 |
An antibiotic policy to prevent emergence of resistant bacilli.
Topics: Amoxicillin; Cefotaxime; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Organizational Policy; Penicillins; Prospective Studies; Sepsis | 2000 |
In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Streptococcal Infections; Streptococcus pneumoniae | 2000 |
Concurrent quantification and pharmacokinetic analysis of cefotaxime in rat blood and brain by microdialysis and microbore liquid chromatography.
Topics: Animals; Blood-Brain Barrier; Brain; Cefotaxime; Cephalosporins; Chromatography, Liquid; Corpus Striatum; Femoral Vein; Jugular Veins; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity | 2000 |
Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation.
Topics: Administration, Oral; Amoxicillin; Cefotaxime; Cephalosporins; Humans; Infusions, Intravenous; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Spain; Streptococcus pneumoniae | 2000 |
A child with spider bite and glomerulonephritis: a diagnostic challenge.
Topics: Animals; Cefotaxime; Cephalosporins; Child; Glomerulonephritis; Hematuria; Humans; Male; Oxacillin; Penicillins; Spider Bites; Spiders; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
Outbreak of Klebsiella pneumoniae producing transferable AmpC-type beta-lactamase (ACC-1) originating from Hafnia alvei.
Topics: Amino Acid Sequence; Aztreonam; Bacterial Proteins; Base Sequence; beta-Lactamases; Cefepime; Cefotaxime; Cefoxitin; Ceftazidime; Ceftriaxone; Cephalosporins; Cephamycins; Cloning, Molecular; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; France; Hafnia; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Monobactams; Plasmids; Polymerase Chain Reaction | 2000 |
A novel large plasmid carrying multiple beta-lactam resistance genes isolated from a Klebsiella pneumoniae strain.
Topics: Aminoglycosides; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Genetic Vectors; Humans; Kanamycin; Klebsiella pneumoniae; Plasmids; Transformation, Bacterial | 2000 |
A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Brazil; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; DNA, Bacterial; Enterobacteriaceae; Gene Transfer Techniques; Humans; Kinetics; Molecular Sequence Data; Sequence Homology, Amino Acid | 2000 |
Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-9) from Escherichia coli in Spain.
Topics: Amino Acid Sequence; beta-Lactamases; Cefotaxime; Cephalosporins; Cloning, Molecular; Escherichia coli; Escherichia coli Proteins; Hydrolysis; Molecular Sequence Data; Sequence Homology, Amino Acid; Spain | 2000 |
Antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae in southwestern Japan and correlation of penicillin-binding protein 2b and 2x mutations in susceptibilities of penicillin G and cefotaxime.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Hexosyltransferases; Humans; Infant; Infant, Newborn; Japan; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin G; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Pneumococcal Infections; Polymerase Chain Reaction; Serotyping; Streptococcus pneumoniae | 2000 |
Oral or IV antibiotics for the treatment of febrile children with UTIs?
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Fever; Humans; Infant; Infusions, Intravenous; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections | 1999 |
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
Topics: Adolescent; Adult; Aeromonas; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Community-Acquired Infections; Cross Infection; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Prognosis; Risk Factors | 2000 |
Salmonella meningitis and a green iguana.
Topics: Animals; Cefotaxime; Cephalosporins; Humans; Iguanas; Infant, Newborn; Male; Meningitis, Bacterial; Salmonella Infections | 2000 |
Multiple organ failure complicating probable scrub typhus.
Topics: Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Female; Humans; Infant, Newborn; Multiple Organ Failure; Ofloxacin; Orientia tsutsugamushi; Scrub Typhus; Treatment Outcome | 2000 |
Bacteremia and possible endocarditis caused by Moraxella phenylpyruvica.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Male; Moraxella; Neisseriaceae Infections; Ofloxacin; Penicillins | 2000 |
[Clinical thinking and decision making in practice. A patient with persistent fever].
Topics: Adult; Cefotaxime; Cephalosporins; Diagnosis, Differential; Fever; Humans; Male; Salmonella typhi; Typhoid Fever | 2000 |
[Antibiotic sensitivity of enterobacteria in intensive care units].
Topics: Ascitic Fluid; Blood; Catheterization; Cefepime; Cefotaxime; Cefpirome; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; France; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory System; Urine | 2000 |
Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance.
Topics: Animals; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cell Division; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Mice; Models, Biological; Phenotype; Porins; Selection, Genetic | 2000 |
Gastric wall erosion by an amebic liver abscess in a 3-year-old girl.
Topics: Amebicides; Anti-Infective Agents; Biopsy; Cefotaxime; Cephalosporins; Chemotherapy, Adjuvant; Child, Preschool; Female; Fever; Humans; Iodoquinol; Liver Abscess, Amebic; Melena; Metronidazole; Rupture, Spontaneous; Stomach Rupture | 2000 |
Photodistributed telangiectasia following use of cefotaxime.
Topics: Cefotaxime; Cephalosporins; Dermatitis, Photoallergic; Facial Dermatoses; Humans; Male; Middle Aged; Telangiectasis; Urinary Tract Infections | 2000 |
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Topics: Ampicillin; Anti-Infective Agents; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 2000 |
Spontaneous bacterial empyema caused by Aeromonas veronii biotype sobria.
Topics: Aeromonas; Cefotaxime; Cephalosporins; Empyema, Pleural; Hepatitis B, Chronic; Humans; Hydrothorax; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged | 2000 |
Evaluation of stability of cefotaxime (30-microg) and ceftazidime (30-microg) disks impregnated with clavulanic acid (10 microg) for detection of extended-spectrum beta-lactamases.
Topics: beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Stability; Escherichia coli; Evaluation Studies as Topic; Microbial Sensitivity Tests; Time Factors | 2000 |
A rapid procedure to prepare cefotaxime.
Topics: Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Magnetic Resonance Spectroscopy | 2000 |
[The effect of netilmicin, amikacin, ceftazidime and cefotaxime on the adhesive properties of microorganisms isolated from newborn infants].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Bacterial Adhesion; Candida albicans; Cefotaxime; Ceftazidime; Cephalosporins; Depression, Chemical; Dose-Response Relationship, Drug; Feces; Gentamicins; Humans; Infant, Newborn; Netilmicin; Respiratory System | 2000 |
Effect of cefotaxime on cytokine production in newborns and adults in vitro.
Topics: Adult; Cefotaxime; Cell Survival; Cephalosporins; Cytokines; Humans; In Vitro Techniques; Infant, Newborn; Interleukin-1; Interleukin-2; Interleukin-6; Lipopolysaccharides; Lymphotoxin-alpha; Middle Aged; Monocytes | 2000 |
Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae.
Topics: Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Cloning, Molecular; Hexosyltransferases; Humans; Hungary; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Polymerase Chain Reaction; Streptococcus pneumoniae; Transformation, Bacterial | 2000 |
Solitary hepatic abscess with associated glomerulonephritis in a neonate.
Topics: Abscess; Anti-Bacterial Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Drainage; Drug Therapy, Combination; Female; Glomerulonephritis; Humans; Infant, Newborn; Liver Diseases; Magnetic Resonance Imaging; Micrococcus; Staphylococcal Infections; Vancomycin | 2000 |
[Clinical thinking and decision-making in practice. A patient with persistent fever].
Topics: Adverse Drug Reaction Reporting Systems; Cefotaxime; Cephalosporins; Fever; Humans; Netherlands; Pharmacopoeias as Topic | 2000 |
Failure to produce detectable antibodies to Legionella pneumophila by an immunocompetent adult.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Cefotaxime; Cephalosporins; Clarithromycin; Coculture Techniques; Enzyme-Linked Immunosorbent Assay; Erythromycin; Fluorescent Antibody Technique, Direct; Fluorescent Antibody Technique, Indirect; Humans; Immunocompetence; Legionella pneumophila; Legionnaires' Disease; Male; Middle Aged; Penicillins; Sputum; Travel; Turkey; United Kingdom | 2000 |
[Clinical thinking and decision making in practice. A patient with persistent fever].
Topics: Adult; Cefotaxime; Cephalosporins; Female; Fever; Humans; Male; Salmonella typhi; Typhoid Fever | 2000 |
Death from inappropriate therapy for Lyme disease.
Topics: Adult; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Cefotaxime; Cephalosporins; Diagnostic Errors; Fatal Outcome; Female; Humans; Iatrogenic Disease; Lyme Disease; Thrombosis | 2000 |
Bacteriologic outcome of children with cefotaxime- or ceftriaxone-susceptible and -nonsusceptible Streptococcus pneumoniae meningitis.
Topics: Adolescent; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Cerebrospinal Fluid; Child; Child, Preschool; Female; Humans; Infant; Male; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Retrospective Studies; Streptococcus pneumoniae; Treatment Outcome | 2000 |
In vitro susceptibility of Helicobacter pylori to, and in vivo suppression by, antimicrobials used in selective decontamination of the digestive tract.
Topics: Administration, Topical; Amphotericin B; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Decontamination; Digestive System; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Polymyxins; Tobramycin | 2000 |
Safety and efficacy of recombinant granulocyte colony-stimulating factor as an adjunctive therapy for Streptococcus pneumoniae meningitis in non-neutropenic adult patients: a pilot study.
Topics: Adult; Aged; Anti-Inflammatory Agents; Cefotaxime; Cephalosporins; Chemotherapy, Adjuvant; Dexamethasone; Drug Therapy, Combination; Female; Granulocyte Colony-Stimulating Factor; Humans; Male; Meningitis, Pneumococcal; Middle Aged; Pilot Projects; Recombinant Proteins; Streptococcus pneumoniae | 2000 |
Resistance to ceftriaxone and cefotaxime in non-typhoidal Salmonella enterica in England and Wales, 1998-99.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Salmonella enterica | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
[Retro-auricular inflammation of one month evolution. Acute mastoiditis with subperiosteal abscess].
Topics: Abscess; Acute Disease; Cefotaxime; Cephalosporins; Combined Modality Therapy; Disease Progression; Exudates and Transudates; Female; Humans; Infant; Injections, Intravenous; Mastoiditis; Middle Ear Ventilation; Streptococcal Infections; Streptococcus pneumoniae; Suction; Tomography, X-Ray Computed; Treatment Outcome | 2000 |
Comparative activity of cefodizime and ceftriaxone against respiratory pathogens in an in vitro pharmacodynamic model simulating concentration-time curves.
Topics: Bronchi; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Models, Biological; Mucus; Respiratory Tract Diseases; Serum Bactericidal Test; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors | 2000 |
Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.
Topics: beta-Lactamases; Cefotaxime; Cephaloridine; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Escherichia coli Infections; Genes, Bacterial; Humans; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data | 2001 |
Pneumococcal psoas abscess: report of two cases.
Topics: Cefotaxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Psoas Abscess; Streptococcus pneumoniae | 2000 |
Isolation in France of a clinical strain of Streptoccus pneumoniae susceptible to amoxycillin and resistant to cefotaxime.
Topics: Aged; Amoxicillin; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; France; Humans; Male; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2000 |
Revision of quality control limits for cefotaxime disk susceptibility tests.
Topics: Bacteria; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Quality Control; Reagent Strips | 2000 |
[Successful medical treatment of spinal epidural abscess].
Topics: Administration, Oral; Cefotaxime; Cephalosporins; Child, Preschool; Cloxacillin; Drug Therapy, Combination; Epidural Abscess; Female; Follow-Up Studies; Humans; Injections, Intravenous; Osteomyelitis; Penicillins; Spinal Diseases; Time Factors | 2001 |
Stability of cefotaxime sodium in solid state.
Topics: Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humidity; Spectrophotometry, Ultraviolet; Temperature; Thermodynamics | 2000 |
Simultaneous determination of cefotaxime and desacetylcefotaxime in human plasma and cerebrospinal fluid by high-performance liquid chromatography.
Topics: Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Reproducibility of Results; Sensitivity and Specificity | 2001 |
[Comparative antibacterial activity of cefotaxime, ceftazidime and cefepime with regard to different strains of Enterobacter aerogenes selected for their resistance to third generation cephalosporins].
Topics: beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacter aerogenes | 2000 |
Emergence of a high-level cefotaxime-resistant Streptococcus pneumoniae strain in New Zealand.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Deoxyribonucleases, Type II Site-Specific; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Middle Aged; New Zealand; Pneumococcal Infections; Restriction Mapping; Streptococcus pneumoniae | 2001 |
[Cephalosporins of the third generation in therapy of children with severe infections].
Topics: Adolescent; Cefoperazone; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Hospital Bed Capacity, 500 and over; Humans; Infant; Infant, Newborn; Infections | 2000 |
In vitro and in vivo combinations of cefotaxime and minocycline against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Kinetics; Mice; Microbial Sensitivity Tests; Minocycline; Survival Analysis | 2001 |
Non-serogroup O:1 Vibrio cholerae bacteremia and cerebritis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Cholera; Ciprofloxacin; Humans; Male; Meningitis, Bacterial; Vibrio cholerae | 2001 |
Supraglottitis complicated by mediastinitis.
Topics: Aged; Anti-Infective Agents; Cefotaxime; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Female; Floxacillin; Glottis; Humans; Infusions, Intravenous; Laryngitis; Mediastinitis; Metronidazole; Penicillins; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Invasive pneumococcal disease.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Diagnosis, Differential; Echocardiography, Transesophageal; Erythromycin; Female; Follow-Up Studies; Humans; Injections, Intravenous; Middle Aged; Penicillins; Pneumococcal Infections; Radiography, Thoracic; Streptococcus pneumoniae; Time Factors; Tomography, X-Ray Computed; Vancomycin | 2001 |
Albumin: a look at the evidence.
Topics: Bacterial Infections; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Humans; Kidney Diseases; Peritonitis; Randomized Controlled Trials as Topic; Serum Albumin | 2001 |
Rotavirus encephalopathy: pathogenesis reviewed.
Topics: Acyclovir; Antiviral Agents; Australia; Cefotaxime; Central Nervous System Infections; Cephalosporins; Child, Preschool; Electroencephalography; Humans; Infant; Magnetic Resonance Imaging; Male; Reverse Transcriptase Polymerase Chain Reaction; RNA; Rotavirus Infections | 2001 |
Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Humans; Infant; Pneumococcal Infections; Pneumonia, Pneumococcal; Retrospective Studies; Streptococcus pneumoniae | 2001 |
Soft tissue and cartilage infection by Salmonella oranienburg in a healthy girl.
Topics: Amoxicillin; Animals; Biopsy; Cartilage Diseases; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Female; Guinea Pigs; Humans; Microbial Sensitivity Tests; Penicillins; Rodent Diseases; Salmonella enterica; Salmonella Infections; Serotyping; Soft Tissue Infections; Tomography, X-Ray Computed | 2001 |
Molecular characterization of a novel plasmid-encoded cefotaximase (CTX-M-12) found in clinical Klebsiella pneumoniae isolates from Kenya.
Topics: Amino Acid Substitution; beta-Lactamases; Cefotaxime; Cephalosporins; Evolution, Molecular; Humans; Kenya; Klebsiella pneumoniae; Molecular Sequence Data | 2001 |
[Cefotaxime, twenty years later. Observational study in critically ill patients].
Topics: Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Community-Acquired Infections; Critical Illness; Cross Infection; Drug Utilization; Humans; Intensive Care Units; Prospective Studies; Spain | 2001 |
Affinities of cephalosporins for penicillin-binding proteins and their antibacterial activities in the presence of human serum albumin.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Ceftriaxone; Cephalosporins; Escherichia coli; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding; Serum Albumin | 2000 |
Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240-->Gly.
Topics: Amino Acid Sequence; Amino Acid Substitution; Aspartic Acid; beta-Lactamases; Brazil; Cefotaxime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Gene Transfer Techniques; Glycine; Humans; Molecular Sequence Data; Mutation; Sequence Homology, Amino Acid | 2001 |
[Distribution and drug-resistance of 345 strains gram-negative bacilli from hospitalized patients with lower respiratory tract infections diseases].
Topics: Bronchiectasis; Cefotaxime; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Klebsiella pneumoniae; Lung Diseases, Obstructive; Pseudomonas aeruginosa; Respiratory Tract Infections | 1998 |
Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model.
Topics: Amoxicillin; Area Under Curve; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Models, Biological; Penicillins; Streptococcus pneumoniae; Streptococcus pyogenes | 2001 |
Radiosterilization of cefotaxime: investigation of potential degradation compounds by liquid chromatography-electrospray mass spectrometry.
Topics: Cefotaxime; Cephalosporins; Chromatography, Liquid; Hydrolysis; Spectrometry, Mass, Electrospray Ionization | 2001 |
Flow-injection spectrophotometric determination of certain cephalosporins based on the formation of dyes.
Topics: Cefadroxil; Cefotaxime; Cephalosporins; Chemistry, Pharmaceutical; Colorimetry; Coloring Agents; Flow Injection Analysis; Spectrophotometry | 2001 |
Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Humans; Hungary; Levofloxacin; Ofloxacin; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 2001 |
LC determination of cephalosporins in in vitro rat intestinal sac absorption model.
Topics: Animals; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, Liquid; Drug Stability; In Vitro Techniques; Intestinal Absorption; Intestinal Mucosa; Models, Animal; Rats | 2002 |
Long-Term outcome of neonatal Citrobacter koseri (diversus) meningitis treated with imipenem/meropenem and surgical drainage.
Topics: Carbapenems; Cefotaxime; Cephalosporins; Citrobacter; Combined Modality Therapy; Drainage; Enterobacteriaceae Infections; Female; Humans; Infant, Newborn; Meningitis, Bacterial; Prognosis; Treatment Outcome | 2001 |
Antimicrobial susceptibilities among clinical isolates of extended-spectrum cephalosporin-resistant Gram-negative bacteria in a Taiwanese University Hospital.
Topics: Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Prescriptions; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Hospitals, University; Humans; Taiwan | 2002 |
Sepsis in a newborn due to Pseudomonas aeruginosa from a contaminated tub bath.
Topics: Ampicillin; Anti-Bacterial Agents; Baths; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Gentamicins; Humans; Infant, Newborn; Pseudomonas aeruginosa; Pseudomonas Infections | 2001 |
Invasive Salmonella virchow infection in childhood.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Humans; Immunocompetence; Male; Salmonella; Salmonella Infections; Severity of Illness Index; Treatment Outcome | 2001 |
[Acute subdural abscess due to mixed infection of Eikenella corrodens and Streptococcus constellatus].
Topics: Acute Disease; Brain; Cefotaxime; Cephalosporins; Child; Eikenella corrodens; Empyema, Subdural; Female; Gram-Negative Bacterial Infections; Humans; Magnetic Resonance Imaging; Streptococcal Infections | 2001 |
[Effect of cefodizime on cellular immunity in patients with lung cancer].
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Female; Humans; Immunity, Cellular; Lung Neoplasms; Male; Middle Aged; Respiratory Tract Infections | 1999 |
Very low cefotaxime concentrations select for hypermutable Streptococcus pneumoniae populations.
Topics: Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; DNA-Binding Proteins; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Streptococcus pneumoniae | 2002 |
Integron-located oxa-32 gene cassette encoding an extended-spectrum variant of OXA-2 beta-lactamase from Pseudomonas aeruginosa.
Topics: Acetyltransferases; Amino Acid Sequence; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Molecular Sequence Data; Mutagenesis, Site-Directed; Pseudomonas aeruginosa; Sequence Homology, Amino Acid | 2002 |
Outbreak of acute renal failure due to cefodizime-vancomycin association in a heart surgery unit.
Topics: Acute Kidney Injury; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cardiac Surgical Procedures; Cefotaxime; Cephalosporins; Disease Outbreaks; Female; Humans; Male; Middle Aged; Vancomycin | 2001 |
In vitro activity of telithromycin against Streptococcus pneumoniae resistant to other antibiotics, including cefotaxime.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2002 |
In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
Topics: Anti-Bacterial Agents; Blood; Cefotaxime; Ceftriaxone; Cephalosporins; Databases, Factual; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory System; Streptococcus pneumoniae | 2002 |
Three cefotaximases, CTX-M-9, CTX-M-13, and CTX-M-14, among Enterobacteriaceae in the People's Republic of China.
Topics: beta-Lactamases; Blotting, Southern; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; China; DNA, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Genes, Bacterial; Humans; In Situ Hybridization; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2002 |
Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle.
Topics: Animals; Capillaries; Cefotaxime; Cephalosporins; Cricetinae; Drug Contamination; Humans; Injections, Intravenous; Microcirculation; Microspheres; Muscle, Skeletal; Particle Size; Reperfusion Injury; Single-Blind Method | 2002 |
Neisseria meningitidis with decreased susceptibility to penicillin in Istanbul, Turkey.
Topics: Adolescent; Adult; Carrier State; Cefotaxime; Cephalosporins; Cerebrospinal Fluid; Child; Female; Humans; Male; Meningitis, Meningococcal; Microbial Sensitivity Tests; Middle Aged; Nasopharynx; Neisseria meningitidis; Penicillin Resistance; Penicillins; Turkey | 2002 |
The excretion of cephem antibiotics into saliva is inversely associated with their plasma protein-binding activities.
Topics: Adult; Animals; Area Under Curve; Cefotaxime; Cefozopran; Ceftizoxime; Cephalosporins; Chromatography, High Pressure Liquid; Diffusion; Female; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Kinetics; Male; Perfusion; Protein Binding; Rats; Rats, Sprague-Dawley; Saliva; Statistics, Nonparametric | 2002 |
Selection of Klebsiella pneumoniae mutants with high-level cefotaxime resistance during growth in serum containing therapeutic concentrations of cefotaxime.
Topics: beta-Lactamases; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Culture Media; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutagenesis, Site-Directed; Mutation; Plasmids | 2002 |
Interaction of human organic anion transporters with various cephalosporin antibiotics.
Topics: Animals; Biological Transport; Cefadroxil; Cefotaxime; Ceftriaxone; Cell Line; Cephaloridine; Cephalosporins; Cephalothin; Estrone; Humans; Kinetics; Liver-Specific Organic Anion Transporter 1; Mice; Mice, Transgenic; Organic Anion Transport Protein 1; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Tritium | 2002 |
Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
Topics: Adolescent; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2002 |
Hajj-related Neisseria meningitidis serogroup w135 in Mauritius.
Topics: Adult; Cefotaxime; Cephalosporins; Child, Preschool; Disease Outbreaks; Fatal Outcome; Female; Humans; Infant; Male; Mauritius; Meningitis, Meningococcal; Middle Aged; Neisseria meningitidis; Serotyping; Travel | 2002 |
Parotitis caused by Salmonella choleraesuis varietas Kunzendorf.
Topics: Cefotaxime; Cephalosporins; Chronic Disease; Humans; Male; Middle Aged; Parotitis; Salmonella; Salmonella Infections; Suppuration | 2002 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17.
Topics: Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Conjugation, Genetic; DNA Transposable Elements; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Plasmids; Sequence Analysis, DNA | 2002 |
Eradication of endotracheal tube biofilm by nebulised gentamicin.
Topics: Administration, Inhalation; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Biofilms; Cefotaxime; Cefuroxime; Cephalosporins; Cross Infection; Female; Gentamicins; Humans; Infusions, Parenteral; Intubation, Intratracheal; Male; Middle Aged; Pneumonia, Bacterial; Statistics, Nonparametric | 2002 |
[Frontal headache and subacute fever in a previously healthy woman].
Topics: Adult; Cefotaxime; Cellulitis; Cephalosporins; Combined Modality Therapy; Disease Susceptibility; Exophthalmos; Female; Fever; Graves Disease; Headache; Humans; Ophthalmoplegia; Orbital Diseases; Sinusitis; Streptococcal Infections; Tomography, X-Ray Computed | 2002 |
CTX-M-14, a plasmid-mediated CTX-M type extended-spectrum beta-lactamase isolated from Escherichia coli.
Topics: Amino Acid Substitution; Aztreonam; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Escherichia coli; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Monobactams; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial; Taiwan | 2002 |
TEM-71, a novel plasmid-encoded, extended-spectrum beta-lactamase produced by a clinical isolate of Klebsiella pneumoniae.
Topics: Amino Acid Substitution; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; DNA, Bacterial; Isoelectric Focusing; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Substrate Specificity | 2002 |
Ceftriaxone and cefotaxime use in Victorian hospitals.
Topics: Bacterial Infections; Cefotaxime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Utilization Review; Guideline Adherence; Hospitals; Hospitals, Teaching; Humans; Logistic Models; Practice Guidelines as Topic; Victoria | 2002 |
Erythema migrans associated with intravenous cephalosporin therapy.
Topics: Adolescent; Adult; Blotting, Western; Cefotaxime; Cephalosporins; Erythema Chronicum Migrans; Female; Humans; Immunoglobulin G; Infusions, Intravenous; Lyme Disease; Male | 2002 |
Meningococcal disease presenting as bronchiolitis.
Topics: Bronchiolitis; Cefotaxime; Cephalosporins; Diagnosis, Differential; Humans; Infant; Male; Meningococcal Infections; Neisseria meningitidis; Penicillin G; Penicillins; Sepsis | 2002 |
Effect of penicillin resistance of Streptococcus pneumoniae on the presentation, prognosis, and treatment of pneumococcal endocarditis in adults.
Topics: Adult; Aged; Cefotaxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Endocarditis, Bacterial; Female; Heart Failure; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Penicillins; Pneumococcal Infections; Prognosis; Prospective Studies; Spain; Streptococcus pneumoniae; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Emergence of a novel penicillin-nonsusceptible, invasive serotype 35B clone of Streptococcus pneumoniae within the United States.
Topics: Adolescent; Adult; Alleles; Aminoacyltransferases; Bacterial Proteins; Carrier Proteins; Cefotaxime; Cephalosporins; Child; Communicable Diseases, Emerging; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Middle Aged; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumococcal Infections; Streptococcus pneumoniae; United States | 2002 |
Boosted IgE response after anaphylaxis reaction to cefuroxime with cross-reactivity with cefotaxime.
Topics: Anaphylaxis; Cefotaxime; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Male; Middle Aged | 2002 |
[Initial antibiotic therapy in maternal-fetal infections which include ampicillin even in countries where listeriosis is an incidental disease].
Topics: Adult; Amikacin; Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clinical Protocols; Fatal Outcome; Female; Humans; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Listeriosis; Male; Penicillins; Respiratory Distress Syndrome, Newborn | 2002 |
Cross-reactivity of cefotetan and ceftriaxone antibodies, associated with hemolytic anemia, with other: cephalosporins and penicillin.
Topics: Anemia, Hemolytic; Antibodies; Cefamandole; Cefoperazone; Cefotaxime; Cefotetan; Cefoxitin; Ceftriaxone; Cells, Cultured; Cephalosporins; Cephalothin; Cross Reactions; Humans; Models, Chemical; Penicillins | 2002 |
Citrobacter koseri pneumonia and meningitis in an infant.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Citrobacter koseri; Enterobacteriaceae Infections; Gentamicins; Humans; Infant, Newborn; Lung Abscess; Male; Meningitis, Bacterial; Pneumonia, Bacterial | 2002 |
In vitro and in vivo activities of newer fluoroquinolones against Vibrio vulnificus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Colony Count, Microbial; Fluoroquinolones; Mice; Microbial Sensitivity Tests; Minocycline; Survival Analysis; Time Factors; Vibrio Infections; Vibrio vulnificus | 2002 |
Determination of cefotaxime and desacetylcefotaxime in cerebrospinal fluid by solid-phase extraction and high-performance liquid chromatography.
Topics: Calibration; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Infant; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2002 |
[Using L-form bacterium ATP bioluminescence assay for rapid testing L-form bacterial susceptibility].
Topics: Adenosine Triphosphate; Cefotaxime; Cephalosporins; Humans; L Forms; Luminescent Measurements; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2001 |
[Purity analysis of cephalosporins with capillary zone electrophoresis].
Topics: Cefazolin; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Electrophoresis, Capillary | 1999 |
Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniae.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Reference Standards; Streptococcus pneumoniae | 2003 |
Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Erythromycin; Kinetics; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Time Factors | 2003 |
Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics.
Topics: Animals; Anti-Bacterial Agents; Biological Transport; Cefadroxil; Cefamandole; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cell Line; Cell Survival; Cephaloridine; Cephalosporins; Cephalothin; Dinoprost; Dose-Response Relationship, Drug; Humans; Kinetics; Mice; Mice, Transgenic; Organic Anion Transporters, Sodium-Independent; Probenecid; Rats; Transfection; Uricosuric Agents | 2003 |
[Treatment of penicillin-resistant pneumococcal infections in adults].
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Humans; Meningitis, Pneumococcal; Penicillin Resistance; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2003 |
Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut.
Topics: Bacterial Toxins; Cefotaxime; Cephalosporins; Clostridioides difficile; Colony Count, Microbial; Culture Media; Digestive System; Feces; Humans; Models, Biological; Spores, Bacterial | 2003 |
Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillin Resistance; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae | 2003 |
Haemophilus influenzae bla(ROB-1) mutations in hypermutagenic deltaampC Escherichia coli conferring resistance to cefotaxime and beta-lactamase inhibitors and increased susceptibility to cefaclor.
Topics: Amoxicillin-Potassium Clavulanate Combination; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Drug Therapy, Combination; Enzyme Inhibitors; Escherichia coli; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests; Mutation; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Effects of Ser130Gly and Asp240Lys substitutions in extended-spectrum beta-lactamase CTX-M-9.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hydrolysis; Kinetics; Models, Molecular; Molecular Conformation; Mutation; Plasmids | 2003 |
Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.
Topics: Amino Acid Sequence; beta-Lactamases; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacter cloacae; Hydrolysis; Kinetics; Models, Molecular; Protein Conformation; Protein Structure, Secondary; Substrate Specificity | 2004 |
Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America.
Topics: Cefotaxime; Cephalosporin Resistance; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Latin America; Microbial Sensitivity Tests; Penicillins; Ribotyping; Serotyping; Streptococcus pneumoniae | 2003 |
In vitro activities of piperacillin against beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.
Topics: Ampicillin Resistance; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Hexosyltransferases; Humans; Kinetics; Meningitis, Haemophilus; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin | 2004 |
Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae.
Topics: Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Data Interpretation, Statistical; Drug Utilization; Enterobacter cloacae; Enterobacteriaceae Infections; Hospitals, University; Humans; Microbial Sensitivity Tests; Spain | 2004 |
Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.
Topics: Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Clostridioides difficile; Diarrhea; Drug Prescriptions; Drug Resistance; Drug Utilization; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Public Policy; Retrospective Studies; United Kingdom | 2004 |
The glycopeptide vancomycin does not enhance toll-like receptor 2 (TLR2) activation by Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cell Wall; Cephalosporins; Genes, Reporter; HeLa Cells; Humans; Interleukin-8; Lactams; Lipopolysaccharide Receptors; Luciferases; Membrane Glycoproteins; Microbial Sensitivity Tests; Plasmids; Receptors, Cell Surface; Streptococcus pneumoniae; Toll-Like Receptor 2; Toll-Like Receptors; Transfection; Vancomycin | 2004 |
In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria.
Topics: Acinetobacter baumannii; Ampicillin; Anti-Bacterial Agents; Aztreonam; beta-Lactams; Cefepime; Cefoperazone; Cefotaxime; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enzyme Inhibitors; Gram-Negative Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serratia marcescens; Sulbactam | 2004 |
Antimicrobial susceptibility of respiratory Haemophilus influenzae strains isolated from pediatric respiratory tract infections.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Respiratory Tract Infections | 2004 |
Spectrophotometric determination of certain cephalosporins in pure form and in pharmaceutical formulations.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Chemistry, Pharmaceutical; Sensitivity and Specificity; Spectrophotometry | 2004 |
[Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].
Topics: Argentina; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Chromosomes, Bacterial; Genes, Bacterial; Genotype; Humans; Isoelectric Point; Microbial Sensitivity Tests; Phenotype; Proteus; Proteus Infections; Proteus mirabilis; Proteus penneri; Proteus vulgaris; Species Specificity | 2005 |
Acidity constants of cefetamet, cefotaxime and ceftriaxone; the effect of the substituent at C3 position.
Topics: Carbon; Carboxylic Acids; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chemistry, Pharmaceutical; Chemistry, Physical; Hydrogen-Ion Concentration; Ions; Kinetics; Models, Chemical; Models, Statistical; Molecular Conformation; Molecular Structure; Potentiometry; Protons; Stereoisomerism; Thiazoles; Triazines | 2005 |
Investigation of the mechanism of resistance to third-generation cephalosporins by class C beta-lactamases by using chemical complementation.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Crystallography, X-Ray; Directed Molecular Evolution; Drug Design; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mutation | 2005 |
Activity of CM-40874 against Enterobacter resistant to third generation cephalosporins.
Topics: Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1989 |
[Comparison of three microbiological methods for detection of expanded-spectrum betalactamases in Enterobacteriaceae isolated in Santa Fe (Argentina)].
Topics: Argentina; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Hydrolysis; Isoelectric Focusing; Microbial Sensitivity Tests; Monobactams; Polymerase Chain Reaction; Sensitivity and Specificity; Substrate Specificity | 2005 |
[Comparison of different phenotypic methods detecting extended spectrum beta-lactamases in Pseudomonas aeruginosa and Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Sensitivity and Specificity | 2005 |
Emergence of cefotaxime resistance in Citrobacter freundii causing necrotizing fasciitis and osteomyelitis.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Citrobacter freundii; Enterobacteriaceae Infections; Ertapenem; Fasciitis, Necrotizing; Female; Humans; Middle Aged; Osteomyelitis; Wounds and Injuries | 2006 |
[A rare aetiology of the post-partum fever: ovarian vein thrombophlebitis].
Topics: Abdominal Pain; Adult; Cefotaxime; Cephalosporins; Female; Fever; Humans; Ovarian Diseases; Ovary; Postpartum Period; Regional Blood Flow; Thrombophlebitis; Tomography, X-Ray Computed; Ultrasonography | 2006 |
Detection of a novel variant bla(CTX-M-3) extended spectrum beta-lactamase gene in a community-acquired Escherichia coli isolate.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Child, Preschool; Community-Acquired Infections; Escherichia coli; Escherichia coli Infections; Female; Genetic Variation; Greece; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Urinary Tract Infections | 2006 |
[High effectiveness of the method with cefpirome in detection of extended-spectrum beta-lactamases in different species of gram-negative bacilli].
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cefpirome; Cephalosporins; Clavulanic Acid; Gram-Negative Bacteria; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Species Specificity | 2006 |
CTX-M-1- and CTX-M-15-type beta-lactamases in clinical Escherichia coli isolates recovered from food-producing animals in France.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cattle; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Deoxyribonuclease EcoRI; Deoxyribonucleases, Type II Site-Specific; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; France; Microbial Sensitivity Tests; Plasmids; Poultry; Swine | 2006 |
Serotype distribution and antimicrobial susceptibility of S. pneumoniae causing invasive disease in Thai children younger than 5 years old, 2000-2005.
Topics: Cefotaxime; Cephalosporins; Child, Preschool; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Serotyping; Streptococcus pneumoniae; Thailand | 2007 |
A comparative study of capillary zone electrophoresis and pH-potentiometry for determination of dissociation constants.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefoperazone; Cefotaxime; Cefoxitin; Cephalexin; Cephalosporins; Electrophoresis, Capillary; Hydrogen-Ion Concentration; Kinetics; Molecular Structure; Potentiometry | 2007 |
One year trends in the gram-negative bacterial antibiotic susceptibility patterns in a medical intensive care unit in South India.
Topics: Carbapenems; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; India; Intensive Care Units; Microbial Sensitivity Tests | 2007 |
Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Topics: Amoxicillin; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae | 2008 |
Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity.
Topics: Anti-Bacterial Agents; Cefdinir; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
First molecular characterization of group B streptococci with reduced penicillin susceptibility.
Topics: Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; Blotting, Western; Cefepime; Cefotaxime; Ceftizoxime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Sequence Data; Oxacillin; Penicillin Resistance; Penicillin-Binding Proteins; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Streptococcal Infections; Streptococcus agalactiae | 2008 |
In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftaroline; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae | 2008 |
Inhibitory effects of Cefazolin and Cefodizime on the activity of mushroom tyrosinase.
Topics: Agaricales; Cefazolin; Cefotaxime; Cephalosporins; Enzyme Inhibitors; Fungal Proteins; Inhibitory Concentration 50; Kinetics; Monophenol Monooxygenase | 2009 |
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Australia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Dose-Response Relationship, Drug; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pacific Islands; Treatment Failure; World Health Organization | 2009 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
Emergence of extended-spectrum beta-lactamase PER-1 in Proteus vulgaris and Providencia stuartii isolates from Algiers, Algeria.
Topics: Algeria; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Imipenem; Microbial Sensitivity Tests; Piperacillin; Polymerase Chain Reaction; Proteus vulgaris; Providencia | 2009 |
New variant of CTX-M-type extended-spectrum beta-lactamases, CTX-M-71, with a Gly238Cys substitution in a Klebsiella pneumoniae isolate from Bulgaria.
Topics: Anti-Bacterial Agents; beta-Lactamases; Bulgaria; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data | 2009 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2009 |
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone.
Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature | 2009 |
Ceftazidime: comparative in-vitro study.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbenicillin; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1981 |
Microemulsion and mixed micelle for oral administration as new drug formulations for highly hydrophilic drugs.
Topics: Administration, Oral; Animals; Biological Availability; Cefotaxime; Cefpirome; Cephalosporins; Drug Carriers; Drug Compounding; Emulsions; Female; Intestinal Absorption; Micelles; Rabbits | 2010 |
Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Sensitivity and Specificity | 2009 |
Occurrence of ST23 complex phylogroup A Escherichia coli isolates producing extended-spectrum AmpC beta-lactamase in a French hospital.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; France; Hospitalization; Humans; Molecular Sequence Data; Mutation; Phylogeny; Promoter Regions, Genetic | 2010 |
Affinity of ceftaroline and other beta-lactams for penicillin-binding proteins from Staphylococcus aureus and Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefotaxime; Ceftaroline; Cephalosporins; Drug Resistance, Microbial; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae | 2010 |
[Analysis of multiple cephalosporins in blood and urine by HPLC].
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Cefoperazone; Cefotaxime; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Forensic Toxicology; Humans; Male; Sensitivity and Specificity; Specimen Handling | 2009 |
Structural insights into substrate recognition and product expulsion in CTX-M enzymes.
Topics: Anti-Bacterial Agents; beta-Lactamases; Catalytic Domain; Cefotaxime; Cephalosporins; Crystallography, X-Ray; Molecular Dynamics Simulation; Molecular Sequence Data; Molecular Structure; Protein Structure, Tertiary; X-Ray Diffraction | 2010 |
Study on the binding behavior of bovine serum albumin with cephalosporin analogues by chemiluminescence method.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefaclor; Cefadroxil; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Luminescence; Luminescent Measurements; Phthalic Acids; Serum Albumin, Bovine; Thermodynamics; Tryptophan | 2010 |
Extended-spectrum beta-lactamase-mediated resistance among bacterial isolates recovered from ocular infections.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Resistance, Multiple, Bacterial; Eye Infections, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Prospective Studies | 2012 |
Effect of spacer sequences between bla(CTX-M) and ISEcp1 on bla(CTX-M) expression.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Cephalosporin Resistance; Cephalosporins; DNA Transposable Elements; DNA, Intergenic; Gene Expression; Klebsiella pneumoniae; Plasmids; Promoter Regions, Genetic; RNA, Bacterial; RNA, Messenger | 2011 |
Faecal shedding of CTX-M-producing Escherichia coli in horses receiving broad-spectrum antimicrobial prophylaxis after hospital admission.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactamases; Cefotaxime; Cephalosporins; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Escherichia coli Proteins; Feces; Female; Horses; Longitudinal Studies; Male; Polymerase Chain Reaction | 2012 |
BioDMET: a physiologically based pharmacokinetic simulation tool for assessing proposed solutions to complex biological problems.
Topics: Algorithms; Animal Structures; Animals; Biological Transport; Biotransformation; Body Fluids; Cefotaxime; Cefpirome; Cephalosporins; Computer Simulation; Contrast Media; Databases, Factual; Eukaryotic Cells; Guinea Pigs; Haplorhini; Humans; Internet; Iohexol; Mice; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Reproducibility of Results; Software; Tissue Distribution; User-Computer Interface | 2012 |
Chromosome-encoded extended-spectrum class A β-lactamase MIN-1 from Minibacterium massiliensis.
Topics: beta-Lactamases; Cefepime; Cefotaxime; Cephalosporins; Chromosomes, Bacterial; Gram-Positive Bacteria; Molecular Sequence Data; Penicillins | 2012 |
Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Topics: Automation, Laboratory; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Diagnostic Errors; DNA, Bacterial; Escherichia coli; Genotype; Hospitals; Humans; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan:
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Intensive Care Units; Microbial Sensitivity Tests; Taiwan | 2015 |
National prevalence of resistance to third-generation cephalosporins in Escherichia coli isolates from layer flocks in France.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Chickens; Escherichia coli; Feces; France; Microbial Sensitivity Tests | 2013 |
Maternal carriage of extended-spectrum beta-lactamase-producing Escherichia coli isolates in Argentina.
Topics: Anti-Bacterial Agents; Argentina; beta-Lactamases; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Gestational Age; Humans; Maternal Exposure; Microbial Sensitivity Tests; Pregnancy; Prevalence; Vagina | 2013 |
Resistance to third-generation cephalosporins in human non-typhoidal Salmonella enterica isolates from England and Wales, 2010-12.
Topics: Alleles; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; DNA, Bacterial; England; Humans; Microbial Sensitivity Tests; Prevalence; Salmonella enterica; Salmonella Infections; Salmonella Infections, Animal; Sequence Analysis, DNA; Wales | 2014 |
Methodological agreement on the in vitro activity of ceftaroline against cefotaxime-susceptible and -resistant pneumococci.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Cefotaxime; Ceftaroline; Cephalosporins; Humans; Microbial Sensitivity Tests; Serotyping; Streptococcus pneumoniae | 2014 |
Comparative evaluation of six phenotypic methods for detecting extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Enterobacteriaceae; False Negative Reactions; False Positive Reactions; Female; Humans; India; Male; Microbial Sensitivity Tests; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Predictive Value of Tests | 2014 |
Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium.
Topics: Aryldialkylphosphatase; Cefepime; Cefotaxime; Ceftizoxime; Cephalosporins; Fluoroquinolones; Humans; In Vitro Techniques; Levofloxacin; Moxifloxacin | 2015 |
Prevalence and distribution of beta-lactamase coding genes in third-generation cephalosporin-resistant Enterobacteriaceae from bloodstream infections in Cambodia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Cambodia; Cefotaxime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multiplex Polymerase Chain Reaction; Prevalence; Prospective Studies; Sequence Analysis, DNA; Young Adult | 2015 |
Filtering with Electric Field: The Case of E. coli Porins.
Topics: Anti-Bacterial Agents; Cefepime; Cefotaxime; Cephalosporins; Electricity; Escherichia coli; Molecular Dynamics Simulation; Porins; Protein Structure, Tertiary; Thermodynamics; Water | 2015 |
Inhibitory effects of cefotaxime on the activity of mushroom tyrosinase.
Topics: Agaricales; Anti-Bacterial Agents; Biocatalysis; Catalytic Domain; Cefotaxime; Cephalosporins; Drug Design; Enzyme Inhibitors; Fluorescence; Inhibitory Concentration 50; Kinetics; Molecular Docking Simulation; Monophenol Monooxygenase; Oxidation-Reduction; Oxidoreductases; Tyrosine | 2016 |
[Rapid detection of extended-spectrum beta-lactamases by flow cytometry method].
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporins; Clavulanic Acid; Drug Combinations; Enterobacteriaceae; Flow Cytometry; Humans | 2015 |
Acquisition of Broad-Spectrum Cephalosporin Resistance Leading to Colistin Resistance in Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Colistin; Drug Resistance, Bacterial; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2016 |
[Cerebellar syndrome induced by metronidazole: a rare side effect].
Topics: Anti-Bacterial Agents; Brain Abscess; Cefotaxime; Cephalosporins; Cerebellar Ataxia; Diagnosis, Differential; Diverticulitis; Drug Therapy, Combination; Dysarthria; Humans; Linezolid; Liver Abscess; Lung Abscess; Magnetic Resonance Angiography; Male; Metronidazole; Middle Aged; Paraneoplastic Syndromes; Vasculitis | 2016 |
Previous Antibiotic Exposure Increases Risk of Infection with Extended-Spectrum-β-Lactamase- and AmpC-Producing Escherichia coli and Klebsiella pneumoniae in Pediatric Patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prospective Studies; Young Adult | 2016 |
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.
Topics: Abiotrophia; Anti-Infective Agents; Carnobacteriaceae; Cefepime; Cefotaxime; Cephalosporins; Clindamycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Vancomycin | 2016 |
Simultaneous Determination of Eight β-Lactam Antibiotics, Amoxicillin, Cefazolin, Cefepime, Cefotaxime, Ceftazidime, Cloxacillin, Oxacillin, and Piperacillin, in Human Plasma by Using Ultra-High-Performance Liquid Chromatography with Ultraviolet Detection
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefazolin; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, High Pressure Liquid; Cloxacillin; Drug Monitoring; Humans; Oxacillin; Piperacillin; Ultraviolet Rays | 2016 |
ESBL Detection: Comparison of a Commercially Available Chromogenic Test for Third Generation Cephalosporine Resistance and Automated Susceptibility Testing in Enterobactericeae.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella; Microbial Sensitivity Tests; Molecular Biology; Species Specificity; Swine | 2016 |
Crystal structure of EstSRT1, a family VIII carboxylesterase displaying hydrolytic activity toward oxyimino cephalosporins.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Carboxylic Ester Hydrolases; Catalytic Domain; Cefepime; Cefotaxime; Cephalosporins; Cloning, Molecular; Crystallography, X-Ray; Escherichia coli; Gene Expression; Hydrolysis; Isoenzymes; Models, Molecular; Protein Interaction Domains and Motifs; Protein Structure, Secondary; Recombinant Proteins; Sequence Alignment; Structural Homology, Protein | 2016 |
[An analysis of 181 cases with blood stream infection caused by Streptococcus agalactiae in children from 2011 to 2015: a multi-center retrospective study].
Topics: Anti-Bacterial Agents; Bacteremia; Cefotaxime; Ceftriaxone; Cephalosporins; Child; China; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Infant, Newborn; Male; Meningitis, Bacterial; Penicillins; Retrospective Studies; Streptococcal Infections; Streptococcus agalactiae | 2016 |
Performance of a novel fluorogenic chimeric analog for the detection of third-generation cephalosporin resistant bacteria.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Fluorescent Dyes; Microbial Sensitivity Tests; Phenolsulfonphthalein; Plasmids; Sensitivity and Specificity | 2016 |
The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Population Surveillance; Taiwan; Urine; Young Adult | 2016 |
Rapid EUCAST disc diffusion testing of MDR Escherichia coli and Klebsiella pneumoniae: inhibition zones for extended-spectrum cephalosporins can be reliably read after 6 h of incubation.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefotaxime; Cephalosporins; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Reagent Kits, Diagnostic; Reproducibility of Results; Time Factors | 2017 |
Evaluation of the relationship between the minimum inhibitory concentration of ceftiofur and third-generation cephalosporins in Escherichia coli isolates from food-producing animals.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefotaxime; Cefpodoxime; Ceftazidime; Ceftizoxime; Cephalosporins; Chickens; Escherichia coli; Female; Microbial Sensitivity Tests; Sus scrofa | 2017 |
Prevalence and Transmission of Antimicrobial Resistance in a Vertically Integrated Veal Calf Production System.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Cattle; Cefepime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Feces; Food Contamination; Food Microbiology; Food Supply; Foodborne Diseases; Genes, Bacterial; Male; Prospective Studies; Red Meat; United States | 2017 |
Cephalosporin-resistant Escherichia coli isolated from farm workers and pigs in northern Vietnam.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Cephalosporins; Disease Reservoirs; Escherichia coli; Escherichia coli Infections; Farmers; Farms; Humans; Livestock; Microbial Sensitivity Tests; Occupational Exposure; Phenotype; Polymerase Chain Reaction; Surveys and Questionnaires; Swine; Zoonoses | 2018 |
Invasive pneumococcal disease in Indian adults: 11 years' experience.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Comorbidity; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Humans; India; Male; Meningitis; Microbial Sensitivity Tests; Middle Aged; Mortality; Penicillin Resistance; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; Pneumonia; Prevalence; Prospective Studies; Serogroup; Streptococcus pneumoniae; Vaccines, Conjugate; Vancomycin; Young Adult | 2019 |
Co-harboring of cephalosporin (bla)/colistin (mcr) resistance genes among Enterobacteriaceae from flies in Thailand.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cephalosporins; Colistin; Diptera; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Microbial Sensitivity Tests; Thailand | 2018 |
The biodegradation of cefuroxime, cefotaxime and cefpirome by the synthetic consortium with probiotic Bacillus clausii and investigation of their potential biodegradation pathways.
Topics: Anti-Bacterial Agents; Bacillus clausii; Biodegradation, Environmental; Cefotaxime; Cefpirome; Cefuroxime; Cephalosporins; Probiotics; Waste Disposal, Fluid | 2019 |
The esterase B from Sphingobium sp. SM42 has the new de-arenethiolase activity against cephalosporin antibiotics.
Topics: Bacterial Proteins; Bacteroidetes; Cefotaxime; Ceftriaxone; Cephalosporins; Serine Endopeptidases; Sphingobacterium; Substrate Specificity | 2018 |
Differential active site requirements for NDM-1 β-lactamase hydrolysis of carbapenem versus penicillin and cephalosporin antibiotics.
Topics: Ampicillin; beta-Lactamases; Carbapenems; Catalytic Domain; Cefotaxime; Cephalosporins; Codon; Drug Resistance, Bacterial; Escherichia coli; High-Throughput Nucleotide Sequencing; Imipenem; Mutation; Penicillins | 2018 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Evolution of TEM-type extended-spectrum β-lactamases in Escherichia coli by cephalosporins.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple, Bacterial; Escherichia coli; Evolution, Molecular; Humans; Microbial Sensitivity Tests; Mutation; Sequence Analysis, DNA | 2019 |
Structural Insights into Catalytic Relevances of Substrate Poses in ACC-1.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Proteins; beta-Lactamases; Catalysis; Cefotaxime; Cefoxitin; Cephalosporins; Microbial Sensitivity Tests; Nitrogen; Plasmids | 2019 |
Biosynthetic Incorporation of Site-Specific Isotopes in β-Lactam Antibiotics Enables Biophysical Studies.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Binding Sites; Carbon Isotopes; Cefotaxime; Cephalosporins; Drug Discovery; Drug Resistance, Microbial; Penicillin G; Penicillium; Protein Conformation | 2020 |
BaeR participates in cephalosporins susceptibility by regulating the expression level of outer membrane proteins in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Hydrolases; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Porins; Trans-Activators | 2021 |
Neo-antigens for the serological diagnosis of IgE-mediated drug allergic reactions to antibiotics cephalosporin, carbapenem and monobactam.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactams; Carbapenems; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Humans; Immunoglobulin E; Immunoglobulin G; Meropenem; Monobactams; Penicillins; Skin Tests | 2020 |
TAK1 Mediates ROS Generation Triggered by the Specific Cephalosporins through Noncanonical Mechanisms.
Topics: Animals; Anti-Bacterial Agents; Blotting, Western; Cefotaxime; Cell Survival; Cephalosporins; Macrophages; MAP Kinase Kinase Kinase 5; MAP Kinase Kinase Kinases; Membrane Potential, Mitochondrial; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Oxidative Stress; RAW 264.7 Cells; Reactive Oxygen Species; Signal Transduction | 2020 |
Predicting Oral Beta-lactam susceptibilities against Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillins; Pneumonia, Pneumococcal; Streptococcus pneumoniae | 2021 |
Molecular epidemiology of cefotaxime-resistant but ceftazidime-susceptible Enterobacterales and evaluation of the in vitro bactericidal activity of ceftazidime and cefepime.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Enterobacteriaceae; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Proteus mirabilis | 2021 |
Detection of expanded-spectrum cephalosporin hydrolysis by lateral flow immunoassay.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Hydrolysis; Immunoassay; Microbial Sensitivity Tests | 2022 |
Cefotaxime-induced drug reaction with eosinophilia and systemic symptom in a child with cross-reactivity to other cephalosporins and cosensitization to teicoplanin.
Topics: Adult; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Hypersensitivity Syndrome; Eosinophilia; Humans; Male; Metronidazole; Teicoplanin; Vancomycin | 2023 |
Treatment options for neonatal infections in the post-cefotaxime era.
Topics: Ampicillin; Anti-Bacterial Agents; Calcium; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Communicable Diseases; Gentamicins; Humans; Infant, Newborn; Infant, Newborn, Diseases; Microbial Sensitivity Tests | 2022 |
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefotaxime; Cephalosporins; COVID-19 Drug Treatment; Drug Resistance, Bacterial; Erythromycin; Humans; Pandemics; Penicillins; Pneumococcal Infections; Pneumococcal Vaccines; SARS-CoV-2; Serogroup; Spain; Streptococcus pneumoniae; Vaccines, Conjugate | 2022 |
Cephalosporin as Potent Urease and Tyrosinase Inhibitor: Exploration through Enzyme Inhibition, Kinetic Mechanism, and Molecular Docking Studies.
Topics: Cefotaxime; Ceftriaxone; Cephalosporins; Kinetics; Molecular Docking Simulation; Monophenol Monooxygenase; Urease | 2022 |
Epidemiology and infection control of Methicillin-resistant Staphylococcus aureus in a German tertiary neonatal intensive and intermediate care unit: A retrospective study (2013-2020).
Topics: Cefotaxime; Cephalosporins; Cross Infection; Humans; Infant; Infant, Newborn; Infection Control; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Staphylococcal Infections | 2022 |
Cephalosporin translocation across enterobacterial OmpF and OmpC channels, a filter across the outer membrane.
Topics: Cefepime; Cefotaxime; Ceftazidime; Cephalosporins; Chromatography, Liquid; Enterobacteriaceae; Escherichia coli; Lipid Bilayers; Monobactams; Porins; Tandem Mass Spectrometry | 2022 |
Penicillin- and Cephalosporin-Resistant Pneumococcal Meningitis: Treatment in the Real World and in Guidelines.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Cohort Studies; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Mitomycin; Monobactams; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 2022 |
Mapping the determinants of catalysis and substrate specificity of the antibiotic resistance enzyme CTX-M β-lactamase.
Topics: beta-Lactamases; Catalysis; Cefotaxime; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Escherichia coli; Monobactams; Substrate Specificity | 2023 |
Antimicrobial resistance in
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Japan; Microbial Sensitivity Tests; Monobactams; Raccoon Dogs | 2022 |
Prevalence of extended spectrum beta lactamase and molecular detection of blaTEM, blaSHV and blaCTX-M genotypes among Gram negative bacilli isolates from pediatric patient population in Gaza strip.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Ceftazidime; Ceftriaxone; Cephalosporins; Child; Escherichia coli; Genotype; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Prevalence | 2023 |
Empirical Treatment in Acute Bacterial Meningitis: a Plea for High Doses of Cefotaxime or Ceftriaxone.
Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Humans; Meningitis; Meningitis, Bacterial; Meningitis, Pneumococcal; Microbial Sensitivity Tests | 2023 |